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Polybrominated diphenyl ethers (PBDEs) are flame retardants (FRs) used as additives against 
fire ignition accidents, present in everyday consumer products including carpets, electronic 
appliances, clothing and textiles, thermal insulation and cable coatings. PBDE continuous and 
excessive use in consumer products, has raised concerns regarding their potential adverse 
health effects including endocrine and thyroid disruption and neurodevelopmental disorders 
in children. Hence, legislative restrictions on the production and use of PBDEs in the global 
market have been imposed by the competent authorities. However, limited data exist on the 
fate, environmental levels and potential effects on human health of PBDE alternatives such as 
emerging halogenated FRs (EHFRs), phthalate esters (PEs), non-halogenated phosphorous 
FRs (PFRs) and alternative plasticisers. Oral bioaccessibility (i.e. uptake) studies have been 
widely used as a research tool to determine the potential human exposure to ingested 
contaminants via solid matrices such as indoor dust. Colon Extended ­ Physiologically Based 
Extraction Test (CE-PBET) is a well-established bioaccessibility protocol specifically 
developed for the testing of organic compounds, rich in dietary components which act as a 
“biological sink” for organic pollutants, enhancing thus the sorption capacity of the system. 
Also, strong adsorbents such as Tenax TA®, silicone-activated contaminant traps, 
cyclodextrins and silicone rods have also been proposed as “absorption sink” materials. 
Taken all together, the aim of the PhD studies presented here is two-fold: a) to assess human 
exposure to legacy and alternatives FRs via indoor dust ingestion and inhalation and b) to 
develop a robust and unified oral bioaccessibilty method with the inclusion of Tenax TA® as 
a non-biologically active “infinite sink” to the previously established CE-PBET model.  
Regarding the in vitro gut bioaccessibility, a novel physical separation of the incubated dust 
with the Tenax TA was successful by employing a regenerated cellulose (RC) dialysis 
membrane method. The newly developed system was optimised for Tenax TA® bead loading 
(i.e. 0.25, 0.5 or 0.75g) and allowed sorption to be studied in the stomach, small intestine and 
colon compartments. Our results show that sorption on Tenax TA® in the stomach was 43.7% 
and 25.6% for BDE28 and BDE47 respectively, unlike in the colon compartment which was 
nearly 50% for BDE154 and BDE183. With Tenax TA® inclusion, gut bioaccessibility 
reached 40% for BDE153 and BDE183, with greater increases seen for less hydrophobic FRs 
such as BDE28 and BDE47 (60.6%). The combination of Tenax TA® as an infinite sink 
together with the lipid-rich colon compartment of CE-PBET act as a substantial advance 
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towards a cost-effective and more realistic estimates of FR uptake via the gut and can liaise 
regulators to redefine human exposure estimates.  
We also investigated the presence of PBDEs and alternative FRs such as emerging 
halogenated FRs (EHFRs) and organophosphate flame retardants (PFRs) in indoor dust 
samples from British and Norwegian houses as well as British stores and offices. BDE209 
was the most abundant PBDE congener with median concentrations of 4,700 ng g-1 and 3,400 
ng g-1 in UK occupational and house dust, respectively, 30 and 20 fold higher than in 
Norwegian house dust. Monomeric PFRs (m-PFRs), including triphenyl phosphate (TPHP), 
tris(chloropropyl) phosphate (TCPP) and tris(2-chloroethyl) phosphate (TCEP) dominated all 
the studied environments. This is the first report of isodecyldiphenyl phosphate (iDPP) and 
trixylenyl phosphate (TXP) in indoor environments. iDPP was the most abundant oligomeric 
PFR (o-PFR) in all dust samples, with median concentrations one order of magnitude higher 
than TXP and bisphenol A bis(diphenyl phosphate (BDP). iDPP and TXP worst-case 
scenario exposures for British workers during an 8h exposure in the occupational 
environment were equal to 34 and 1.4 ng kg bw-1 day-1, respectively considerably below the 
proposed reference values.  
With respect to inhalation as an alternative route of exposure, this is the first study assessing 
the in vitro pulmonary uptake of established PEs including dimethyl phthalate (DMP), diethyl 
phthalate (DEP) and di-(2-ethylhexyl) phthalate (DEHP) and alternative plasticisers used as 
phthalate substitutes such as bis(2-ethylhexyl) terephthalate (DEHT) and cyclohexane-1,2-
dicarboxylic acid diisononyl ester (DINCH) present in indoor dust. Two artificial lung fluids, 
mimicking two distinctively different interstitial conditions were used, namely artificial 
lysosomal fluid (ALF, pH=4.5) representing the fluid that inhaled particles would contact 
after phagocytosis by alveolar and interstitial macrophages within the lung and Gamble’s 
solution (GMB, pH=7.4) as a fluid for deep lung deposition of dust within the interstitial fluid 
of the lung. Our results suggest that low molecular weight (MW) and short-chained 
phthalates such as DMP and DEP are highly bioaccessible (>75%) in both artificial 
pulmonary media tested, whereas high MW compounds such as DEHP, DINCH and DEHT 
were <5% bioaccessible. Such findings confirm the hypothesis of hydrophobicity and water 
solubility primarily influencing inhalation bioaccessibility of organic pollutants.  
Finally, human exposure to alternative FRs is expected to increase in the future, hence 
continuous monitoring is required. The in vitro bioaccessibility methods presented in this 
thesis can thus form the foundation upon which an integrated and robust testing strategy for 





















Literature review was based on “Towards a unified approach for the determination of the 
bioaccessibility of organic pollutants”  
Collins, C.D., Craggs, M., Garcia-Alcega, S., Kademoglou, K., Lowe, S., 2015. Environ. Int. 
78, 24–31. doi:10.1016/j.envint.2015.02.005 
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1. Introduction  
1.1 Emerging flame retardants 
Flame retardants (FRs) are widely used in everyday consumer products including carpets, 
electronic appliances, clothing and textiles, thermal insulation and cable coatings. Since the 
1970s, polybrominated diphenyl ethers (PBDEs) have been widely used in consumer 
products as FRs (Alaee et al., 2003). Various human health effects are associated with PBDE 
exposure such as disruption of the endocrine and thyroid homeostasis (Legler and Brouwer, 
2003) and impaired neurodevelopmental growth of children (Costa and Giordano, 2007). The 
commercial mixtures Penta-BDE and Octa-BDE have been listed as persistent organic 
pollutants (POPs) for elimination under the Stockholm Convention (Stockholm Convention, 
2009a, 2009b), while the Deca-BDE mixture is currently under review. The use of Deca-BDE 
was banned in Norway in 2008 (EBFRIP, 2008), while it was included by the EU in the 
amended Annex XVII of REACH (EC No 1907/2006), banning its production, use and 
marketing in the EU (European Commission, 2016). As a result of the REACH amendment, 
furniture and fire safety regulations in the UK are currently under review by the national 
competent authorities (UK Department for Business, Energy & Industrial Strategy, 2016). 
Due to legislative restrictions on their commercial use, PBDEs have been replaced with 
alternatives, known as “emerging” halogenated flame retardants (EHFRs) including 2-
ethylhexyl-2,3,4,5-tetrabromobenzoate (EH-TBB; Penta-BDE replacement), bis(2-
ethylhexyl)-3,4,5,6-tetrabromophthalate (BEH-TEBP; Penta-BDE replacement), 1,2-
bis(2,4,6-tribromophenoxy) ethane (BTBPE; Octa-BDE replacement), decabromodiphenyl 
ethane (DBDPE; Deca-BDE replacement) and Dechlorane Plus (DPs; Deca-BDE 
replacement) (Stapleton et al., 2008; Wang et al., 2011) and organophosphate flame 
retardants (PFRs) such as tris(2-chloroethyl) phosphate (TCEP) and 
tris(chloropropyl)phosphate (TCPP) (van der Veen and de Boer, 2012a).  
Several studies have indicated that also EHFRs and PFRs may pose potential risks to humans.  
EH-TBB and BEH-TEBP, major components in the commercial product Firemaster 550®, 
have been proven to act as endocrine disruptors and obesogens when orally administered to 
rats (Patisaul et al., 2013) and can bind and activate the transcription of peroxisome 
proliferator-activated receptor γ (PPAR γ) ligands, while triphenyl phosphate (TPHP)-
18 
 
induced in vitro adipocyte differentiation and diverted osteogenic differentiation towards 
lipid accumulation has been reported (Pillai et al., 2014). DPs, EH-TBB, BEH-TEBP and 
PFRs, such as TCEP and tris(1,3-dichloro-2-propyl) phosphate (TDCIPP) have been detected 
in human breast milk and blood in Asian populations (Ben et al., 2013; Kim et al., 2014), as 
well as in blood, hair and nails in USA residents (Liu et al., 2016). TDCIPP has been linked 
with reduction in free thyroxine and increase in prolactin secretion in US men, while TPHP 
was associated with weakening sperm quality (Meeker and Stapleton, 2010). An in vitro 
estrogenic and anti-androgenic potency of TDCIPP, tris(2-butoxyethyl) phosphate (TBOEP), 
and TPHP on human osteosarcoma (U2OS) cell line exposed to indoor dust extracts has also 
been reported (Suzuki et al., 2013). In the EU, restrictions on the use of chlorinated PFRs, 
such as TDCIPP and TCPP, have been issued based on toxicological concerns related to their 
carcinogenic potency (ECHA, 2008a, 2008b). 
Monomeric PFR (m-PFRs), including TDCIPP, TCPP and TCEP, are routinely used as FRs 
in flexible polyurethane foams (PUFs) and textiles (Ali et al., 2012; Cao et al., 2014b). TPHP 
can be used as a plasticiser and a FR in PVC, thermoplastics and synthetic polymers, while 
TBOEP is exclusively used as a plasticiser in floor polish and rubber products (Marklund et 
al., 2003; Stapleton et al., 2009; van der Veen and de Boer, 2012a). The use of EHFRs and 
m-PFRs in consumer products has thus increased and this is reflected by their high abundance 
in indoor dust in the UK (Brommer and Harrad, 2015), China (Cao et al., 2014a), Japan 
(Tajima et al., 2014), Sweden (Newton et al., 2015) and Norway (Cequier et al., 2014). PFRs 
such as TCPP, TCEP and TBOEP dominate house, office and hotel environments, with levels 
in hotel dust six fold higher than office dust from China (Cao et al., 2014b). A few studies 
have reported oligomeric PFRs (o-PFRs) in considerable amounts in dust, such as tetraekis(2-
chlorethyl)-dichloroisopentyl diphosphate (V6), an alternative of Penta-BDE, TCPP and 
TDCIPP (ECHA, 2008c), along with resorcinol bis(diphenyl phosphate (RDP) and bisphenol 
A bis(diphenyl phosphate (BDP) as Deca-BDE alternatives in electronic and plastic 
consumer products (Ballesteros-Gómez et al., 2014; Brandsma et al., 2013; Matsukami et al., 
2015). Since house dust acts as a repository sink for EHFRs and PFRs, dust originating from 
indoor environments (e.g. houses, offices, stores) is considered as a major source of human 
exposure to FRs (Alves et al., 2014; Jones-Otazo et al., 2005).  
In April 2016, the Washington State House Bill 2545 (Toxic-free Kids and Families Act) was 
approved to ban children’s products and residential upholstered furniture from the market 
containing more than 0.1% of TCEP, TDCIPP, Deca-BDE, hexabromocyclododecane 
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(HBCD) and tetrabromobisphenol A (TBBPA) with an effective date set for June 2016. 
Additional six FRs, including TPHP, TCPP, V6, EH-TBB, BEH-TEBP, and isopropylated 
triphenyl phosphate (IPTPHP) will be evaluated and recommended to the Legislature for 
possible restriction in consumer products (State of Washington, 2016). The implementation 
of this bill may potentially trigger the phasing out PBDE alternatives, thus initiate the 
development and use of newer FRs. Therefore, the continuous and rigorous assessment of 
legacy and alternative FRs in the indoor environment is essential due to their potential 
adverse effects on human health.  
1.2 Plasticisers  
Phthalate esters (PEs) are widely used as plasticiser additives enhancing the durability, 
elasticity and flexibility of polymeric products (Wilkes et al., 2005). The ubiquitous nature of 
plasticisers and their lack of migration stability allows them to be distributed throughout the 
indoor environment, leading to their classification as major indoor organic contaminants 
(Zhang and Smith, 2003). Due to limited toxicological information available and their 
“pseudo-persistent” environmental fate and behaviour, alternative plasticisers presented in 
this thesis are categorised together with PEs into two groups with respect to their molecular 
weight (MW) and application in consumer products (Bui et al., 2016). Low MW phthalates, 
such as dimethyl phthalate (DMP) and diethyl phthalate (DEP), are typically added as 
chemical stabilisers during the manufacture of personal care products, solvents, air refreshers, 
pharmaceutical coatings and as colouring or fragrance additives (Hauser et al., 2004; Heudorf 
et al., 2007). High MW phthalates, such as di-(2-ethylhexyl) phthalate (DEHP), benzylbutyl 
phthalate (BBzP) and di-iso-nonyl phthalate (DiNP), are primarily used in polyvinyl chloride 
(PVC) production with main applications in floor polishing and wall coatings, PVC tubing, 
children toys, medical products (e.g. blood preservation flasks) and food packaging materials 
(Dodson et al., 2015). High phthalate levels have been reported in indoor dust from houses 
and day-care centres in Denmark (Langer et al., 2010), (Bekö et al., 2013), Sweden (Luongo 
and Östman, 2016), Germany (Fromme et al., 2013), Kuwait (Gevao et al., 2013) and the 
USA (Dodson et al., 2015). Within the EU legislative framework, the use of DEHP, 
diisobutyl phthalate (DiBP), di-n-butyl phthalate (DnBP) and BBzP have been partly 
restricted in children’s toys and cosmetic products to 0.1% by weight (EU Directives 
2005/84/EC; 2004/93/EC), leading to increasing use of alternative plasticisers such as bis(2-
ethylhexyl) terephthalate (DEHT) and cyclohexane-1,2-dicarboxylic acid diisononyl ester 
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(DINCH) as substitutes for traditional phthalates in PVC materials (Bui et al., 2016; Correia-
Sá et al., 2017).  
Apart from indoor dust ingestion acting as an important route of human exposure to PEs 
(Alves et al., 2014), alternative routes such as inhalation and dermal uptake have may have 
substantial contribution to human exposure (Bekö et al., 2013; Xie et al., 2016).  Due to their 
physicochemical properties, phthalate esters and alternative plasticisers tend to volatilise and 
partition from the gas phase as aerosols and following sorption processes, they are absorbed 
onto dust particles (settled or floor) (Bui et al., 2016; Weschler et al., 2008). Phthalates bound 
onto the dust particles can be inhaled, following desorption which can occur in the pulmonary 
environment - analogous to orally ingested dust particles in the gastrointestinal fluids with 
desorption releasing organic contaminants that can pass to the systemic circulation (Collins et 
al., 2015). According to (Wormuth et al., 2006) human exposure to phthalates varies with 
respect to age; DMP inhalation exposure is nearly 100% for infants, toddlers and younger 
children and 70-90% for teenagers and adults whereas it is almost 30% for DEP and DnBP in 
toddlers and younger children and nearly 20% for BBzP in children and 20% for DiNP in 
teenagers. Hence, inhalation of phthalate-contaminated dust may act as an alternative 
exposure route, probably greater than vapour phase phthalate exposure due to long residence 
time and deep lung deposition of dust particles. Constant phthalate desorption from indoor 
dust to the lung environment is a dynamic process, leading to continuous phthalate release 
and bioavailability, thus lung bioaccessibility contribution as a first tier of chronic human 
exposure to phthalates may play a substantial role (Jaakkola et al., 1999; Oberdorster, 1995; 
Oie et al., 1997).  
1.3 Bioaccessibility and human exposure  
Within this chapter, we address solid matrices, namely soil and indoor dust, as they are 
known “suspects” of human ingestion of hydrophobic organic compounds (HOCs) 
(Watanabe & Sakai, 2003; Abb et al., 2010). The contaminants associated with these matrices 
often differ; in soils, there are concerns from the direct ingestion from inadvertent hand to 
mouth activity or ‘pica’ of polycyclic aromatic hydrocarbons (PAHs), polychlorinated 
biphenyls (PCBs) and dioxins from past and present industrial activities, including gasworks, 
petroleum exploration and refining processes (James et al., 2011). During the past decade, 
ingestion of dust contaminated with FRs by toddlers and younger children has received 
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attention as there is the potential to exceed previously established guidance values (Stapleton 
et al., 2012; US EPA, 2010). 
The total pollutant concentration of the ingested matrix (as a mass fraction) is frequently used   
for the determination of the risk posed by toxic chemicals to public health. This is considered 
to be a conservative approach, but aligns with the precautionary principle (i.e. first-do-no-
harm) being adopted in 1998 by the Science and Environmental Health Network as a 
guideline in environmental policy decision making, tailored for “when an activity raises 
threats of harm to human health or the environment, precautionary measures should be taken 
even if some cause and effect relationships are not fully established scientifically” (Kriebel et 
al., 2001; Raffensperger and Tickner, 1999). Hence, under the regime of identifying and 
controlling potential environmental hazards, the precautionary principle has been extensively 
used in environmental risk assessments worldwide regarding contaminated land and pesticide 
registration (Rosner and Markowitz, 2002; Zander, 2010). However, synthetic chemicals are 
extremely useful to the modern lifestyle and a more scientifically rigorous approach may 
result in a better quantification of their health impacts. To address this need, a number of 
bioaccessibility tests have been developed which determine the transfer of pollutants from the 
contaminated solid matrix into the gut fluid, including physiologically based extraction tests 
(PBET) in fed or unfed status, meaning with or without the addition of carbohydrates, food 
components and bile salts, e.g. SBET (BGS; UK), SHIME (LabMet; Belgium), DIM (RUB; 
Germany) and TIM (TNO; the Netherlands) (Ruby et al., 1996; Oomen et al., 2002; Bruce et 
al., 2007; Cave et al., 2010b; Tilston et al., 2011).  
Bioaccessibility tests have proliferated because of their relative simplicity, high throughput, 
significantly reduced ethical considerations, sustainability, reduced costs and the ability to 
develop a reproducible standard operating procedure (UK Env Agency, 2005). It is known 
that the bioaccessible fraction can be considerably less than the total. In soils, the recoveries 
of lindane, endosulfan 1, endosulfan II, endrin, DDE and DDD following intestinal extraction 
were between 5.5 to 13.5% (Scott & Dean, 2005). Assessing 20 marine and freshwater fish 
species, (Wang et al., 2011a) found bioaccessible DDT concentrations were between 5.5 and 
17.6%. (Wang et al., 2013b) reported the average bioaccessibility of DDT in a total dust 
sample to be 24.5%. While these tests do not predict the actual amount of chemical that will 
be transferred across the gut lining and enter the blood stream, i.e. the bioavailable fraction, 
they do offer the ability to fine tune the risk assessment. While bioaccessibility tests have 
been used in research for many years they are not widely accepted by the regulatory 
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authorities; the US test for lead is a notable exception (US EPA, 2008).  However, these tests 
are currently being used in the UK as part of a ‘body of evidence’ approach when 
determining the risks of contaminated land. This low level of adoption has two principle 
reasons; a) the lack of validation by animal trials and b) the wide variability seen both within 
and between tests regarding statistical parameters such as method reproducibility assessed by 
coefficient of variation (CV) values and outliers, as well as general test formats mimicking 
the human gut stream (saliva, stomach, GI, colon), presence of food components in the 
gastric compartment, mass of sample loaded (g), analytical method etc. (Oomen et al., 2002; 
Koch et al., 2013)  
Within this chapter, we focus on the emerging FRs presented in sections 1.1 and 1.2 
regarding gut bioaccessibility, since these chemical classes have received less attention than 
the toxic elements and there is more uncertainty on which components from a wide spectrum 
of the current bioaccessibility test formats are influential (Agency, 2005; EPA, 2008). Also, 
the purpose of this chapter is to bring together the numerous bioaccessibility methods that 
have been used the past decade for organic pollutants e.g. FOREhST (Cave et al., 2010), CE-
PBET (Tilston et al., 2011), SHIME (fasting status) (Laird et al., 2007; Yu et al., 2012) and 
sorptive CE-PBET with the addition of silicone rods (Gouliarmou et al., 2013) and assess if 
from these, a common set of principles can be proposed. Current configurations vary widely 
in the total incubation time, composition of the incubating media and the amount of material 
being introduced. Significantly our review focuses on a range of matrices soil and dust, 
whereas previous reviews have only addressed soil (Dean & Ma, 2007). We are also 
reviewing a wider range of HOCs including legacy and alternative FRs, polycyclic aromatic 
hydrocarbons (PAHs), phthalate esters (PEs) and organochlorine pesticides (OCPs) (Gron et 
al., 2007; Yu et al., 2009; Wang et al., 2011b; Cheng et al., 2013). 
Definition of Bioaccessibility 
The assumption that 100% of the ingested toxicant within a matrix being available is 
unrealistic (Collins et al., 2015). Animal bioavailability studies (e.g. rodents or swine) are 
representative of the in vivo situation, but are often hindered due to financial and ethical 
restrictions (Oomen et al., 2003; Ruby et al., 2002). To avoid risk overestimation, 
bioaccessibility, i.e. the maximal fraction of an organic pollutant released from an ingested 
matrix (e.g. dust) into the gastro-intestinal tract (GIT) fluids of the organism has been 
proposed as a more realistic but conservative approach in human exposure assessment of 
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persistent organic pollutants (POPs), serving as a surrogate to bioavailability (Brandon et al., 
2006; Dean and Ma, 2007; Oomen et al., 2000). There are a number of definitions of 
bioaccessibility, these can be particularly confusing because they can relate to both human 
ingestion and microbial degradation. We use the following definition ‘The maximal amount 
of contaminant released from the test matrix in a synthetic gastrointestinal system' (Semple et 
al., 2004). This fraction represents the maximum amount of a contaminant that is available 
for absorption within the human gastrointestinal tract (Oomen et al., 2000). It is also 
important to separate bioaccessibility from bioavailability, usually the latter requires transfer 
across a biological membrane, i.e. across the intestinal cell wall where it then enters the 
systemic circulation (blood or lymph). Under this regime, oral bioavailability is the collective 
effect of ingestion, bioaccessibility and absorption (Oomen et al., 2002) (Fig. 1). Several 
physiologically-based extraction tests (PBET) have been proposed to assess organic pollutant 
release and uptake from an ingested matrix via the GIT fluids in vitro (Brandon et al., 2006; 
Cave et al., 2010; Gouliarmou and Mayer, 2012; Tilston et al., 2011; Van de Wiele et al., 
2004), as a substitute to in vivo studies (James et al., 2011) or for high-throughput estimates 
of bioaccessibility when animal studies are not feasible (Rodríguez-Navas et al., 2017; Ruby 




Figure 1 Schematic representation of dust particle ingestion and oral bioaccessibility via the 
gastrointestinal tract (GIT). Shown in the figure are the most important intestinal 
compartments and mechanisms related to FR absorption via the GIT, reaching the body’s 
systemic circulation. 
In figure 2, we present the basic sorption and desorption processes regarding ingested solid 
matrices (e.g. indoor dust) and bioaccessibility. When in contact with an aqueous or air 
matrix, organic contaminants become associated with the solid matrix through physical and 
chemical processing, sorption processes, surface binding as well as within-pores diffusion. 
Once the particles are ingested and enter the GI tract, then the sorption processes are reversed 
leading to release of xenobiotics from the solid matrix to the GI fluids (i.e. bioaccessible 
fraction) with eventual transport into the blood circulation. Human ingestion of a solid matrix 
(e.g. soil, indoor dust) is partly governed by particle size, particularly in the case of accidental 
ingestion. This pathway is frequently the primary human exposure route from contaminated 
solid matrices. In bioaccessibility studies, most tests are concerned with the particle size that 
is considered adhesive to hands, but a range of values have been recommended < 250 µm 
(Calabrese et al., 1996; Stanek, 2000), < 50 µm (Ljung et al., 2006) and < 45 µm (Siciliano et 
al., 2010). In pigs, the bioavailability of the PAH benzo[a]pyrene was correlated with the 
carbon in in the sand and silt fraction, i.e < 50 µm (Duan et al., 2014). Finally, <250 µm was 
recommended by (Yu et al., 2012) as the most appropriate particle cut-off size of dust 
particles to be likely ingested by humans, therefore used in their study regarding oral 




Figure 2 Particle properties affecting the bioaccessibile fractions via solid matrix (food, soil 
or dust) ingestion. (Solid matrix is shown in grey and the organic contaminants bound to it 
are highlighted in red). 
1.4 Indoor dust and bioaccessibility 
Although there is significant geographical and seasonal variation, non-dietary dust ingestion 
acts as an important source of human exposure to pesticides and FRs which are contained in 
every-day consumer products (Shalat et al., 2003; Hazrati & Harrad, 2006). These chemicals 
are non-covalently bound additives for prevention of fire ignition in consumer products and 
electronic household equipment such as personal computers and television sets, as well as 
plastics, textiles and flexible polyurethane foam (PUF) (Bakker et al., 2008).  Given its 
colloid and complex character as a heterogeneous mixture of organic compounds and the 
particle-bound organic matter derived from biological matrices ranging from skin cells, 
pollen, human and animal hair to fungal spores (Butte & Heinzow, 2002), dust is present in 
houses, offices, cars many other indoor environments where urban populations spend up to 
90% of their time (Brasche & Bischof, 2005).  
Oral bioaccessibility studies of dusts have investigated a range of organic contaminants such 
as PCBs, organochlorine pesticides (OCPs), PBDEs and phthalate esters respectively (Ertl & 
Butte, 2012; Kang et al., 2012; Kang et al., 2013; Wang et al., 2013d).  (Wang et al., 2013b) 
employed a PBET test (stomach and small intestine compartments only), performing a risk 
assessment of OCPs under the hypothesis of dust ingestion as a major route to total OCP 
exposure for children and found that the bioaccessibility of DDT in dust samples (mean 
24.5%) was higher than HCH (mean 10.4%), while the intestinal desorption was higher than 
the gastric phase. The log Kow for DDT is 6.9, whereas for the HCH isomers log KOW values 
range from 3.7 - 4.14. Bioaccessibility of PCBs in dust was 37.3% and 20.8% and 13.6% for 
tri-PCB, tetra-PCBs and octa-PCBs respectively, mainly due to the log KOW which increases 
with respect to the degrees of chlorination (Wang et al., 2013c). 
Children spend more than 90% of their time indoors (e.g. house, day-care centres) and, 
compared to adults, their breathing zone tends to be closer to the floor (Kocbach Bølling et 
al., 2013). Children’s higher metabolic and body development rate, rate of oxygen 
consumption, smaller lung surface area per kg and lower body weight, together with 
behavioural and activity factors such as floor mobility may result in higher dust inhalation 
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rates compared to adults, leading to greater internal exposure to environmental contaminants 
(Moya et al., 2004). Children are thus considered particularly vulnerable to FR exposure and 
associations between phthalate exposure and respiratory health problems such as asthma and 
allergies have been reported (Bornehag et al., 2004; Bornehag and Nanberg, 2010; Fromme et 
al., 2013). Prenatal exposure to PEs has been linked with neurodevelopmental disorders 
during adult life (Bellinger, 2013), while phthalate-induced oxidative stress and asthma-
related pulmonary inflammation have been reported for adults (Franken et al., 2017).  In 
children, allergic reactions and chronic respiratory problems such as asthma, bronchial 
hyperactivity and inflammation have been linked with high DEHP and BBzP levels in indoor 
dust and with the use of indoor PVC flooring (Hsu et al., 2012), (Doelman et al., 1990; 
Jaakkola and Knight, 2008; Mendell, 2007). Asthma occurrence in children has been linked 
with considerable DEHP concentrations in indoor dust (Bornehag et al., 2004), while 
inhalation of DEHP-contaminated dust triggered a nasal mucosa immune response in adults 
previously allergic to dust (Deutschle et al., 2008).  
The most abundant PBDE congeners present in dust are BDE47, BDE99, BDE183 and 
BDE209 (Watanabe & Sakai, 2003; Yu et al., 2012). BDE209 was the least bioaccessible 
compound (10-20%) compared to the lower brominated PBDE congeners which had values 
between 40 to 60% (Lepom et al., 2010; Yu et al., 2012). Despite this low bioaccessibility 
potential, the study of BDE209 is still essential, due to its high levels in dust compared to the 
rest of PBDE congeners (µg vs ng levels) (ECB, 2002; Harrad et al., 2008; Sjodin et al., 
2008); because of the debromination potential of BDE209, lower brominated PBDEs are 
likely to be generated and released to indoor environment, thus becoming more bioaccessible 
(Gerberding, 2004; Lee & He, 2010).  
There is high variance in the amount of dust incubated in bioaccessibility tests to date, 
ranging from 9 mg up to 1 g. Additionally, inconsistency exists regarding the ratio between 
the matrix (solid) and gastric solutions (liquid). (Yu et al., 2009) suggest a liquid-to-solid 
(L/S) dependent release of PBDEs from food matrix (Grass carp fish) when L/S ratio was 
lower than 100, resulting in incomplete release of PBDEs to the GI fluids. In the case of 
contaminant saturation phenomena in the GI fluids, a decrease in the bioaccessibility would 
be expected as L/S ratio increases. A fixed L/S ratio between 100 to 150 is therefore 
recommended to achieve successful contaminant release from the matrix to the GI fluids 
(Abdallah et al., 2012).  
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Variation in the bioaccessibility values have been reported for dust particle size fractions as 
was observed for soils. (Wang et al., 2013b) assessed OCP bioaccessibility values in four 
different indoor dust particle fractions between <63 µm, 63-100, 100-280 and 280-2000 µm 
respectively. Their findings suggest no significant difference in bioaccessibility between 
outdoor and indoor dust (p<0.05) or between 63-100 µm and 100-280 µm fractions, whereas 
significantly higher (p<0.05) bioaccessibility was reported for the <63 µm fraction compared 
to the 280-2000 µm suggesting higher accumulation potential of OCP in the <63 µm fraction. 
For the case of phthalate esters, the highest bioaccessible fraction was reported for dimethyl 
phthalate (DMP) in dust particles <63 µm (DMP bioaccessibility mean 15.5% in gastric 
conditions, 23.1% in intestinal conditions and 38.6% for total digestive juice), while 
significantly lower (p<0.05) values were reported in 280-2000 µm size fraction (Wang, Wu, 
et al., 2013). Finally, and for the case of PBDEs, (Yu et al., 2013) suggest statistically 
significant negative correlation (R2=0.473; p=0.028) between particle size and 
bioaccessibility for tri- and hepta-BDEs with the highest value of 45% for size fraction <30 
µm, but not for the case of BDE209. Taken all together, such findings support evidence for 
higher health risk for dust particles <63 µm compared to particle fractions higher than 63 µm 
with respect to volatile and semi-volatile organic compounds such as low MW phthalate 
esters and PBDEs with low bromine content.  
1.5 Basis of the “infinite” sink in bioaccessibility   
An organic chemical’s tendency towards lipophilicity or hydrophobicity is a central 
controller in their bioaccessibility (Henry & DeVito, 2003), through their potential to sorb to 
the soil matrix and desorb from particles within the gastro-intestinal tract (Fig. 2). Two 
bioaccessibility protocols specifically developed for the testing of HOCs are the Fed ORganic 
Estimation Human Simulation Test (FOREhST) (Cave et al., 2010a) and the Colon Extended 
­ Physiologically Based Extraction Test (CE-PBET) both operated in the fed state as this is 
known to enhance the desorption of HOCs, with dietary components such as complex 
carbohydrates and peptides (e.g. starch, xylan, cysteine) acting as a “biologically active sink” 
for organic pollutants (Hack & Selenka, 1996; Tilston et al., 2011). CE-PBET also introduces 
an extended colon section as the final stage of the extraction, which is carbohydrate rich and 
will further enhance bioaccessibility (Fig. 3). Both these tests contain bile salts which are 
known to increase the bioaccessibility as they have both hydrophobic and hydrophilic regions 
(Oomen et al., 2000). The bioaccessibility of PAHs is reduced with increasing 
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hydrophobicity in both FOREhST (Cave et al., 2010a) and CE-PBET (Tilston et al., 2011). 
(Hack & Selenka, 1996) concluded that salinity, pH value, addition of bile salts and digestive 
enzymes were identified as key factors bioaccessibility determination. In an attempt to 
incorporate a biologically active sink in a bioaccessibility test format, (Van de Wiele et al., 
2005) employed a modified SHIME method with the addition of in vitro cultured human 
colon microbiota to assess the estrogenic potency of  four PAHs (i.e. pyrene, phenanthrene, 
benzo(a)pyrene and naphthalene) and their metabolites after soil ingestion; PAH metabolites 
were found to induce an estrogenic effect in vitro in the colon compartment as GIT 
biotransformation products due to their high degree of aromaticity. However, such an in vitro 
approach focuses on potential xenobiotic microbial biotransformation primarily, rather than 
mimicking the in vivo colon epithelium environment where enzymatic metabolism is likely to 
occur (Van de Wiele et al., 2005).  
The central role of a sink was also highlighted by (James et al., 2011), where C18 membranes 
enhanced desorption from soils by 1-2 orders of magnitude depending on the test employed. 
Both studies agree that the inclusion of a sink avoids under-estimation of the bioaccessible 
fraction in organic studies. However, (James et al., 2011) found that despite accuracy in the 
measurement of soil PAH content, in vitro models with the sink did not adequately 
correspond to the results of an in vivo bioavailability study performed on juvenile swine (R2 = 
0.45). Using a two-compartment PBET method (i.e. stomach and small intestine), (Tao et al., 
2009) reported bioaccessibility values between 4% and 97% through in vitro testing of 
organochloride pesticide (OCP) contaminated soils. Differences in soil properties, 
particularly organic content, and the physicochemical properties of the analytes such as log 
Kow and water solubility were cited as reasons for variation within the test. When compared 
with in vivo tests, the FOREhST model underestimated the bioavailability of DDT in a mouse 
model by 3-15 fold (Smith et al., 2012), while it also under predicted the bioavailability of 
PAHs in soil by 50 fold (Juhasz et al., 2014). The under prediction of in vivo bioavailability 
may be addressed by adding a non-biologically active ‘sink’ (e.g. silicone, Tenax TA) to the 
bioaccessibility test, to simulate the uptake from the gastric solution enhancing the 
physiological relevance of the test by mimicking the large surface area, and sorptive 
potential, of the human GI tract (Collins et al., 2013).  
Sink conditions better mimic the sorption/desorption processes in the human GIT in vivo and, 
coupled with the lipid-rich environment of the GI lumen and a long matrix:fluid contact time, 
may improve the bioaccessibility estimates of HOCs, such as PBDEs (Collins et al., 2015; 
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Zhang et al., 2016, 2015).  Strong non-biological adsorbents such as silicone-activated 
contaminant traps, cyclodextrins and silicone rods have also been proposed as “absorption 
sink” materials in PBET systems, to improve bioaccessibility estimates for PAH-
contaminated soil and biochar (Gouliarmou et al., 2013; Mayer et al., 2016; Zhang et al., 
2015). In the case of CE-PBET, the inclusion of an activated charcoal as an infinite sink 
significantly increased the PAH bioaccessibility estimates (1.2 – 2.8 fold), by removing more 
PAH from a range of field soils of varying total organic carbon (TOC) and black carbon (BC) 
content (Collins et al., 2013). As part of the International Organization for Standardization 
(ISO) guideline on bioavailability, an exhaustive (20h) Tenax-based extraction method 
achieved increased mobilisation (i.e. bioaccessibility) of HOCs from soils and sediments onto 
this infinite sink and has been proposed for standarisation (ISO, 2015; Ortega-Calvo et al., 
2015). Tenax TA® is a versatile absorption sink with large surface area and high sorption 
capacity for HOCs and was thus used as an “infinite” sink in PBET systems, studying the 
uptake of FRs and PAHs via indoor dust (Fang and Stapleton, 2014) and soil (Li et al., 2015), 
respectively(Fang and Stapleton, 2014a; Li et al., 2015). Cornelissen et al (1997) employed 
Tenax TA® studying sorption/desorption kinetics of PAHs, alkylbenzenes and PCBs from 
dredged sediments; the sink captured the organic pollutants from the solid matrix but the 
Tenax TA® beads adhered to the glassware with consequent problems for physical separation 
and recovery of Tenax TA® from the matrix (Cornelissen et al., 1997). The variability in 
Tenax TA® mass recovery, its separation from the matrix and the design of an appropriate 
vessel for Tenax TA® inclusion (e.g. stainless steel net) during PBET incubation has 
discouraged further applications of Tenax TA® in environmental exposure studies (C. Li et 
al., 2016; Mayer et al., 2016). Hence, in order to establish a harmonised in vitro gut 
bioaccessibility method under the influence of the ISO 16751 method on the environmental 
availability of non-polar compounds being currently approved for registration, Tenax TA® 
addition was selected as an adsorptive sink in the present study as the most appropriate non-
biological adsorbent for assessing in vitro bioaccessibility of FRs. 
1.6 PhD thesis objectives 
The bioaccessibility of a range of compounds sorbed to a variety of matrices is frequently 
below 100%, proving its potential to fine tune human health risk assessment. For this 
potential to be realised we must understand the controlling factors in such tests and adopt 
them to create a single model approach. It has been clearly established above that the 
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predominant controls on bioaccessibility are a) the matrix the pollutant is attached to, b) the 
physico-chemical properties of the pollutant and c) the configuration of the test; the first two 
points cannot be controlled by the experimental operator, whereas the latter can.   
Figure 3 - Schematic representation of a proposed CE-PBET bioaccessibility test format with 
the inclusion of Tenax TA® as an absorption sink 
Good practice has been established by BARGE (the Bioaccessibility Research Group in 
Europe; http://www.bgs.ac.uk/barge/home.html), which states that a bioaccessibility test 
should have the following components: 
i. It should be physiologically based, mimicking the human GI physico-chemical 
environment in the stomach and small intestine.  
ii. It should represent a conservative case; 
iii. There should be one set of conditions for all potentially harmful elements (PHE) 
being studied; 
iv. It must be demonstrated that the test is a good analogue of in vivo conditions 
v. The test must be able to produce repeatable and reproducible results within and 
between testing laboratories. 
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According to Collins et al (2015), a unified in vitro bioaccessibility test should address the 
aforementioned points with respect to the following remarks during method development and 
validation:  
i  -  It is suggested that the addition of water-based digestive compartments (e.g. saliva) is of 
limited importance compared to the use of the stomach and small intestine, as contacts times 
are short (5 min) and compounds of interest are sparingly water soluble.  There is potential 
for the addition of the colon compartment, this increases the potential bioaccessibility. There 
is also the requirement of a sink to provide a desorption gradient as would be anticipated in 
the GI tract. 
ii + iii -  The system should be in the fed state to maximise the desorption of the 
contaminants. Conservatism would also be ensured by addition of a colon compartment and a 
‘sink’. These conservative conditions should be applied collectively when conducting any 
bioaccessibility test. 
iv – This has yet to be demonstrated.  Results to date appear to under predict bioavailability 
in real soils. This is possibly a consequence of the tests not being operated in the most 
conservative condition (see i-iii). 
 v -  No single test design has been agreed upon. Only CE-PBET and FORhEST have been 
designed specifically for HOCs.  Points i-iii need to be agreed in the research community 
before this an inter laboratory trial can proceed. Then the expensive in-vivo tests can be 
conducted or soils from previous animal trials used. 
Given the fact that human uptake of FRs in exposure studies is generally considered as 100% 
bioaccessible, leading to potential risk overestimation, a series of in vitro tests has to be 
developed, validated and employed with respect to traditional routes of exposure such as 
ingestion, as well as formerly unexplored exposure pathways such as inhalation. Apart from a 
few studies on in vitro metabolism of FRs and plasticisers, limited data exist on the uptake 
and absorption potential of FRs, thus making the practice of in vitro bioaccessibility studies a 
necessity due to their cost-effective and time-efficient nature. The aim of the studies 
presented in this thesis is thus two-fold; a), to assess human exposure to legacy FRs such as 
PBDEs as well as alternatives of emerging concern including EHFRs, PFRs and phthalate 
esters via indoor dust and b) to develop in vitro bioaccessibilty methods with the inclusion of 
Tenax TA® as a non-biologically active “infinite sink”, thus providing a cost-effective and 
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more realistic estimate of FR uptake via the gut and redefine human exposure. The research 
work presented in the following chapters begins with an extensive human exposure 
assessment via indoor dust ingestion to a wide range of FRs with diverse physicochemical 
properties and proceeds in exploring alternative in vitro testing strategies for human uptake to 
FRs, including a modification of a previously established gut bioaccessibility test with the 
inclusion of Tenax TA as an absorption sink, followed by a novel in vitro pulmonary 
bioaccessibility test for organic pollutants. Both in vitro bioaccessibility tests aim to tackle 
potential risk overestimation, hence provide a simple approach in first-tier human risk 
assessments for abiotic matrices giving a conservative, yet realistic indication of risk. 
1.7 PhD thesis outline 
In chapter 1, a brief overview of the physicochemical characteristics and environmental fate 
of legacy and alternative FR studied in this thesis are presented. This was followed by and 
some of the key elements of in vitro bioaccessibility and human exposure to HOCs such as 
flame retardants via indoor dust and soil ingestion have been outlined. Even though soil does 
not fall within the scope of the present study, it is included in this chapter as it is the most 
extensively tested matrix in vitro bioaccessibility studies, as well as the current regime in in 
vitro dust bioaccessibility testing are largely based upon assays developed for soils. In 
chapter 2, the emerging occurrence and human exposure to legacy and alternative FRs via 
indoor dust from two diverse geographical regions, the UK and Norway, were presented and 
human exposure assessment results were critically discussed against existing data. Moving to 
chapter 3, a novel experimental method assessing the in vitro bioaccessibility of legacy FRs 
via indoor dust ingestion was developed; Tenax TA® was employed as an absorption 
“infinite” sink aided by dialysis membrane for successful encapsulation and physical 
separation of the Tenax TA from the dust as a matrix. This novel experimental approach was 
targeting towards the development and validation of a unified and exhaustive GIT extraction 
for the testing of hydrophobic organic compounds (HOCs) such as FRs using artificial GIT 
fluids as briefly discussed earlier in this chapter. Method development steps involved Tenax 
TA® mass optimisation and FR sorption capacity evaluation, alongside method validation of 
the selected CE-PBET parameters using indoor dust standard reference material for organic 
contaminants in house dust SRM 2585 (NIST, USA) as a well-characterised and homogenous 
dust sample. In chapter 4, we introduce inhalation as a previously unexplored alternative 
route of exposure for phthalate esters and non-phthalate alternative plasticisers. A novel in 
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vitro inhalation bioaccessibility method using two artificial lung fluids, namely Gamble’s 
solution and artificial lysosomal fluid was employed with respect to the physiological and 
inflammatory status of the pulmonary environment. Alongside traditional phthalate esters, 
phthalate-free alternative plasticisers were included in the list of target analytes tested since 
they act as substitutes to legacy phthalate esters in consumer products. Finally, chapter 5 
provides an overview of the results obtained in this thesis, discussing potential 
methodological limitations and future perspectives of in vitro bioaccessibility studies. Taken 
all together, we propose two novel in vitro bioaccessibility test formats with respect to indoor 
dust ingestion and inhalation as two substantial exposure routes for FRs. Our main outcome 
from this thesis is orchestrating the foundation steps in designing and harmonising in vitro 
methods for the testing of organic compounds as an essential tool in risk assessment of 
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Indoor dust has been acknowledged as a major source of flame retardants (FRs) and dust ingestion is 
considered a major route of exposure for humans. In the present study, we investigated the presence of 
PBDEs and alternative FRs such as emerging halogenated FRs (EHFRs) and organophosphate flame 
retardants (PFRs) in indoor dust samples from British and Norwegian houses as well as British stores 
and offices. BDE209 was the most abundant PBDE congener with median concentrations of 4,700 ng 
g-1 and 3,400 ng g-1 in UK occupational and house dust, respectively, 30 and 20 fold higher than in 
Norwegian house dust. Monomeric PFRs (m-PFRs), including triphenyl phosphate (TPHP), 
tris(chloropropyl) phosphate (TCPP) and tris(2-chloroethyl) phosphate (TCEP) dominated all the 
studied environments. To the best of our knowledge, this is the first report of isodecyldiphenyl 
phosphate (iDPP) and trixylenyl phosphate (TXP) in indoor environments. iDPP was the most abundant 
oligomeric PFR (o-PFR) in all dust samples, with median concentrations one order of magnitude higher 
than TXP and bisphenol A bis(diphenyl phosphate (BDP). iDPP and TXP worst-case scenario 
exposures for British workers during an 8h exposure in the occupational environment were equal to 34 
and 1.4 ng kg bw-1 day-1, respectively. The worst-case scenario for BDE209 estimated exposure for 
British toddlers (820 ng kg bw-1 day-1) did not exceed the proposed reference dose (RfD) (7,000 ng kg 
bw-1 day-1), while exposures for sum of m-PFRs (Σm-PFRs) in British toddlers and adults (17,900 and 
785 ng kg bw-1 day-1 respectively) were an order of magnitude higher than for Norwegian toddlers and 













 PBDEs, EHFRs and PFRs were analysed in Norwegian and UK house, store & office dust 
 First report of iDPP and TXP in indoor dust with several o-PFRs also detected  
 m-PFRs dominated all indoor environments, followed by EHFRs, PBDEs, and o-PFRs 
 BDE209 levels were significantly higher in British than Norwegian house dust  





Flame retardants (FRs) are widely used in everyday consumer products including carpets, 
electronic appliances, clothing and textiles, thermal insulation and cable coatings. Since the 
1970s, polybrominated diphenyl ethers (PBDEs) have been widely used in consumer 
products as FRs (Alaee et al., 2003). Various human health effects are associated with 
PBDEs exposure such as disruption of the endocrine and thyroid homeostasis (Legler and 
Brouwer, 2003) and neurodevelopmental growth of children (Costa and Giordano, 2007). The 
commercial mixtures Penta-BDE and Octa-BDE have been listed as persistent organic 
pollutants (POPs) for elimination under the Stockholm Convention (Stockholm Convention, 
2009a, 2009b), while the Deca-BDE mixture is currently under review. The use of Deca-BDE 
was banned in Norway in 2008 (EBFRIP, 2008), while it was included by the EU in the 
amended Annex XVII of REACH (EC No 1907/2006), banning its production, use and 
marketing in the EU (European Commission, 2016). As a result of the REACH amendment, 
furniture and fire safety regulations in the UK are currently under review by the national 
competent authorities (UK Department for Business, Energy & Industrial Strategy, 2016). 
Due to legislative restrictions on their commercial use, PBDEs have been replaced with 
alternatives, known as “emerging” halogenated flame retardants (EHFRs) including 2-
ethylhexyl-2,3,4,5-tetrabromobenzoate (EH-TBB; Penta-BDE replacement), bis(2-
ethylhexyl)-3,4,5,6-tetrabromophthalate (BEH-TEBP; Penta-BDE replacement), 1,2-
bis(2,4,6-tribromophenoxy) ethane (BTBPE; Octa-BDE replacement), decabromodiphenyl 
ethane (DBDPE; Deca-BDE replacement) and Dechlorane Plus (DPs; Deca-BDE 
replacement) (Stapleton et al., 2008; Wang et al., 2011) and organophosphate flame 
retardants (PFRs) such as tris(2-chloroethyl) phosphate (TCEP) and 
tris(chloropropyl)phosphate (TCPP) (van der Veen and de Boer, 2012a).  
In response to consumer and regulatory pressures worldwide, alongside high production 
volumes and excessive use of FRs in consumer products, high levels of PBDEs (also known 
as legacy FRs) and their alternatives including EHFRs and PFRs have been identified in 
abiotic matrices such as soil, indoor air and dust (Covaci et al., 2011; Dodson et al., 2012; 
Newton et al., 2015), in aquatic and terrestrial biota such as fish, marine mammals and polar 
bears (Anh et al., 2016; de Wit et al., 2010) as well as in human biological matrices including 
breast milk, blood and urine (Kalantzi et al., 2004; Kim et al., 2014; Sjödin et al., 1999; 
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Venier et al., 2016). Hence, given the considerable FR amounts identified in abiotic matrices 
(e.g. air and indoor dust), as well as their hydrophobic and potentially bioaccumulative 
nature, human exposure to FRs as a result of unintentional dust ingestion and inhalation have 
been identified as substantial routes of exposure (Alves et al., 2014; Jones-Otazo et al., 2005).  
To bridge this knowledge gap, the main objectives of the present study are:  
a) To assess the presence of legacy and alternative FRs in three different indoor 
environments from two European countries (the UK and Norway) 
b) To estimate and compare human intakes to a wide range of FRs via dust ingestion 
using the same dust samples for non-working adults and toddlers in Norwegian and 
British houses, as well as for working adults in British stores and offices.  
2.2 Materials and Methods 
2.2.1 Sampling 
Ten indoor dust samples were collected from pre-existing vacuum cleaner bags (houses) in 
Norway (Oslo) as a part of the A-TEAM cohort sampling during November 2013 – April 
2014 (Papadopoulou et al., 2016). Twenty-two indoor dust samples from pre-existing vacuum 
cleaner bags (10 houses, 6 stores and 6 offices; Table SI-1) were collected in Reading (UK) 
during August – December 2013. The UK house dust samples were collected from the houses 
of University of Reading employees, while UK office and store vacuum cleaner bags were 
collected in Reading with respect to the participant’s approval and willingness to cooperate in 
the present study. All dust samples were sieved to <250 μm using a methanol-washed 
metallic sieve; this size fraction of dust is likely to be ingested according to (Yu et al., 2012). 
Oven-baked Na2SO4 (granular) was also sieved as field blank. All dust samples were kept in 
hexane-washed amber glass bottles and stored at 4°C till analysis.
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Table 1 – Sample codes with country of origin, source, collection year, mass used (g) and flooring material 
Sample code Country Source Collection year Mass used (g) Flooring material General remarks 
H1 UK House 2013 0.034 wall-to-wall Carpet  
H2 UK House 2013 0.032 wall-to-wall Carpet  
H3 UK House 2013 0.031 wall-to-wall Carpet  
H4 UK House 2013 0.032 wall-to-wall Carpet  
H5 UK House 2013 0.033 wall-to-wall Carpet  
H6 UK House 2013 0.032 wall-to-wall Carpet  
H7 UK House 2011 0.030 wall-to-wall Carpet  
H8 UK House 2011 0.031 wall-to-wall Carpet  
H9 UK House 2012 0.032 wall-to-wall Carpet  
H10 UK House 2011 0.032 wall-to-wall Carpet  
H11 Norway House 2013 0.030 Laminated floor  
H12 Norway House 2013 0.030 Wooden floor  
H13 Norway House 2013 0.032 Laminated floor  
H14 Norway House 2013 0.032 Other/not-defined  
H15 Norway House 2013 0.033 Wooden floor  
H16 Norway House 2013 0.030 No data  
H17 Norway House 2013 0.032 No data  
H18 Norway House 2013 0.033 parquet  
H19 Norway House 2013 0.032 Wooden floor  
H20 Norway House 2013 0.031 Flooring  
S1 UK Office 2013 0.031 wall-to-wall Carpet Library offices 
S2 UK  Office 2013 0.030 Laminated floor and carpet flooring University offices 
S3 UK Store 2013 0.030 Laminated wood flooring 
Store with office supplies, printers, 
office furniture 
S4 UK Store 2013 0.031 
wall-to-wall Carpet; PVC floor in 
repair room only 
Computer store 
S5 UK Store 2013 0.032 Laminated wood flooring Luggage store 
S6 UK Office 2013 0.032 wall-to-wall Carpet Lettings office 
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S7 UK Office 2013 0.031 
wall-to-wall Carpet (two floors) 
and laminated floor (30% 1st floor) 
Bank offices 
S8 UK Store 2013 0.032 
Laminated wood flooring (two 
floors) 
Kitchenware store 
S9 UK Office 2013 0.032 
Laminated flooring (1st floor) 
wall-to-wall Carpet (2nd  floor) 
Lettings office 
S10 UK Office 2013 0.032 wall-to-wall Carpet Construction management office 
S11 UK Store 2013 0.032 wall-to-wall Carpet Phone store 




2.2.2 Extraction and clean-up 
The method was based on a previous study (Van den Eede et al., 2012a) with some 
modifications. Briefly, 30 mg of dust was extracted with 2.5 mL hexane:acetone (3:1 v/v) 
using ultra-sonication extraction for 10 min and vortexing for 1 min three times. 50 μL of an 
ISTD mix (prepared in iso-octane) were added ranging from 5 to 200 ng (13C-EH-TBB-d17, 
13C-BTBPE, 13C-BEH-TEBP-d17, 13C-syn-DP, 13C-anti-DP, 13C-BDE-209, BDE-77, BDE-
128, TCEP-d12, TPHP-d15, TDCPP-d15, TBEP-d6, and TAP). The supernatant was 
collected after each extraction cycle and evaporated to near dryness under a gentle stream of 
N2. The combined extract was concentrated to one mL in hexane, then was loaded on 
aminopropyl (NH2) silica cartridges (500 mg, 3 mL, Agilent, USA) and further fractionated 
with 10 mL hexane (F1) and 12 mL of ethyl acetate (F2). F1 was further concentrated, 
following a clean-up on an acidified silica cartridge (5%, 1 g, 6 mL) and elution with 12 mL 
dichloromethane. F2 was equally aliquoted into two portions, F2a and F2b. Then, F1, F2a 
and F2b were evaporated, reconstituted with 100 μL of iso-octane (F1 & F2a) and methanol 
(F2b), respectively, and then filtered. Finally, the extracts were transferred to injection vials 
and analyzed on GC-ECNI-MS (F1, for PBDEs and EHFRs), GC-EI-MS (F2a, for m-PFRs, 
except TXP) and LC-QqQ-MS (F2b, for o-PFRs and TXP). All samples were analysed in 
batches of 20 samples in two consecutive days, along with one SRM 2585 (NIST, USA) as 
quality control and two field blanks. Oligomeric PFRs were detected in all procedural blanks. 
The average blank value was calculated in ng/g and then subtracted from the sample o-PFR 
values.  
2.2.3 QA/QC  
Overall, 28 and 31 compounds (out of 33) were detected in house and occupational dust 
samples, respectively (Tables SI-2, SI-3, SI-4, and SI-5). SRM 2585 (n=2, NIST, USA) was 
used for QC testing and the results were in line with the literature (Table 2). Four Na2SO4 
samples (30mg) were used as procedural blanks for background checking and results were 
blank corrected for all analytes by subtraction of the mean field blank values from the raw FR 
values (expressed in ng/g) according to (Abdallah and Covaci, 2014) (Table 3). Method 
limits of detection (mLOD) were calculated as three times the standard deviation of the 
procedural blanks. For non-detected analytes, mLOD was calculated based on signal-to-
noise-ratio 3:1. According to (Van den Eede et al., 2012a), analytical method validation by 
matrix spiking demonstrated good accuracy ranging from 81 to 130%. Typical recoveries 
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ranged between 80 and 110% at both spiking levels, though occasional deviations were 
observed at low spiking concentrations. Precision between different days was generally 
below 24% relative standard deviation (RSD) at low concentrations and below 11% RSD at 
high concentrations.  
Figure 4 - Schematic representation of aminopropyl silica fractionation (step 1) and 5% acidified 
silica (AS) clean up (step: 2) based on (Van den Eede et al., 2012b) 
2.2.4 Data Analysis 
GraphPad Prism® version 7.00 for Windows, (GraphPad Software, La Jolla CA, USA) was 
used for statistical analysis. Compounds with detection frequencies (DF) lower than 40% 
were excluded from statistical analysis. Where needed, non-detections were replaced by half 
of mLOD for statistical analysis. All data were checked for normality using the D’agostino 
and Pearson tests, data that failed the normality test were log-transformed and checked for 
normality again. Not all data were normally distributed after log-transformation. Ordinary 
two-way ANOVA (Uncorrected Fisher’s test, p<0.05) was performed to assess statistically 
significant differences of FRs between UK house and occupational concentrations and 
between UK and Norwegian houses. Due to some data failing to pass normality tests, 
Spearman’s correlation (p<0.05) was employed to assess statistical dependence and 
correlation between FRs in the three different dust categories.  






STDEV *RSD% Ref value Accuracy % 
BDE28 15.3 6.8 44.1 46.9 33 
BDE47 446.5 26.9 6 497 90 
BDE66 22.8 1.7 7.4 29.5 77 
BDE85 117.5 10.6 9.1 145 81 
BDE100 35.8 3.8 10.5 43.8 82 
BDE153 137.5 42.9 31.2 119 116 
BDE154 99 33.8 34.2 83.5 119 
BDE183 52.5 27.1 51.6 43 122 






Ref value Accuracy % 
TEHP 252.7 11.4 4.5 NM
**
 NM 
TnPP 17 6.3 36.8 NM NM 
TnBP 266.3 21.6 8.1 197 135 
EHDPHP 1049.2 57.3 5.5 NM NM 
TCEP 962.6 48.6 5 899 107 
TBOEP 50460.2 2444.3 4.8 45795 110 
TPHP 963 52.9 5.5 1052 92 
TMPP 53435.1 652 1.2 NM NM 
TDCIPP 2221.8 69.8 3.1 1933 115 
TCPP 1156 98.5 8.5 1063 109 
V6 47 24 51.1 NM NM 
TDBPP 18 7 38.9 NM NM 
iDPP 122 15 12.3 NM NM 
RDP nd nd nd NM NM 
TXP 73 2 2.7 NM NM 
BDP nd nd nd NM NM 
*RSD= (Stdev/mean)*100, **NM=not measured, †taken from (Cequier et al., 2014) 
Our results of PBDEs and PFRs were in compliance with SRM 2585 indicative levels and 
PFR levels from (Cequier et al., 2014). PBDEs levels ranged from 90 to 118% (median: 95%) 
with the exception of BDE-28 (33%) and BDE-183 (122%). As for some PFRs, no indicated 
values were available while drafting of the current manuscript, therefore no comparison could 





Table 3 - Values of target analytes in field blanks (ng/g) and method limit of detection (mLOD) 
PBDEs BL1 BL2 BL3 BL4 AVG STEDV 
mLOD* 
(ng/g) 
BDE28 1.3 1.0 1.3 N.D. 1.2 0.2 0.5 
BDE47 1.0 1.0 1.3 N.D. 1.1 0.2 0.5 
BDE66 N.D.** N.D. N.D. N.D. N.D. N.D. 0.6† 
BDE85 N.D. N.D. N.D. N.D. N.D. N.D. 0.6 
BDE100 N.D. N.D. N.D. N.D. N.D. N.D. 0.6 
BDE153 N.D. N.D. N.D. N.D. N.D. N.D. 0.7 
BDE154 N.D. N.D. N.D. N.D. N.D. N.D. 0.6 
BDE183 N.D. N.D. N.D. N.D. N.D. N.D. 0.6 
BDE209 N.D. N.D. 5.7 4.3 5.0 1.0 3.0 
EHFRs BL1 BL2 BL3 BL4 AVG STEDV mLOD 
EH-TBB N.D. N.D. N.D. N.D. N.D. N.D. 1.3 
BTBPE N.D. N.D. N.D. N.D. N.D. N.D. 1.3 
BEH-TEBP N.D. N.D. N.D. N.D. N.D. N.D. 1.3 
syn-DP N.D. N.D. N.D. N.D. N.D. N.D. 1.6 
anti-DP N.D. N.D. N.D. N.D. N.D. N.D. 1.6 
αTBECH 0.3 0.7 0.3 0.7 0.5 0.2 0.7 
βTBECH 0.3 0.3 0.3 0.3 0.3 0.0 0.6 
DBDPE N.D. N.D. N.D. N.D. N.D. N.D. 13.3 
PFRs BL1 BL2 BL3 BL4 AVG STEDV mLOD 
TEHP 16.7 13.0 10.3 9.7 12.4 3.2 9.5 
TnPP N.D. N.D. N.D. N.D. N.D. N.D. 26.7 
TnBP 12.3 10.0 11.0 12.0 11.3 1.1 3.2 
EHDPHP 4.7 N.D. N.D. N.D. 4.7 N.D. 2.3 
TCEP N.D. N.D. N.D. N.D. N.D. N.D. 44.1 
TBOEP 159.3 158.0 121.7 153.0 148.0 17.7 53.3 
TPHP 4.3 N.D. N.D. N.D. 4.3 N.D. 2.7 
ΣTMPP 3.3 N.D. N.D. N.D. 3.3 N.D. 5.4 
TDCIPP 61.3 N.D. 71.7 N.D. 66.5 7.4 21.9 
ΣTCPP 17.3 N.D. 15.0 N.D. 16.2 1.6 4.9 
V6 1.0 0.7 0.7 0.6 0.8 0.2 0.5 
TDBPP 0.9 0.7 0.6 0.6 0.7 0.2 0.5 
iDPP 4.9 4.2 4.7 3.9 4.4 0.4 1.3 
RDP 3.9 2.6 3.0 2.6 3.0 0.6 1.8 
TXP 2.8 1.9 2.1 2.1 2.2 0.4 1.1 
BDP 6.1 3.9 4.7 3.5 4.6 1.1 3.4 
* mLOD= 3 x STDEV of blank;  
** N.D. = not detected  




2.3 Results and discussion 
This study reports concentrations of four groups of FRs in dust from UK stores and offices 
(n=6 offices and n=6 stores), UK houses (n=10) and Norwegian houses (n=10). Studied 
chemicals included nine PBDE congeners, eight EHFRs, ten monomeric PFRs, and six 
oligomeric PFRs (Tables S1-8, SI-9, SI-10, SI-11, SI-12, and SI-13). Overall, the UK 
occupational dust samples had the highest FR contamination, followed by UK and 
Norwegian house dust. In an attempt to define newly identified PFRs, this group is divided in 
monomeric (m-PFRs), including TPHP, TnBP, TCPP, TDCIPP etc., and oligomeric (o-
PFRs), including V6, BDP and RDP, using the abbreviation nomenclature as suggested by 
(Matsukami et al., 2015). In our study, monomeric PFRs presented the highest levels in total, 
followed by EHFRs, PBDEs and oligomeric PFRs. 
2.3.1 PBDEs 
Most PBDEs were frequently detected in UK houses and occupational dust with DF>50%, 
unlike in the Norwegian house dusts (Fig. 1A, B, C; Table SI-8, SI-10, and SI-12). BDE28 to 
BDE183 levels were relatively lower compared to BDE209, probably because of the global 
phase out of Penta- and Octa-BDE commercial mixtures (Dodson et al., 2012). Similar to 
indoor dust samples from Belgium, China and Sweden (Ali et al., 2011; Newton et al., 2015; 
Zheng et al., 2011) median level of BDE47 was four-fold higher in UK (12 ng g-1) than in 
Norwegian house dust samples. Median concentrations of BDE47 (9.1 ng g-1) and BDE183 
(11 ng g-1) in occupational dust were within the concentration range of studies from Belgium 
and Germany (Ali et al., 2011; Brommer et al., 2012), but lower than the USA (Michigan) 
and China (Batterman et al., 2010; Cao et al., 2014b). BDE209 , the most abundant PBDE 
congener, was detected in all samples, with median concentrations of 4,700 ng g-1 and 3,400 
ng g-1 in UK occupational and house dust, respectively, which is much higher than a recent 
study of Norwegian classroom dust (507 ng g-1) (Cequier et al., 2014) and also in the 
Norwegian house dust samples from the present study (160 ng g-1) (Fig 1A). A statistically 
significant difference of BDE209 concentrations was observed between UK and Norwegian 
house dust (p=0.014).  Since DBDPE acts a major replacement of BDE209, the 
BDE209/DBDPE ratio is indicative of the progress of phasing out Deca-BDE. The median 
BDE209 /DBDPE ratio was <1 for Norwegian house dust while it was >3 in UK house dust. 
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Table 4 Descriptive statistics of PBDEs and EHFRs measured in the UK house dust samples (N=10). Concentrations and mLOD in ng/g. 
















BDE28 0.9 1.1 2.1 7.7 10.6 2.5 3.9 3.9 100 0.5 
BDE47 2.6 4.9 10.9 38.7 684 15.7 83.8 212.0 100 0.5 
BDE66 <0.6 <0.6 <0.6 9.6 9.6 9.6 9.6 0.0 10 0.6 
BDE85 <0.6 1.0 3.7 66.3 126 4.7 27.6 55.2 50 0.6 
BDE100 <0.6 1.8 3.2 14.3 272 5.4 35.0 89.2 90 0.6 
BDE153 1.6 3.3 8.2 15.6 448 9.3 52.0 139 100 0.7 
BDE154 0.9 1.9 4.1 9.1 273 5.5 34.3 89.6 90 0.6 
BDE183 3.8 4.6 5.8 14.3 133 10.3 25.7 47.6 70 0.6 
Σ8PBDEs 19.4 25.3 49.9 175.6 1958.4 63 272 637   
BDE209 265 1636 3351 13843 50601 3810 11081 17437 100 3.0 
Σ9PBDEs 304 1689 3451 14194 54518 3936 11625 18710   
















EH-TBB 2.5 3 5.0 20.5 32.0 6.7 10.7 11.2 90 1.3 
BTBPE <1.3 <1.3 <1.3 100 100 36.3 48.7 45.2 30 1.3 
BEH-TEBP 18.0 62.3 106 179 234 95 116 67.9 100 1.3 
syn-DP 2.1 2.85 4.5 14.3 31.5 5.7 9.1 11.2 60 1.6 
anti-DP 1.6 4.48 6.8 10.6 31.6 7.0 9.5 8.9 100 1.6 
α-TBECH <0.7 0.7 1.2 5.4 5.6 2.2 3.1 2.3 60 0.7 
β-TBECH <0.6 <0.6 0.6 1.7 1.7 1.4 1.4 0.4 30 0.6 
DBDPE 531 849 1091 4594 39221 1902 5576 11924 100 13.3 
Σ8EHFRs 572 923 1245 4925 39659 2055 5774 12071   
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BDE28 <0.5 1.8 2.6 3.7 3.8 2.5 2.7 1.0 50 0.5 
BDE47 <0.5 1.7 2.3 49.0 94.4 4.6 20.7 41.2 50 0.5 
BDE66 <0.6 <0.6 1.3 1.3 1.3 1.3 1.3 0.0 10 0.6 
BDE85 <0.6 <0.6 5.8 5.8 5.8 5.8 5.8 0.0 10 0.6 
BDE100 <0.6 <0.6 23.3 23.3 23.3 23.3 23.3 0.0 10 0.6 
BDE153 <0.7 <0.7 8.9 14.7 14.7 3.4 6.2 7.4 30 0.7 
BDE154 <0.6 <0.6 9.6 9.6 9.6 2.6 5.2 6.3 20 0.6 
BDE183 <0.6 <0.6 3.6 98.2 130 7.5 34.7 63.3 40 0.6 
Σ8PBDEs 35.6 39.0 48.3 196 285.2 50.6 94.0 111.2   
BDE209 26.7 97.3 161 536 3084 203 518 929 100 3.0 

















EH-TBB <1.3 3.8 5.4 8.7 9.2 3.7 5.1 3.4 50 1.3 
BTBPE 299 299 299 299 299 299 299 0 10 1.3 
BEH-TEBP 7.9 12.1 27.1 156 426.0 38.3 89.6 132.0 100 1.3 
syn-DP <1.6 <1.6 2.6 3.4 3.4 2.2 2.4 1.1 30 1.6 
anti-DP 1.6 1.8 3.1 4.7 5.1 2.9 3.2 1.5 40 1.6 
α-TBECH <0.7 1.2 1.2 2.3 3.1 1.1 1.4 1.0 40 0.7 
β-TBECH <0.6 <0.6 <0.6 <0.6 <mLOD 0.6 0.6 0.6 0 0.6 
DBDPE 81.8 219 686 834 1802 484 689 536 80 13.3 




Table 6 - Descriptive statistics of PBDEs and EHFRs measured in the UK stores and offices (N=12). Concentrations and mLOD in ng/g. 















BDE28 0.7 4.9 8.5 15.0 7352 13.6 677 2213 92 0.5 
BDE47 <0.5 8.3 9.1 17.2 119 13.5 22 33.9 83 0.5 
BDE66 1.0 1.0 3.4 5.8 5.8 2.4 3.4 3.4 17 0.6 
BDE85 1.0 1.1 2.1 7.3 8.8 2.4 3.5 3.6 33 0.6 
BDE100 1.9 2.1 4.0 5.5 27.9 4.2 6.6 8.7 67 0.6 
BDE153 3.0 5.0 5.2 8.1 29.2 6.8 8.3 7.3 92 0.7 
BDE154 1.9 2.5 3.4 4.6 14.9 3.7 4.5 3.8 83 0.6 
BDE183 2.2 7.9 11.4 27.0 44.4 11.8 16.3 12.8 100 0.6 
Σ8PBDEs 13.3 32.7 48.4 90.5 7602.0 54.2 684.1 2190.5   
BDE209 92.2 2068.0 4654 4654 10874 2937 4529 3098 100 3.0 
Σ9PBDEs 118.8 2133.5 4751 4835.0 26078 3045 5897 7479   















EH-TBB 1.6 5.3 18.1 45.2 143 13.9 29.4 41.1 92 1.3 
BTBPE 13.3 18.9 27.1 40.8 79.9 28.2 32.9 21.4 67 1.3 
BEH-TEBP 25.3 111.0 248 1367.0 2541 310.0 678.0 798.0 100 1.3 
syn-DP 3.6 12.1 15.2 80.4 1237 27.9 152 383 83 1.6 
anti-DP <1.6 17.4 43.1 311.0 5547 49.3 555 1579 100 1.6 
α-TBECH 2.3 2.9 4.5 11.4 4201 9.3 426 1326 100 0.7 
β-TBECH <0.6 0.9 1.3 4.25 1462 3.1 164 486 100 0.6 
DBDPE 110 3049 5387 14259 23977 4759 8322 7646 100 13.3 




Such findings can be possibly attributed to low Deca-BDE usage in Norway and its unilateral 
ban since 2008 (EBFRIP, 2008), contrary to the EU where Deca-BDE was added to the 
candidate list of substances of very high concern for authorisation under the REACH 
regulation in 2012 with its use in consumer products eventually banned within the REACH 
framework earlier in 2016 (ECHA, 2012; European Commission, 2016). Unlike the Nordic 
indoor environment where hard-surfaced wooden flooring is more frequently applied (Roos 
and Hugosson, 2008), an evident preference towards carpet flooring in UK houses could 
potentially contribute to the higher BDE209  levels, hence the high BDE209/DBDPE median 
ratio in UK house dust (Jonsson, 2005). However, the median BDE209 /DBDPE ratio in the 
UK occupational dust was <1, probably due to the replacement of Deca-BDE in newer 
products in stores and offices compared to house environment.  
2.3.2 Emerging halogenated FRs  
Nearly all EHFRs were frequently detected (DF>50%) in all three types of dust (Fig. 1A, B, 
C, Table SI-8, SI-10, SI-12). DBDPE and BEH-TEBP were the most abundant EHFRs 
(DF>80%). In house dust, DBDPE median concentration was two-fold higher in UK (1,100 
ng g-1) than Norway (686 ng g-1) (Fig 1A&B), which was in agreement with a previous 
Norwegian study (Cequier et al., 2014) and considerably higher than DBDPE levels in dust 
from Belgium and Sweden (Ali et al., 2011; Newton et al., 2015). The median concentration 
of BEH-TEBP in UK house dust (110 ng g-1) was equivalent to recent studies from USA and 
Sweden (Dodson et al., 2012; Newton et al., 2015). However, BEH-TEBP median in our 
Norwegian dust samples was lower than a previous Norwegian study (Cequier et al., 2014). 
The small sample size of the Norwegian dust collection analysed in the present study (n=10) 
may act as a limiting factor. Our dust samples were collected from pre-existing vacuum 
cleaner bags, whereas in (Cequier et al., 2014) dust samples (n=48)  were collected using 
forensic filters. In UK occupational dust, DBDPE had the highest median concentration 
(5,400 ng g-1), followed by BEH-TEBP (250 ng g-1), both of which were higher than previous 
studies on Belgian and German office dust (Ali et al., 2011; Brommer et al., 2012), but lower 
than a recent Chinese study (Cao et al., 2014b). EH-TBB was several folds lower than BEH-
TEBP in all three types of dust. Additional sources of BEH-TEBP in consumer products 
other than Firemaster 550® (EH-TBB/BEH-TEBP ratio 4:1 in commercial mixture (Stapleton 
et al., 2008) are suspected to be Great Lakes DP-45™ and Firemaster® BZ-54 (Chemtura 
Inc., USA), (Bearr et al., 2012; Zheng et al., 2015). A statistically significant difference 
between UK house and occupational dust concentrations was found for two Deca-BDE 
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alternatives, DBDPE (p<0.05) and anti-DP (p<0.05) (Stapleton et al., 2008; Zhu et al., 2007). 
Anti-DP (median: UK occupational 43.1 ng g-1; UK house 6.8 ng g-1; Norwegian house 4.5 ng 
g-1) was the predominant DP isomer compared to syn-DP (median: UK occupational 15.2 ng 
g-1; UK house 4.6 ng g-1; Norway 2.6 ng g-1), in agreement with other studies (Cequier et al., 
2014; Newton et al., 2015; Zheng et al., 2015). TBECH isomers were less frequently detected 
(DF<60%), with concentrations of α-TBECH consistently higher than β-TBECH, although 
the β-TBECH isomer was not detected in Norwegian house dust samples. This may be 
attributed to β-TBECH being less volatile compared to α-TBECH, leading to lower β-
TBECH levels in indoor dust, unlike the 50:50 α/β TBECH isomer ratio in the commercial 
mixture (Tao et al., 2016; Wong et al., 2015).  
2.3.3 Monomeric PFRs  
All m-PFRs were frequently detected (DF>50%) in all three types of samples, apart from 
TnPP which was found <mLOD in all samples (Fig. 1 D, E, F; Table SI-9, SI-11 & SI-13). 
The median concentration of sum of 10 m-PFRs (Σ10m-PFRs) (88,000 ng g
-1) in UK 
occupational dust was similar to UK house dust (79,000 ng g-1), but four-fold higher than in 
Norwegian house dust (23,000 ng g-1). Individual PFR levels in our UK house dust samples 
were in agreement with a recent study of UK house dust (Brommer and Harrad, 2015). TCPP 
and TBOEP presented the highest median concentrations in UK houses (65,000 ng g-1 and 
8,100 ng g-1, respectively) (Fig.1E), with TCPP median in UK houses two-fold higher than 
house dust from Japan (30,900 ng g-1) and considerably lower from another Japanese house 
study (1,570,000 ng g-1) (Kanazawa et al., 2010). In Norwegian houses, TBOEP ranked first 
(18,000 ng g-1), nearly two-fold higher than previously reported data from USA house dust 
(11,000 ng g-1) (Dodson et al., 2012) and in agreement with (Cequier et al., 2014). TBOEP 
(median 33,000 ng g-1) and TCPP (median 25,000 ng g-1) were also two predominant m-PFRs 
in UK occupational dust. Used as a plasticiser in flexible PVC, thermoplastics and food 
packaging, EHDPHP median concentration (20,000 ng g-1) ranked as the third highest m-PFR 
in occupational dust, one to two orders of magnitude higher than its median in UK house 
dust. This may suggest that EHDPHP usage in the UK occupational environment and its  
application in new consumer products are steadily increasing. EHDPHP median 
concentration in UK house dust (2,400 ng g-1) was 12-fold higher than in the Norwegian 
house dust, yet marginally lower than recently reported UK house dust concentrations 
(Brommer and Harrad, 2015). No statistically significant difference was observed between 
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UK and Norwegian house dust concentrations (p=0.07) or between UK house and 
occupational dust samples (p=0.055) for EHDPHP.  
TCPP median concentration in UK houses from our study was 30 times higher compared to 
Norwegian house median concentration, while TCPP in Norwegian house dust was lower 
than levels from Belgium and another Norwegian house dust study (Cequier et al., 2014; Van 
den Eede et al., 2011). A statistically significant difference was found for TCPP (p=0.016) 
when comparing UK and Norwegian house dust concentrations. This may be possibly 
attributed to higher TCPP usage in the UK where TCPP is a TCEP replacement, while TCPP 
production and use in Norway have decreased during the past decade (ECHA, 2008a; van der 
Veen and de Boer, 2012a). Median concentrations of TPHP and TDCIPP in UK house dust 
were two-fold higher (1,500 and 750 ng g-1, respectively) than in Norwegian houses (830 and 
340 ng g-1, respectively), but lower than TPHP and TDCIPP levels reported from the USA 
(Betts, 2013; Stapleton et al., 2009). TMPP and TEHP were marginally different between 
house dusts in the two countries, while the median concentration of TnBP was two-fold 
higher in Norwegian house dust compared to UK house dust. Concentrations of m-PFRs have 
recently been reported in floor and surface dust, sampled with dust collection filters, from the 
same Norwegian population group (n=61) (Xu et al., 2016). The range of m-PFRs levels in 
floor and surface dust (collected from the living room) from Xu et al (2016) is of the same 
order as the vacuum cleaner dust in the present study (n=10, Norwegian house dust). TBOEP 
dominated the Norwegian house environment both in our study and in Xu et al (2016). The 
TBOEP concentration range in the present study (1300-48,000 ng g-1) was within the range of 
floor (727-311,000 ng g-1) and settled dust (<mLOD-540,000 ng/g) from Xu et al (2016), yet 
with higher median concentrations (our study: 18,000 ng g-1; Xu floor dust: 8,100 ng g-1; Xu 
settled dust: 6,800 ng g-1). Such results may be attributed to: a) differences in sample size; b) 
vacuum cleaner dust was sieved, but floor and settled were not; the large particles, like sand 
and hair, might dilute the contamination in dust sample; c) vacuum cleaner dust is 
representative of the entire house, while Xu et al (2016) only studied the living room; d) 
vacuum cleaner dust represents long term indoor contamination, while floor and settled dust 
represent short term contamination. This suggests that the sampling strategy factors such as 
collection season, area, tools and population selection, could potentially influence the study 
outcome. Therefore, researchers are advised to choose a sampling strategy firmly based on 




Figure 5 - Boxplots of indoor dust concentrations for selected PBDEs, EHFRs and PFRs from Norwegian houses (A&D) (N=10), UK houses (B&E) (N=10) and 
UK stores and offices (C&F) (N=12). Shown in the whiskers are 25th and 75th percentiles, median (central line), mean (+ symbol) and outlier (x symbol) values. 
All data shown are log transformed. Please note the linear scale for concertation (ng g-1) on y axis. 
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2.3.4 Oligomeric and monomeric PFRs  
Although TXP and TDBPP are considered as monomeric PFRs (Table SI-5), we will discuss 
them together with oligomeric PFRs (o-PFRs) due to the novel character of their 
environmental emissions and their usage in similar FR products (Matsukami et al., 2015). To 
the best of our knowledge, this is the first report of iDPP and TXP in the indoor environment. 
Most o-PFRs were detected in all three types of dust (DF>80%) (Fig.1 D, E, F; Table SI-9, 
SI-11, and SI-13), apart from RDP (no detection in Norwegian house dust) and TDBPP 
(DF<50% in UK and Norwegian house dust samples). All o-PFRs were frequently detected 
in occupational dust samples with substantially higher concentrations compared to the house 
dust samples. iDPP was the most abundant o-PFR in our dust samples, ranging from 600-
145,000 ng g-1, 110-1,700 ng g-1 and 6-260 ng g-1 in UK occupational dust, UK house dust 
and Norwegian house dust, respectively. Also, median concentrations of BDP (UK 
occupational dust 480 ng g-1; UK house dust 66 ng g-1; Norwegian house 35 ng g-1), TXP 
(UK occupational dust 240 ng g-1; UK house dust 26 ng g-1; Norwegian house dust 9.1 ng g-1) 
and V6 (UK occupational dust 40 ng g-1; UK house dust 17 ng g-1; Norwegian house dust 4 
ng g-1) were relatively higher than RDP and TDBPP, which were in general close to the 
mLOD. Maximum values for iDPP and BDP were close to 145,000 ng g-1 and 6,000 ng g-1, 
respectively, both found in dust from a toy store. In a personal computer (PC) store, the 
maximum concentration of TXP was near 6,000 ng g-1. iDPP concentrations of UK house and 
occupational dusts were statistically significantly different (p=0.019). We can assume that 
this is a result of the faster replacement rates of consumer products in the occupational 
environment compared to UK houses. No significant difference was found for TXP and BDP 
(p=0.07), possibly as a result of the small sample size analysed in the present study (10 UK 
houses and 12 stores and offices).  
A few studies have reported the presence of oligomeric PFRs in indoor dust and SRM 2585. 
RDP and BDP have been identified in our dust samples, but not in SRM2585 (Table SI-6). 
(Brandsma et al., 2013) reported higher concentrations of BDP and RDP in house dust when 
collected on/around electric items than in distance. Although it has been reported in baby 
products and car dust since 2011, V6 may have been used in consumer products since the 
early 1990s considering that SRM 2585 was prepared using a pool of samples collected 
during mid to late 1990s (Fang et al., 2013; Stapleton et al., 2011). An average concentration 
of 117 ± 6 ng g-1 for V6 was reported by (Fang et al., 2013) in SRM2585 with LC-APCI-
MS/MS, two-fold higher than our result (47 ± 23 ng g-1) where  LC-ESI-MS/MS was 
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employed for instrumental analysis. Since TDBPP, iDPP, and TXP were also present in SRM 
2585 with very low levels (Table SI-6), we can assume their commercial use has been 
ongoing earlier than has been generally perceived or that such compounds may be impurities 
of PFRs, such as TPHP, TMPP and EHDPHP (Derouet et al., 1996; UK Environment 
Agency, 2009a).   
3.5 iDPP and TXP commercial mixtures 
According to the UK Environment Agency (2009), iDPP, an alkyl diaryl phosphate ester, is 
manufactured in the UK and distributed by Ferro UK Ltd. and ICL-IP Europe B.V. in 
unknown amounts so far and is used as a FR plasticiser in flexible PVC, synthetic rubber, 
textiles and pigment products. The registered trademarks for iDPP available in Europe are 
Phosflex® 390 and Santicizer® 148 with the commercial mixture composition set as 90% 
iDPP and <5% TPHP as a technical mixture impurity (UK Environment Agency, 2009b). 
Newer PFRs such as iDPP have a general impurity due to their manufacture process which 
potentially causes a diverse contamination profile indoors with similarly structured PFRs, e.g. 
iDPP with EHDPHP. In the present study, iDPP highest concentrations were found in British-
based toys (145,000 ng g-1) and kitchenware stores (15,000 ng g-1). Extensive use of 
laminated wooden flooring, plasticised vinyl polymer products and displays was observed in 
the two stores. As legislation on the use of PBDEs and their alternatives in consumer 
products gets stricter, higher levels of “newer” FR are likely to be observed in the indoor 
environment, including iDPP. TCEP and TDCIPP will be partly restricted to 0.1% by weight 
in children’s products from 2017 by Washington State (USA) (State of Washington, 2016), 
which might pave the way for replacement of earlier PBDE alternatives with newer FRs in 
consumer products.  We may also assume that low levels of iDPP in Norwegian house dust 
could be due to limited commercial availability of iDPP in consumer products in the 
Norwegian market by comparison with the UK.  
Trixylenyl phosphate (TXP) is a triaryl phosphate ester currently manufactured by Chemtura 
Inc. (formerly Great Lakes Chemical Corp., USA) under the registered trademark Kronitex® 
TXP (Chemtura Corp, 2013) and by ICL-IP Ltd. (Israel) as Syn-O-Ad® 8475 (ICL IP Inc., 
2008) with an estimated usage in Europe between 100 – 1000 tonnes/year (ECHA, 2015). In 
2013, the European Chemicals Agency (ECHA) indicated the use of TXP as a tricresyl 
phosphate (TCP) substitute and formally listed it as a “substance of very high concern” 
because of its potential reproductive toxicity (ECHA, 2013). Xylenols such as TXP are 
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naturally derived alcohols with recommended application in wire and cable insulation, fire 
resistant lubricants and PVC applications where low volatility and high resistance products 
are essential (Harper, 2003). In our study, TXP maximum concentration (5,800 ng g-1) was 
reported in a dust sample collected from a computer store. The store’s interior design was 
covered with PVC and carpet flooring, numerous computer displays and repair rooms where 
cables and wires are frequently found. 
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Table 7 Descriptive statistics of PFRs measured in the UK house dust samples (N=10). Concentrations and mLOD in ng/g. 
















TEHP 96.2 105 157 348 465 188 223 144 90 9.5 
TnPP <26.7 <26.7 <26.7 <26.7 <26.7 <26.7 <26.7 <26.7 0 26.7 
TnBP 210 239 262 403 479 294 306 99 100 3.2 
EHDPHP 292 1703 2375 3385 9172 2228 3010 2481 100 2.3 
TCEP 138 590 873 1830 6265 991 1566 1793 100 44.1 
TBOEP 225 2806 8070 24347 58745 6711 16080 19724 100 53.3 
TPHP 190 1129 1509 3724 9549 1716 2737 2915 100 2.7 
TMPP 83 198 293 740 1052 340 459 359 100 5.4 
TDCIPP 346 523 752 1229 3792 836 1081 1019 100 21.9 
TCPP 18331 27054 64546 98080 1010000 64605 152691 303883 100 4.9 
Σ10m-PFRs 19911 34347 78837 134086 1099519 77909 178165 332419   
V6 1.3 11.8 16.6 50.8 756 23.5 96.8 232.0 100 0.5 
TDBPP <0.5 <0.5 <0.5 <0.5 <0.5 <0.5 n.d. n.d. 0 0.5 
iDPP 114 233.0 401 1053.0 1687 452 617 506 100 1.3 
RDP <1.8 <1.8 1.9 3.1 3.1 1.5 1.9 1.2 50 1.8 
TXP <1.1 6.6 26.5 73.6 537  84.0 162.0 100 1.1 
BDP <3.4 25.8 66.8 167.0 485 47.7 116.0 144.0 100 3.4 
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Table 8 Descriptive statistics of PFRs measured in the Norwegian house dust samples (N=10). Concentrations and mLOD in ng/g. 
PFRs - Norway 














TEHP 107 144 178 302 618 206 240 161 90 9.5 
TnPP <26.7 <26.7 <26.7 <26.7 <26.7 <26.7 <26.7 <26.7 0 26.7 
TnBP 229 281 485 649 3123 512 713 859 100 3.2 
EHDPHP 37.1 108 195 818 4011 285 743 1229 100 2.3 
TCEP 56.7 81 120 370 498 158 210 162 100 44.1 
TBOEP 1343 2912 18364 30999 48006 10232 19145 17269 100 53.3 
TPHP 202 240 830 1273 2922 656 931 826 100 2.7 
TMPP 110 131 194 321 3176 252 503 943 100 5.4 
TDCIPP 81 159 344 554 2306 319 511 654 100 21.9 
TCPP 997 1323 1959 5431 33891 2800 5832 10122 100 4.9 
Σ10m-PFRs 3163 5379 22669 40717 98551 15420 28828 32230   
V6 1.2 2.2 4.1 5.3 8.8 3.5 4.1 2.4 80 0.5 
TDBPP <0.5 <0.5 <0.5 0.7 0.7 0.6 0.6 0.1 20 0.5 
iDPP 6.3 28.7 51.3 119 262 51.4 80.5 76.7 100 1.3 
RDP <1.8 <1.8 <1.8 <1.8 <1.8 <1.8 n.d. n.d. 0 1.8 
TXP 2.7 5.7 9.1 81.8 105.0 13.7 32.3 41.6 100 1.1 





Table 9 - Descriptive statistics of PFRs measured in the UK stores and offices (N=12). Concentrations and mLOD in ng/g. 















TEHP 97.7 389 529 1008 2259 548 743 640 75 9.5 
TnPP <26.7 <26.7 <26.7 <26.7 <26.7 <26.7 <26.7 <26.7 0 26.7 
TnBP 223 235 281 329 488 288 297 80.1 100 3.2 
EHDPHP 457 7374 19648 29767 127686 13554 26020 33613 100 2.3 
TCEP 237 456 897 2489 7185 1103 1895 2220 100 44.1 
TBOEP 3371 8531 32700 82439 1.8E+06 40294 305634 647120 100 53.3 
TPHP 1331 3581 5752 11251 38094 5885 8834 9917 100 2.7 
TMPP 118 439 850 1068 1163 638 758 359 100 5.4 
TDCIPP 195 877 1274 9827 12774 1790 3974 5243 100 21.9 
TCPP 5012 10174 25751 51148 155955 25867 44714 53044 100 4.9 
Σ10m-PFRs 11042 32068 87682 189341 2165604 89967 392883 752240   
V6 2.1 6.3 40.4 158 511 36.5 132 192 100 0.5 
TDBPP 2.6 2.6 3.0 15.1 15.1 4.9 6.9 7.1 100 0.5 
iDPP 644 1990 5898 7653 145455 5083 18018 42467 100 1.3 
RDP 2.0 2 6.1 53.5 53.5 8.7 20.5 28.6 100 1.8 
TXP 20.8 69.2 244 1406 5820 240 935 1733 100 1.1 




2.3.6 Correlation between FRs present in dust from different 
environments 
Spearman’s correlation revealed significant and positive correlations among low brominated 
PBDEs in all environments (Fig.2) in agreement with (Cequier et al., 2014) as they formulate 
a group of compounds with similar structural and physico-chemical characteristics and are 
present in the same commercial mixtures. In the occupational environment, where oligomeric 
PFRs were more abundant than PBDEs and EHFRs, iDPP, RDP and BDP were strongly 
correlated between each other, EHDPHP and TPHP (ρ>0.9; p<0.01) and TnBP, TCEP and 
TBOEP (0.6<ρ<0.8; p<0.01) also occurred together probably due to their application as 
plasticisers and FRs in similar consumer products and RDP being used as TCEP substitute 
due to its low release to the environment (van der Veen and de Boer, 2012a). Also, TPHP is 
present in the indoor environment either as an individual FR or as an impurity in the BDP and 
RDP technical mixtures (Mihajlović, 2015; UK Environment Agency, 2009c; van der Veen 
and de Boer, 2012a). In the UK house environment, V6 was highly correlated with TCEP 
(ρ>0.7; p<0.01) probably due to TCEP impurity in V6 formulation, while no significant 
correlation was achieved for Norway, where TCEP use has significantly decreased since 
2003 (van der Veen and de Boer, 2012a). In UK houses, oligomeric PFRs including RDP and 
BDP, were strongly correlated with each other (ρ>0.9; p<0.01), while only BDP was 
correlated with BDE-209 (ρ>0.79; p<0.01), although they are both proposed as Deca-BDE 
alternatives in electronics (Ballesteros-Gómez et al., 2014). In Norwegian houses, TXP was 
moderately to highly correlated with Tetra-BDEs, Hepta-BDEs, and BDE-209 (0.6>ρ>0.7; 
p<0.01), with anti-DP and TCEP (ρ>0.7; p<0.01) and with TDCIPP (ρ>0.7; p<0.05). Αlpha- 
and β-TBECH isomers were highly correlated with each other and BDE-28 (ρ>0.9; p<0.01) 
in all environments and with BEH-TEBP in the occupational environment (ρ>0.7; p<0.01) 
may be caused by the banned Tri-BDE formulations and parallel Firemaster 550® or Great 
Lakes DP-45™ and Firemaster® BZ-54 applications in electronic products.  
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2.3.7 Human exposure assessment 
Different scenarios of human exposure via dust ingestion have been estimated for oligomeric 
PFRs in the present study (Table-1, Tables SI-15, SI-16, and SI-17). All the exposure 
scenario equations and parameters used for adults and toddlers daily estimated intake to FRs 
were based on Eq.1 (USEPA, 1997) and table 10 (Brandsma et al., 2013). In our study, both 
average (20 mg/24 h for adult and 50 mg/24 h for toddler) and high (50 mg/24 h for adult and 
200 mg/24 h toddler) dust intake situations were calculated. The exposure of home-based 
adults and toddlers were assessed with 24 h exposure duration. Intakes for adult workers in 
offices and stores were estimated with 8 and 24h exposure duration, given the assumption of 
a work day split as 16h at home and 8h at work environment. Body weight of 70 kg and 12.3 
kg were used for adults and toddlers, respectively. To the best of our knowledge, this is the 
first study providing multi-scenario exposure assessment for this wide variety of FRs based 
on the same samples from two different countries. However, we recognise that the small 
number and representativeness of samples analysed in the present study represents a major 
uncertainty in these intake calculations. 





𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑥 𝐷𝑢𝑠𝑡 𝑖𝑛𝑔𝑒𝑠𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒 𝑥 𝐸𝑥𝑝𝑜𝑠𝑢𝑟𝑒 𝑑𝑢𝑟𝑎𝑡𝑖𝑜𝑛
𝐵𝑜𝑑𝑦 𝑤𝑒𝑖𝑔ℎ𝑡
 





In all scenarios (Tables SI-15, SI-16, and SI-17), much higher intakes from dust ingestion 
have been calculated for m-PFRs than for PBDEs, EHFRs and o-PFRs. Toddlers were found 
to have much higher estimated exposure to all FR than adults, due to higher dust ingestion 
rates (average exposure scenario 20 and 50 mg per 24 h, for adults and toddlers, respectively; 
high exposure scenario, 50 and 200 mg per 24 h for adults and toddlers, respectively) and 
lower body weight (12.3 kg for toddlers and 70 kg for adults). Close-to-floor activity and 
more frequent hand-mouth-contact are rationales behind using higher dust ingestion rates for 
toddlers. In the worst case scenario, estimated exposure of British toddlers from dust 
 Dust ingestion rate (g/day) 
Body Weight 
(kg) 
 Average High  
Adults 0.02 0.05 70 
Toddlers 0.05 0.2 12.3 
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ingestion were 890, 17,900, and 650 ng kg bw-1 day-1 for ΣPBDEs, Σm-PFRs and ΣEHFRs, 
respectively; while the estimated exposures for Norwegian toddlers were equal to 60, 1,600, 
and 40 ng kg bw-1 day-1 for ΣPBDEs, Σm-PFRs and ΣEHFRs, respectively. Contrary to the 
exposure of Norwegian toddlers, the estimated exposure of BDE209 for British toddlers in 
the worst case scenario was equal to 820 ng kg bw-1 day-1, about 12% of the daily reference 
dose (RfD) (7,000 ng kg bw-1 day-1) (Table SI-17). Based on our assessment, Norwegian stay-
home adults and toddlers, have one order of magnitude lower exposure of ΣPBDEs and Σm-
PFRs from average dust ingestion (50 mg) than British adults and toddlers. For TBOEP 
exposure with average dust intake rate, Norwegian stay-home adults (median 5.3 ng kg bw-1 
day-1) and toddlers (median 75 ng kg bw-1 day-1) were two-fold higher compared to British 
counter parts (2.3 and 33 ng kg bw-1 day-1 respectively). However, Norwegian adults and 
toddlers were found to have lower exposure for other m-PFRs and o-PFRs, such as TPHP and 
BDP, set below the proposed RfD values (Table SI-16&17). (Ali et al., 2013) reported 
slightly higher exposure to ΣPBDEs for both adult and toddler via house dust ingestion in 
Kuwait compared to Norway, but lower than our British non-workers. For Σm-PFRs and 
ΣEHFRs, the calculated intake for adults and toddlers from Kuwait and Pakistan were lower 
compared to our study for Norwegians and British non-workers. In another study from 
Norway, slightly higher median exposure of ΣPBDEs (female 0.4 ng kg bw-1 day-1, children 1 
ng kg bw-1 day-1) and Σm-PFRs (female 16 ng kg bw-1 day-1, children 133 ng kg bw-1 day-1) 
were reported compared to our assessment for Norwegians (Cequier et al., 2014), but lower 
than our British stay-home adult. With 24h of exposure (8h at work and 16h at home) (50 mg 
day-1 dust intake rate), the estimated exposures of British workers for ΣPBDEs, Σm-PFRs and 
ΣEHFRs were higher than Norwegian non-workers (Table SI-15&16). Estimated exposure 
for British workers to ΣEHFRs was two-fold higher (median 0.79 ng kg bw-1 day-1) than 
British stay-home adults (median 0.36 ng kg bw-1 day-1), unlike ΣPBDEs and Σm-PFRs 
exposures in these population groups. In the worst case scenario with high dust intake rate 
(200 mg day-1), the estimated exposure for British workers to Σm-PFRs (1,040 ng kg bw-1 
day-1) was comparable to British stay-home adults (785 ng kg bw-1 day-1), while nearly 15-
fold higher than Norwegians stay-home adults (70 ng kg bw-1 day-1).
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Table 11 - The estimated daily human intake (median and maximum) to selected PFRs in different scenario (ng kg bw-1 day-1).   
Human exposure assessment for selected PFRs (ng kg bw-1 day-1) 
 Compound 
Stay-home toddler  (t=24h) Stay-home adult (t=24h) 
Adult workers (t=8h work 
+16h home) 
UK houses Norway houses UK houses Norway houses UK Offices and Stores 




intake 50 mg/d) 
V6 0.067 3.073 0.016 0.036 0.005 0.216 0.001 0.003 0.007 0.193 
TDBPP 0.002 0.002 0.002 0.003 <0.001 <0.001 <0.001 <0.001 <0.001 0.001 
iDPP 1.63 6.858 0.209 1.065 0.115 0.482 0.015 0.075 0.638 14.174 
RDP 0.008 0.013 0.007 0.007 0.001 0.001 0.001 0.001 0.001 0.006 
TXP 0.108 2.183 0.037 0.427 0.008 0.153 0.003 0.03 0.028 0.657 





V6 0.27 12.293 0.066 0.143 0.012 0.54 0.003 0.006 0.018 0.482 
TDBPP 0.008 0.008 0.01 0.011 <0.001 <0.001 <0.001 0.001 <0.001 0.004 
iDPP 6.52 27.431 0.834 4.26 0.286 1.205 0.037 0.187 1.595 35.435 
RDP 0.031 0.05 0.029 0.029 0.001 0.002 0.001 0.001 0.002 0.014 
TXP 0.431 8.732 0.148 1.707 0.019 0.384 0.007 0.075 0.071 1.641 
BDP 1.086 7.886 0.576 11.333 0.048 0.346 0.025 0.498 0.147 1.643 
* Normal scenario was considered for dust intake of 20 mg and 50 mg per 24 h, for adults and toddlers, respectively; while for high exposure scenario, 50 mg and 200 mg per 
24 h, respectively, dust exposures were considered for stay-home adults and toddlers. Daily exposure for working adults in UK stores and offices has been estimated as well 
using the same parameters (median, maximum, ingestion rate), but for 24h exposure duration (8h work + 16h at home). Body weights, 70 kg for adults and 12.3 kg for toddlers, 
were applied for the estimation 
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Given the small sample size in our study from UK stores and offices, we present here FR 
estimated intakes for the two dust sample groups combined as a general exposure scenario for 
British workers with 8h and 24h (8h at work and 16h at home) exposure duration (SI Table 
15). A more elaborate view on estimated intakes for all FRs for individual offices and stores 
is available in SI. Briefly, in average and high dust intake rate scenarios, exposure for 
ΣPBDEs, Σm-PFRs and ΣEHFRs between UK office employees (SI Table 18) and UK stores 
employees (SI Table 19) were found to be within a comparable range. In the worst case 
scenario, estimated intakes for British-based toys store workers were 14-fold higher for 
TBOEP than EHDPHP, reaching 434 and 30 ng kg bw-1 day-1, respectively. The second 
highest estimated intake for TBOEP was found for workers in a British-based store selling 
office supplies, electronics and furniture equal to 147 and 368 ng kg bw-1 day-1 in average and 
high dust intake rates, respectively. The two cases of store employees (in toys store and office 
supplies store) did not exceed the proposed RfD for TBOEP (1.5x104 ng kg bw-1 day-1) in 
both dust ingestion rate scenarios and 8h of exposure. Human exposure via dust ingestion has 
never been estimated for most o-PFRs, except BDP and RDP (Brandsma et al., 2013). 
Among all o-PFRs, in most scenarios, the highest intakes via dust ingestion were calculated 
for iDPP, followed by BDP or TXP (Table 1). Considering 8h of exposure during a workday, 
British employees were found to have higher estimated exposure of individual o-PFRs than 
British and Norwegian stay-home adults (24 h) (Table 1). The worst-case scenario for iDPP 
was estimated for employees in a British-based toy store, where the estimated exposure was 
335.4 ng kg bw-1 day-1, nearly three-fold higher than the average dust intake scenario, set 
considerably below the proposed LOAEL (Table 1). In the worst case scenario for toddlers, 
Norwegian toddlers may have an exposure of equal to 11.3 ng kg bw-1 day-1 for BDP, while 
British toddlers have TXP exposure equal to 8.7 ng kg bw-1 day-1. In contrast, for Dutch and 
Greek toddlers (worst case scenario), higher BDP exposures were reported equal to 1,100 ng 
kg bw-1 day-1 and 750 ng kg bw-1 day-1, respectively; while their RDP exposure were also 
thousand-fold higher than our assessment (Brandsma et al., 2013). Based on findings in this 
study, exposure to TDBPP does not seem to raise major toxicological concerns for humans, 
as TDBPP was rarely detected in our dust samples or other environmental samples (Lopez et 
al., 2011).  
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Table 12 - Daily exposure of FRs for adults (workers) in UK stores and offices (n=12) with average and high dust ingestion rate 
 
Adults ng/kg bw/day - 
Average ingestion rate -UK 
Workers t=8h at work 
Adults ng/kg bw/day - High 
ingestion rate - Workers 
t=8h at work - Worst case 
scenario 
Adults ng/kg bw/day - 
Average ingestion rate 
-UK Workers t=24h 
(8h work + 16h home) 
Adults ng/kg bw/day - 
High ingestion rate - 
Workers t=16h (8h work 
+16h home) - Worst case 
scenario 
 
 UK worker UK worker UK worker UK worker  
FR Median Maximum Median Maximum Median Maximum Median Maximum 
RfD (ng/kg 
bw day) 
BDE28 0.001 0.700 0.002 1.750 0.001 0.702 0.003 1.756  
BDE47 0.001 0.011 0.002 0.028 0.003 0.142 0.008 0.354 1 x102 
BDE66 0.000 0.001 0.001 0.001 0.002 0.002 0.005 0.006  
BDE85 0.000 0.001 0.001 0.002 0.001 0.025 0.002 0.062  
BDE100 0.000 0.003 0.001 0.007 0.001 0.054 0.002 0.136  
BDE153 0.000 0.003 0.001 0.007 0.002 0.088 0.005 0.220 2 x102 
BDE154 0.000 0.001 0.001 0.004 0.001 0.053 0.003 0.134  
BDE183 0.001 0.004 0.003 0.011 0.002 0.030 0.005 0.074  
Σ8PBDEs 0.005 0.724 0.012 1.810 0.014 1.097 0.034 2.742  
BDE209 0.443 1.036 1.108 2.589 1.082 10.674 2.704 26.685 7 x103 
Σ9PBDEs 0.452 2.484 1.131 6.209 1.109 12.867 2.772 32.168  
EH-TBB 0.002 0.014 0.004 0.034 0.003 0.020 0.007 0.049  
BTBPE 0.003 0.008 0.006 0.019 0.008 0.027 0.021 0.067  
BEH-
TEBP 
0.024 0.242 0.059 0.605 0.044 0.287 0.110 0.716  
syn-DP 0.001 0.118 0.004 0.295 0.002 0.124 0.006 0.310  
anti-DP 0.004 0.528 0.010 1.321 0.005 0.534 0.013 1.336  
αTBECH 0.000 0.400 0.001 1.000 0.001 0.401 0.003 1.003  
βTBECH 0.000 0.139 0.000 0.348 0.000 0.140 0.001 0.349  
DBDPE 0.513 2.284 1.283 5.709 0.721 9.754 1.802 24.385  
ΣEHFRs 0.547 3.732 1.368 9.330 0.785 11.286 1.962 28.215  
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TEHP 0.050 0.215 0.126 0.538 0.080 0.304 0.201 0.759  
TnBP 0.027 0.046 0.067 0.116 0.077 0.138 0.192 0.344 2.4 x104 
EHDPHP 1.871 12.161 4.678 30.401 2.324 13.908 5.809 34.769 6 x106** 
TCEP 0.085 0.684 0.214 1.711 0.252 1.878 0.629 4.694 2.2 x104 
TBOEP 3.114 173.333 7.786 433.333 4.651 184.523 11.629 461.307 1.5 x104 
TPHP 0.548 3.628 1.370 9.070 0.835 5.447 2.088 13.617 7 x104 
TMPP 0.081 0.111 0.202 0.277 0.137 0.311 0.342 0.778  
TDCPP 0.121 1.217 0.303 3.041 0.265 1.939 0.661 4.847 1.5 x104 
TCPP 2.452 14.853 6.131 37.132 14.747 207.234 36.867 518.085 8 x104 
Σ10PFRs 8.351 206.248 20.877 515.620 23.367 415.680 58.418 1039.200  
V6 0.004 0.049 0.010 0.122 0.007 0.193 0.018 0.482  
TDBPP 0.000 0.001 0.001 0.004 0.000 0.001 0.001 0.006  
iDPP 0.562 13.853 1.404 34.632 0.638 14.174 1.595 35.435 3 x107*** 
RDP 0.001 0.005 0.001 0.013 0.001 0.006 0.002 0.014  
TXP 0.023 0.554 0.058 1.386 0.028 0.657 0.071 1.641  
BDP 0.046 0.565 0.115 1.412 0.059 0.657 0.147 1.643  
*
taken from (Cequier et al., 2014), 
**




Table 13 – Daily exposure of FRs from dust for adults (non-workers) from UK and Norway houses with average and high dust ingestion rates  
 
Adults ng/kg bw/day - Average ingestion rate -  Non-workers 
t=24h 
Adults ng/kg bw/day - High ingestion rate -Non-
workers -  t=24h - Worst case scenario 
 
 UK houses Norwegian houses UK houses Norwegian houses  
FR Median Maximum Median Maximum Median Maximum Median Maximum 
RfD (ng/kg 
bw day) 
BDE28 0.001 0.003 0.001 0.001 0.002 0.008 0.002 0.004  
BDE47 0.003 0.196 0.001 0.027 0.009 0.489 0.002 0.068 1 x102 
BDE66 0.003 0.003 0.000 0.000 0.007 0.007 0.001 0.001  
BDE85 0.001 0.036 0.002 0.002 0.003 0.090 0.004 0.004  
BDE100 0.001 0.078 0.007 0.007 0.002 0.194 0.017 0.017  
BDE153 0.002 0.128 0.001 0.004 0.006 0.320 0.002 0.011 2 x102 
BDE154 0.001 0.078 0.001 0.003 0.003 0.195 0.004 0.007  
BDE183 0.002 0.038 0.001 0.037 0.004 0.095 0.003 0.093  
Σ8PBDEs 0.014 0.560 0.014 0.081 0.036 1.399 0.035 0.204  
BDE209 0.957 14.457 0.046 0.881 2.394 36.144 0.115 2.203 7 x103 
Σ9PBDEs 0.986 15.577 0.074 1.044 2.465 38.941 0.184 2.610  
EH-TBB 0.001 0.009 0.002 0.003 0.004 0.023 0.004 0.007  
BTBPE 0.008 0.029 0.085 0.085 0.021 0.071 0.214 0.214  
BEH-
TEBP 
0.030 0.067 0.008 0.122 0.076 0.167 0.019 0.304  
syn-DP 0.001 0.009 0.001 0.001 0.003 0.023 0.002 0.002  
anti-DP 0.002 0.009 0.001 0.001 0.005 0.023 0.002 0.004  
α-TBECH 0.000 0.002 0.000 0.001 0.001 0.004 0.001 0.002  
β-TBECH 0.000 0.001 0.000 0.000 0.000 0.002 0.000 0.001  
DBDPE 0.312 11.206 0.196 0.515 0.779 28.015 0.490 1.287  
ΣEHFRs 0.356 11.331 0.293 0.728 0.889 28.328 0.732 1.821  
TEHP 0.045 0.133 0.051 0.177 0.112 0.332 0.127 0.441  
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TnBP 0.075 0.137 0.139 0.892 0.187 0.342 0.346 2.231 2.4 x104 
EHDPHP 0.679 2.621 0.056 1.146 1.696 6.551 0.139 2.865 6 x106** 
TCEP 0.249 1.790 0.034 0.142 0.624 4.475 0.086 0.356 2.2 x104 
TBOEP 2.306 16.784 5.247 13.716 5.764 41.961 13.117 34.290 1.5 x104 
TPHP 0.431 2.728 0.237 0.835 1.078 6.821 0.593 2.087 7 x104 
TMPP 0.084 0.301 0.055 0.907 0.209 0.751 0.139 2.269  
TDCIPP 0.215 1.083 0.098 0.659 0.537 2.709 0.246 1.647 1.5 x104 
TCPP 18.442 288.571 0.560 9.683 46.104 721.429 1.399 24.208 8 x104 
Σ10PFRs 22.525 314.148 6.477 28.157 56.312 785.371 16.192 70.394  
V6 0.005 0.216 0.001 0.003 0.012 0.540 0.003 0.006  
TDBPP 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.001  
iDPP 0.115 0.482 0.015 0.075 0.286 1.205 0.037 0.187 3 x107*** 
RDP 0.001 0.001 0.001 0.001 0.001 0.002 0.001 0.001  
TXP 0.008 0.153 0.003 0.030 0.019 0.384 0.007 0.075  
BDP 0.019 0.139 0.010 0.199 0.048 0.346 0.025 0.498  
*taken from (Cequier et al., 2014), 
**
taken from (UK Environment Agency, 2009c),*** taken from (UK Environment Agency, 2009b) 
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Table 14 - Daily exposure of FRs from dust for toddlers from UK and Norway houses with average and high dust ingestion rate  
 Toddlers ng/kg bw/day - Average ingestion rate t=24h 
Toddlers ng/kg bw/day - High ingestion rate - 
t=24h -  Worst case scenario 
 
 UK houses Norwegian houses UK houses Norwegian houses  
FR Median Maximum Median Maximum Median Maximum Median Maximum 
RfD (ng/kg bw 
day)* 
BDE28 0.013 0.048 0.014 0.020 0.053 0.192 0.055 0.081  
BDE47 0.049 2.785 0.011 0.388 0.195 11.138 0.045 1.553 1 x102 
BDE66 0.039 0.039 0.005 0.005 0.156 0.156 0.021 0.021  
BDE85 0.015 0.512 0.024 0.024 0.060 2.049 0.094 0.094  
BDE100 0.013 1.106 0.095 0.095 0.052 4.423 0.379 0.379  
BDE153 0.033 1.821 0.012 0.060 0.133 7.285 0.049 0.239 2 x102 
BDE154 0.017 1.110 0.021 0.039 0.067 4.439 0.084 0.156  
BDE183 0.024 0.541 0.015 0.528 0.094 2.163 0.059 2.114  
Σ8PBDEs 0.203 7.961 0.196 1.159 0.811 31.844 0.785 4.637  
BDE209 13.622 205.695 0.654 12.537 54.488 822.780 2.618 50.146 7 x103 
Σ9PBDEs 14.027 221.617 1.047 14.855 56.109 886.468 4.189 59.421  
EH-TBB 0.020 0.130 0.022 0.037 0.081 0.520 0.088 0.150  
BTBPE 0.121 0.407 1.215 1.215 0.483 1.626 4.862 4.862  
BEH-TEBP 0.431 0.951 0.110 1.732 1.724 3.805 0.441 6.927  
syn-DP 0.018 0.128 0.011 0.014 0.073 0.512 0.042 0.055  
anti-DP 0.027 0.128 0.012 0.021 0.110 0.514 0.050 0.083  
α-TBECH 0.005 0.025 0.005 0.013 0.021 0.101 0.020 0.050  
β-TBECH 0.002 0.009 0.002 0.004 0.010 0.037 0.010 0.015  
DBDPE 4.435 159.435 2.789 7.325 17.740 637.740 11.154 29.301  
ΣEHFRs 5.060 161.214 4.166 10.361 20.241 644.855 16.666 41.442  
TEHP 0.638 1.890 0.724 2.512 2.553 7.561 2.894 10.049  
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TNBP 1.065 1.947 1.972 12.695 4.260 7.789 7.886 50.780 2.4 x104 
EHDPHP 9.654 37.285 0.793 16.305 38.618 149.138 3.171 65.220 6 x106** 
TCEP 3.549 25.467 0.488 2.024 14.195 101.870 1.951 8.098 2.2 x104 
TBOEP 32.805 238.801 74.650 195.146 131.220 955.203 298.602 780.585 1.5 x104 
TPHP 6.134 38.817 3.374 11.878 24.537 155.268 13.496 47.512 7 x104 
TMPP 1.191 4.276 0.789 12.911 4.764 17.106 3.154 51.642  
TDCIPP 3.057 15.415 1.398 9.374 12.228 61.659 5.593 37.496 1.5 x104 
TCPP 262.382 4105.691 7.963 137.768 1049.528 16422.764 31.854 551.073 8 x104 
Σ10m-PFRs 320.476 4469.589 92.150 400.614 1281.902 17878.358 368.602 1602.455  
V6 0.067 3.073 0.016 0.036 0.270 12.293 0.066 0.143  
TDBPP 0.002 0.002 0.002 0.003 0.008 0.008 0.010 0.011  
iDPP 1.630 6.858 0.209 1.065 6.520 27.431 0.834 4.260 3 x107*** 
RDP 0.008 0.013 0.007 0.007 0.031 0.050 0.029 0.029  
TXP 0.108 2.183 0.037 0.427 0.431 8.732 0.148 1.707  
BDP 0.272 1.972 0.144 2.833 1.086 7.886 0.576 11.333  
*taken from (Cequier et al., 2014), 
**





2.4 Conclusions  
Our study reports levels of legacy and alternative FRs in house dust samples from Norway 
and the UK, as well as from British stores and offices. The median levels of m-PFRs were 
found to be considerably higher in all environments compared to EHFRs, PBDEs and o-
PFRs. Due to higher FR concentrations in British house dust samples, the estimated human 
intakes for FRs for toddlers in Britain were found to be higher than toddlers in Norway. 
However, the small number and representativeness of samples analysed in the present study 
should be carefully considered as it represents a major uncertainty in these intake 
calculations. In the worst case scenario, BDE209 estimated intake for British toddlers did not 
exceed the proposed RfD, yet it was considerably higher than for Norwegian toddlers, thus 
setting British toddlers more prone to potentially adverse health effects related to BDE209 
exposure compared to Norwegian ones. This is the first study reporting human exposure via 
dust ingestion for most o-PFRs. Toddler estimated intakes for o-PFRs were found to be 
higher than stay-home adults in both countries. In the worst case scenario, iDPP estimated 
intake for employees in a British-based toy store was considerably higher than for other o-
PFRs, together with TDBPP and TXP. This is the first study reporting considerable 
concentrations of iDPP and TXP in the indoor environment of Norway and the UK. iDPP and 
TXP together with other halogen-free alternatives such as EHDPHP, are likely to be 
considered in the future as substances of high toxicological interest for two reasons: a) their 
potential for human exposure via dust ingestion is considerable and b) their toxicological 
potency to humans remains unresolved. TXP reproductive toxicity to humans has been 
reported (ECHA, 2013; Latendresse et al., 1994), while signs of teratogenic alterations have 
been observed when iDPP and EHDPHP were orally administered in rodents (Robinson et 
al., 1986) . Also, inhalation has been proposed as a significant route of exposure for several 
m-PFRs (Cequier et al., 2015; Schreder et al., 2016). Therefore, future research should be 
considered on the possible adverse health effects of o-PFRs in humans and potential 
alternative routes of exposure such as inhalation and dermal uptake, as well as measuring 








Chemicals and Reagents 
Standards of BDE 28, 47, 66, 85, 100, 153, 154, 183 and 209, EH-TBB, BTBPE, Dechlorane plus (syn- 
and anti-DP isomers), BEH-TEBP, TBECH (alpha and beta isomers) and labelled internal standards 
(IS) 13C-BDE 209 were purchased from Wellington Laboratories (Guelph, ON, Canada). BDE 77 and 
128 IS were obtained from AccuStandard Inc. (New Haven, CT, USA). Standards of tri-n-propyl 
phosphate (TnPP), tri-isobutyl phosphate (TiBP), tri-n-butyl phosphate (TnBP), triphenyl phosphate 
(TPHP), tris(2-chloroethyl) phosphate (TCEP) and tris(1,3-dichloropropyl) phosphate (TDCIPP, 
mixture of 2 isomers) were purchased from Chiron AS (Trondheim, Norway). Triamyl phosphate (TAP; 
IS) was purchased from TCI Europe (Zwijndrecht, Belgium). Labeled TPP-d15 IS and tris(2-
butoxyethyl) phosphate (TBOEP) were purchased from Sigma Aldrich. Tris(1-chloro-2-propyl) 
phosphate (TCPP, mixture of 3 isomers) was purchased from Pfaltz & Bauer (Waterbury, CT, USA). 
Purity of analytical standards was >98%, except for TBOEP (>94%). Resorcinol bis(diphenyl 
phosphate) (PBDPP or RDP) and  Bisphenol A bis(diphenyl phosphate) (BPA-BDPP or BDP) were 
purchased from TRC (Toronto, ON, Canada). The purities of the standards were 95.8% for RDP and 
98% for BDP, respectively. Standards of isodecyl diphenyl phosphate (iDPP) were purchased from 
Accustandard (New Haven, CT, USA) and purity was 45% (in a mix with 55% TPHP, marketed as 
“Santicizer 148”), while Trixylenyl phosphate (TXP) standard was purchased from Chemos 
(Regenstauf, Germany) and was of technical grade. Standard stock solutions were prepared in iso-
octane for PBDEs, EHFRs and m-PFRs, whereas standard stock solutions for o-PFRs were prepared in 
MeOH. 
Indoor dust reference material SRM 2585 was purchased from the US National Institute of Standards 
and Technology (NIST, Gaithersburg, MD, USA). Empty, pre-fritted polypropylene filtration tubes (6 
mL) for silica SPE cartridge preparation and Amino Propyl (NH2)/silica-based cartridges (500 mg, 3 
mL) were purchased from Agilent. For 5% acidified silica gel preparation, concentrated sulphuric acid 
(H2SO4, >96%) was used and was purchased from Merck. Briefly, 1.9 mL of pure sulphuric acid was 
added drop-wise to 50 g of hexane-washed, oven-dried silica gel under continuous and vigorous stirring. 
Glass test tubes were cleaned by soaking for at least 12 h in an alkali solution. After washing, the tubes 





Target analytes and analytical characteristics 
Table SI-1 – Nomenclature and analytical characteristics of the internal standards 




(m/z) Category Instrumental analysis 
BDE 77 3,3 ,4,4 -Tetrabromodiphenyl ether IS 79 81 PBDE GC-ECNI-MS 
BDE 128 2,2 ,3,3 ,4,4 -Hexabromodiphenyl ether IS 79 81 PBDE GC-ECNI-MS 
13C-BDE 209 13C-labeled decabromodiphenyl ether IS 495 497 PBDE GC-ECNI-MS 
13C-anti-DP 13C-syn-dechlorane plus IS 664 662 EHFR GC-ECNI-MS 












IS 257 259 EHFR GC-ECNI-MS 
TAP Triamyl phosphate IS 239 169 m-PFR1 GC-EI-MS 




IS 394 396 m-PFR GC-EI-MS/LC-MS-MS 
TBOEP-d6 tris-(butoxyethyl)-phosphate-D6 IS 303 202 m-PFR GC-EI-MS 
TCEP-d12 Tris(2-chloroethyl) phosphate-D12 IS 341 339 -m-PFR GC-EI-MS 




Table SI-2 – Nomenclature and analytical characteristics of PBDEs and EHFRs 





Quantify against IS Category 
Instrumental 
analysis 
BDE28 2,4,4'-Tribromodiphenyl ether Target 79 81 BDE 77 PBDE GC-ECNI-MS 
BDE47 2,2',4,4'-Tetrabromodiphenyl ether Target 79 81 BDE 77 PBDE GC-ECNI-MS 




Target 79 81 BDE 77 PBDE GC-ECNI-MS 












Target 79 81 BDE 128 PBDE GC-ECNI-MS 












Target 464 384 13C- BEH-TEBP EHFR GC-ECNI-MS 
syn-DP syn-dechlorane plus isomer Target 654 652 13C-syn-DP EHFR GC-ECNI-MS 








Target 79 81 BDE 77 EHFR GC-ECNI-MS 





Table SI-3 – Nomenclature and analytical characteristics of monomeric PFRs  










TEHP Tris(2-ethylhexyl)phosphate Target 211 99 TAP m-PFR GC-EI-MS 
TnPP  Tri-n-propyl phosphate Target 99 183 TAP m-PFR GC-EI-MS 
TnBP tri(n-butyl)phosphate Target 211 155 TAP m-PFR GC-EI-MS 
EHDPHP  2-ethylhexyl-di-phenylphosphate Target 251 250 TAP m-PFR GC-EI-MS 
TCEP Tris(2-chloroethyl)phosphate Target 249 251 TCEP-d12 m-PFR GC-EI-MS 
TBOEP tris-(butoxyethyl)-phosphate Target 299 199 TBOEP-d6 m-PFR GC-EI-MS 
TPHP triphenyl phosphate Target 326 325 TPHP-d15 m-PFR GC-EI-MS 




Target 381 379 TDCPP-d15 m-PFR GC-EI-MS 
TCPP** tris(chloropropyl)phosphate Target 277 279 TDCPP-d15 m-PFR GC-EI-MS 
*in four isomers, ** in two isomers;  
Table SI-4 - Nomenclature and analytical characteristics of monomeric PFRs and oligomeric PFRs 
Abbreviation Full name Used as 
Quantifier ion 
(m/z) 
Qualifier ion 1 
(m/z) 















Target 698.6->99 696.6 -> 99.0 700.6 -> 99.0 TDCPP-d15 m-PFR LC-MS-MS 




Target 575.1->77 575.1 -> 152.0 575.1 -> 419.1 TPHP-d15 o-PFR LC-MS-MS 
TXP trixylenyl phosphate Target 411.1 -> 105.0 411.1 -> 77.1 411.1 -> 179.0 TPHP-d15 m-PFR LC-MS-MS 
BDP 
bisphenol A bis(diphenyl 
phosphate) 
Target 693.2->367.1 694.1 -> 367.1 694.1 -> 368.1 TPHP-d15 o-PFR LC-MS-MS 






IS 342.2->82.1 342.2->223.0 342.2->159.5   LC-MS-MS 




GC/ECNI-MS: Two µL of cleaned extract were injected on a DB-5 column (15 m×0.25 mm×0.10 µm) 
using solvent vent injection. The injection temperature was set at 92 °C, hold 0.04 min, ramp 700 
°C/min to 295 °C. Injection was performed under a pressure of 0.19 bar until 1.25 min and purge flow 
to split vent of 50 mL/min after 1.25 min. The GC temperature program was 90 °C, hold 1.50 min, ramp 
10 °C/min to 300 °C, hold 3 min, ramp 40 °C/min to 310 °C, hold 5 min. Helium was used as a carrier 
gas with a flow rate of 1.0 mL/min. The mass spectrometer was employed in selected ion monitoring 
(SIM) mode. Dwell times were set on 35 ms. The ion source, quadrupole and interface temperatures 
were set at 250, 150 and 300 °C, respectively and the electron multiplier voltage was at 2200 V. Methane 
was used as moderating gas.  
GC/EI-MS: One µL of purified extract was injected on a HT-8 column (25 m×0.22 mm×0.25 µm) using 
cold splitless injection. The injection temperature was set at 90 °C, hold 0.03 min, ramp 700 °C/min to 
290 °C. Injection was performed using a pressure of 1 bar until 1.25 min and purge flow to split vent of 
50 mL/min after 1.25 min. The GC temperature program was 90 °C, hold 1.25 min, ramp 10 °C/min to 
240 °C, ramp 20 °C/min to 310 °C, hold 16 min. Helium was used as a carrier gas with a flow rate of 
1.0 mL/min. The mass spectrometer was run in selected ion monitoring (SIM) mode. Dwell times 
ranged between 20 and 30 ms in different acquisition windows. The ion source, quadrupole and 
interface temperatures were set at 230, 150 and 300 °C, respectively and the electron multiplier voltage 
was at 2200 V. 
LC-MS/MS: For the instrumental analysis, an Agilent 1290 Infinity liquid chromatography (LC) system 
(Agilent Technologies, Santa Clara, CA, USA) coupled to an Agilent 6460 Triple Quadrupole mass 
spectrometer (MS) was employed, equipped with a Jetstream® electrospray ionization (ESI) ion source. 
The LC parameters were optimised to provide both good chromatographic separation and minimal run 
tine, in order to maximise sample throughput. A volume of 3 μL of extract was injected on a 
Phenomenex (Torrance, CA, USA) Kinetex Biphenyl reversed phase column (2.1 x 50 mm, 1.7 μm), at 
a column oven temperature of 55 °C. The mobile phases were A: ultrapure H2O and B: MeOH, both 
containing 5 mM ammonium formate. Separation was achieved using a flow rate of 0.5 mL/min and a 
gradient from 55 B to 94% B in 3.4 min, followed by 1 min hold before returning to the initial 
conditions, making the total run time of 4.5 minutes. The column is re-equilibrated for the next run 
during a 2.5 min post time. The source parameters were initially optimised for all main analytes 
individually and subsequently a set of values for these parameters were selected to provide the best 
response for all considered analytes. As such, the drying gas temperature was set at 350 °C, the gas 
flow at 3 L/min, the nebulizer at 25 psi, sheath gas temperature 400 °C, sheath gas flow 12 L/min, 
capillary voltage 2700 V and nozzle voltage 0 V. The MS was operated in dynamic multiple-reaction 
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monitoring (dMRM) mode, with 2-10 ion transitions for each analyte in their specific retention time 
(RT) window (RT ± 0.5 min). The Agilent MassHunter Workstation Software version B.06.00 was used 
for all aspects of data analysis. 
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Table SI 5 – Daily exposure of FRs (ng/kg bw/day) for adult workers (t=8h) in UK offices (n=6) with average and high dust ingestion rate  
 S1 S2 S6 S7 S9 S10  





BDE28 0.000 0.001 0.000 0.000 0.003 0.008 0.001 0.002 0.700 1.750 0.000 0.000  
BDE47 0.002 0.004 0.000 0.000 0.001 0.002 0.001 0.002 0.001 0.002 0.000 0.000 1 x102 
BDE66 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000  
BDE85 0.000 0.001 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000  
BDE100 0.000 0.001 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000  
BDE153 0.001 0.002 0.000 0.001 0.001 0.003 0.000 0.001 0.001 0.002 0.000 0.000 2 x102 
BDE154 0.000 0.001 0.000 0.000 0.000 0.001 0.000 0.001 0.001 0.001 0.000 0.000  
BDE183 0.000 0.001 0.001 0.002 0.004 0.011 0.001 0.003 0.003 0.007 0.000 0.001  
Σ8PBDEs 0.004 0.010 0.001 0.003 0.010 0.025 0.004 0.010 0.705 1.763 0.000 0.001  
BDE209 0.482 1.206 0.076 0.190 0.186 0.465 0.608 1.519 0.545 1.363 0.009 0.022 7 x103 
Σ9PBDEs 0.487 1.217 0.077 0.193 0.196 0.490 0.612 1.529 1.250 3.125 0.009 0.023  
EH-TBB 0.002 0.004 0.000 0.000 0.000 0.001 0.002 0.004 0.004 0.011 0.000 0.000  
BTBPE 0.000 0.000 0.000 0.000 0.001 0.003 0.003 0.008 0.004 0.010 0.000 0.000  
BEH-
TEBP 
0.059 0.147 0.002 0.006 0.008 0.020 0.083 0.208 0.242 0.605 0.005 0.012  
syn-DP 0.000 0.001 0.000 0.000 0.118 0.295 0.006 0.015 0.013 0.031 0.000 0.000  
anti-DP 0.001 0.003 0.000 0.000 0.528 1.321 0.042 0.105 0.037 0.093 0.000 0.000  
aTBECH 0.000 0.001 0.000 0.000 0.002 0.005 0.000 0.001 0.400 1.000 0.000 0.000  
bTBECH 0.000 0.000 0.000 0.000 0.001 0.001 0.000 0.000 0.139 0.348 0.000 0.000  
DBDPE 0.297 0.741 0.700 1.749 0.439 1.098 0.587 1.467 1.922 4.805 0.010 0.026  
ΣEHFRs 0.359 0.898 0.703 1.756 1.098 2.744 0.724 1.809 2.762 6.904 0.016 0.040  
TEHP 0.043 0.107 0.009 0.023 0.000 0.001 0.050 0.126 0.051 0.128 0.000 0.001  
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TnBP 0.039 0.097 0.033 0.081 0.021 0.053 0.027 0.067 0.027 0.067 0.028 0.069 2.4 x104 
EHDPHP 3.023 7.557 0.580 1.449 0.306 0.766 2.272 5.680 1.070 2.676 0.043 0.109 
6 
x106** 
TCEP 0.040 0.101 0.023 0.056 0.039 0.097 0.052 0.131 0.199 0.497 0.521 1.304 2.2 x104 
TBOEP 3.312 8.279 0.468 1.171 0.321 0.803 3.421 8.552 2.078 5.194 0.537 1.341 1.5 x104 
TPHP 0.857 2.143 0.127 0.317 0.145 0.364 1.143 2.858 0.310 0.775 0.444 1.109 7 x104 
TMPP 0.042 0.104 0.011 0.028 0.024 0.059 0.086 0.216 0.076 0.190 0.042 0.106  
TDCPP 0.099 0.246 0.019 0.046 0.066 0.166 0.115 0.287 1.214 3.034 0.204 0.511 1.5 x104 
TCPP 14.853 37.132 0.958 2.396 14.511 36.278 5.343 13.357 2.830 7.076 0.477 1.193 8 x104 
Σ10PFRs 22.307 55.769 2.228 5.571 15.436 38.589 12.510 31.275 7.856 19.641 2.299 5.747  
V6 0.003 0.009 0.000 0.001 0.001 0.002 0.004 0.010 0.000 0.000 0.000 0.001  
TDBPP 0.000 0.000 0.000 0.001 0.000 0.001 0.000 0.000 0.000 0.000 0.000 0.000  
iDPP 0.729 1.822 0.190 0.474 0.086 0.214 0.681 1.703 0.000 0.000 0.061 0.153 
3 
x107*** 
RDP 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000  
TXP 0.007 0.016 0.002 0.005 0.004 0.009 0.035 0.087 0.000 0.000 0.007 0.018  
BDP 0.002 0.004 0.000 0.000 0.003 0.008 0.087 0.218 0.000 0.000 0.068 0.169  
*taken from (Cequier et al., 2014), 
**




Table SI 6- Daily exposure of FRs (ng/kg bw/day) for adult workers (t=8h) in UK stores (n=6) with average and high dust ingestion rate  
 S3 S4 S5 S8 S11 S12  




BDE28 0.000 0.001 0.001 0.002 0.001 0.001 0.001 0.002 0.001 0.002 0.001 0.004  
BDE47 0.001 0.003 0.011 0.028 0.002 0.004 0.001 0.002 0.001 0.002 0.002 0.005 1 x102 
BDE66 0.000 0.000 0.001 0.001 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000  
BDE85 0.000 0.000 0.001 0.002 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000  
BDE100 0.000 0.001 0.003 0.007 0.001 0.001 0.000 0.001 0.000 0.000 0.001 0.001  
BDE153 0.000 0.001 0.003 0.007 0.001 0.002 0.000 0.001 0.000 0.001 0.000 0.001 2 x102 
BDE154 0.000 0.001 0.001 0.004 0.000 0.001 0.000 0.001 0.000 0.000 0.000 0.001  
BDE183 0.001 0.002 0.002 0.004 0.002 0.005 0.003 0.007 0.001 0.002 0.001 0.002  
Σ8PBDEs 0.003 0.008 0.022 0.055 0.006 0.014 0.006 0.014 0.003 0.007 0.006 0.014  
BDE209 0.404 1.010 0.230 0.574 0.739 1.848 1.036 2.589 0.281 0.702 0.580 1.450 7 x103 
Σ9PBDEs 0.407 1.018 0.252 0.629 0.745 1.862 1.041 2.603 0.284 0.710 0.586 1.464  
EH-TBB 0.001 0.001 0.005 0.012 0.014 0.034 0.001 0.002 0.001 0.001 0.003 0.006  
BTBPE 0.002 0.005 0.008 0.019 0.002 0.005 0.002 0.004 0.000 0.000 0.003 0.008  
BEH-
TEBP 
0.018 0.046 0.146 0.364 0.147 0.366 0.018 0.044 0.021 0.053 0.026 0.065  
syn-DP 0.001 0.002 0.001 0.003 0.002 0.005 0.001 0.004 0.001 0.004 0.001 0.003  
anti-DP 0.003 0.007 0.004 0.011 0.006 0.016 0.004 0.010 0.004 0.011 0.003 0.009  
aTBECH 0.000 0.001 0.001 0.001 0.000 0.001 0.000 0.001 0.000 0.001 0.001 0.002  
bTBECH 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.001  
DBDPE 0.288 0.721 0.893 2.232 2.284 5.709 0.217 0.543 1.513 3.783 0.362 0.904  
ΣEHFRs 0.313 0.783 1.057 2.642 2.455 6.136 0.243 0.608 1.541 3.853 0.399 0.998  
TEHP 0.100 0.250 0.032 0.079 0.215 0.538 0.045 0.113 0.000 0.001 0.092 0.230  
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TnBP 0.021 0.053 0.025 0.061 0.023 0.058 0.022 0.055 0.028 0.070 0.046 0.116 2.4 x104 
EHDPHP 1.380 3.451 1.751 4.377 2.123 5.309 3.036 7.589 1.992 4.979 12.161 30.401 6 x106** 
TCEP 0.099 0.249 0.250 0.624 0.124 0.310 0.071 0.178 0.063 0.157 0.684 1.711 2.2 x104 
TBOEP 147.190 367.976 1.640 4.101 2.917 7.292 8.804 22.011 4.993 12.482 173.616 434.040 1.5 x104 
TPHP 0.446 1.115 0.650 1.624 0.435 1.087 1.215 3.038 0.697 1.743 3.628 9.070 7 x104 
TMPP 0.086 0.214 0.109 0.273 0.102 0.254 0.075 0.188 0.102 0.254 0.111 0.277  
TDCPP 1.180 2.949 0.132 0.329 0.088 0.220 0.128 0.319 0.082 0.205 1.217 3.041 1.5 x104 
TCPP 2.277 5.694 2.627 6.569 1.001 2.502 1.926 4.814 0.841 2.102 3.457 8.642 8 x104 
Σ10PFRs 152.781 381.953 7.216 18.041 7.029 17.573 15.324 38.311 8.798 21.994 195.013 487.532  
V6 0.006 0.016 0.049 0.122 0.048 0.120 0.015 0.038 0.001 0.003 0.011 0.027  
TDBPP 0.000 0.000 0.001 0.004 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000  
iDPP 0.650 1.625 0.279 0.698 0.562 1.404 1.448 3.620 0.338 0.845 13.853 34.632 3 x107*** 
RDP 0.000 0.000 0.001 0.001 0.000 0.000 0.000 0.000 0.000 0.000 0.005 0.013  
TXP 0.023 0.058 0.554 1.386 0.026 0.064 0.009 0.023 0.179 0.447 0.134 0.335  
BDP 0.150 0.376 0.107 0.268 0.019 0.047 0.024 0.061 0.006 0.015 0.565 1.412  
*taken from (Cequier et al., 2014), 
**
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Human uptake of flame retardants (FRs) such as polybrominated diphenyl ethers (PBDEs) 
via indoor dust ingestion is commonly considered as 100% bioaccessible, leading to potential 
risk overestimation. Here, we present a novel in vitro colon-extended physiologically-based 
extraction test (CE-PBET) with Tenax TA® as an absorptive “sink” capable to enhance 
PBDE gut bioaccessibility. A cellulose-based dialysis membrane (MW cut-off 3.5kDa) with 
high pH and temperature tolerance was used to encapsulate Tenax TA®, facilitating efficient 
physical separation between the absorbent and the dust, while minimizing re-absorption of 
the ingested PBDEs to the dust particles. As a proof of concept, PBDE-spiked indoor dust 
samples (n=3) were tested under four different conditions; without any Tenax TA® addition 
(control) and with three different Tenax TA® loadings (i.e. 0.25, 0.5 or 0.75 g). Our results 
show that in order to maintain a constant sorptive gradient for the low MW PBDEs, a larger 
mass of Tenax TA® is required, hence 0.5 g of Tenax TA® were used below. Tenax TA® 
inclusion favoured gut bioaccessibility reaching 40% for BDE153 and BDE183, with greater 
increases seen for less hydrophobic PBDEs such as BDE28 and BDE47 (̴ 60%). When tested 
against SRM 2585 (n=3), our new Tenax TA® method did not present any statistically 
significant spiking effect (p>0.05) between treatments. Our study describes an efficient 
method where due to the sophisticated design, the sorption capacity of Tenax TA® is 
predominantly used for PBDEs rather than media components, thus leading to simplified 











 First method employing dialysis membrane for physical separation between Tenax 
TA® and dust 
 Tenax TA® used as an absorption sink trapped in dialysis membrane mimics the 
situation in vivo 
 CE-PBET performance was tested under different Tenax TA® loadings (0.25, 0.5 & 
0.75 g) 






Due to the non-polar and hydrophobic nature of hydrophobic organic compounds (HOCs) 
such as PBDEs, sorption to indoor dust is likely to occur via volatilisation (García-Alcega et 
al., 2016), marking dust ingestion as a potential major route of exposure to FRs for humans 
(Alves et al., 2014; Jones-Otazo et al., 2005). Hence, in vitro bioaccessibility studies have 
been deployed, assessing human exposure to contaminated indoor dust on a wide spectrum of 
HOCs including brominated flame retardants (BFRs) (Abdallah et al., 2012), organophosphate 
FR (OPFRs) (He et al., 2016a; Quintana et al., 2017), pesticides and polychlorinated biphenyls 
(PCBs) (Ertl and Butte, 2012) and polybrominated diphenyl ethers (PBDEs) (Yu et al., 2012). 
However, the lack of an adsorption sink in the various test formats may lead to risk 
underestimation due to the absence of constant concentration gradient (Collins et al., 2015).  
To separate aqueous and solid matrices, a regenerated cellulose (RC) dialysis tubing method 
was employed, studying the sorption and dissolution of perchloroethane and PAHs from clay-
rich materials and sewage sludges, respectively (Allen-King et al., 1995; Woolgar and Jones, 
1999). RC membranes present high pH and temperature tolerances, carry no fixed charge and 
are highly resistant to halogenated hydrocarbons, such as PBDEs (Pollard, 1987). Tubing 
characteristics including length, width, membrane sealing method and molecular weight cut 
off (MWCO) have been evaluated.  For example, 2.5 g of contaminated sewage sludge were 
introduced into 10 cm of dialysis tubing with a 3.5 kDa MWCO (Woolgar and Jones, 1999). 
Alternatively, 20 cm of dialysis tubing (29 mm width; 12-14 kDa MWCO) was used to 
ensure that at least 30% of the analyte mass would remain in the solid phase after 
equilibration (Allen-King et al., 1995). The solid material in the tubing was then introduced 
inside glass bottles with synthetic groundwater spiked with the HOCs of interest. During 
equilibration, all non-settling particles were retained inside the dialysis membrane, while 
dissolved organic pollutants could permeate through the membrane and equilibrate across the 
dialysis tubing by passive diffusion (Allen-King et al., 1995).  
In the work presented here, we describe a novel in vitro method capable to overcome the 
aforementioned challenges concerning physical separation and recovery of Tenax TA® from 
the matrix, while facilitating its successful inclusion and performance as an adsorption sink in 
a previously established bioaccessibility test, namely CE-PBET, for the assessment of oral 
bioaccessibility of PBDEs from indoor dust. Our study aims are to systematically (a) develop 
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an efficient method to separate Tenax TA® and indoor dust as a matrix whilst enabling 
desorption of PBDEs to the Tenax TA® and (b) optimise Tenax TA® as an absorption sink for 
PBDEs in a colon-extended gastro-intestinal bioaccessibility in vitro system (CE-PBET). 
3.2 Materials and methods 
3.2.1 Target analytes and indoor dust  
An indoor dust sample was collected in 2013 from a pre-existing vacuum cleaner bag in an 
office at Reading (UK) and was used during method development tests. The dust sample was 
sieved to <250μm, a particle cut off likely to be ingested by humans (Yu et al., 2012), using a 
hexane-washed, metallic sieve and stored in hexane-washed, amber glass bottles at +4oC. 
Concentrations of all target analytes in all dust samples were determined using methods 
described elsewhere (Kademoglou et al., 2017). Briefly, 30 mg of dust was extracted with 2.5 
mL hexane:acetone (3:1) using ultra-sonication extraction for 10 min and vortexing for 1 min 
three times. The combined extract was concentrated to 1 mL and loaded on aminopropyl 
(NH2) silica cartridges (500 mg, 3 mL, Agilent, USA) and further fractionated with 10 mL 
hexane. The eluate was then further concentrated, following a clean-up on an acidified silica 
cartridge (5%, 1 g, 6 mL) and elution with 12 mL dichloromethane. The dust extracts were 
then evaporated, reconstituted with 100 μL of iso-octane and filtered (0.45 μm). Finally, the 
extracts were transferred to injection vials and analyzed on GC-ECNI-MS. Standard 
reference material for indoor dust SRM 2585 (organic contaminants in house dust), 
purchased from the US National Institute of Standards and Technology (NIST, USA), was 
used for method validation. Both SRM 2585 (used for method validation) and dust samples 
(0.5g) (used for method development) were spiked at environmentally relevant 
concentrations (200 ng; 200 L of PBDEs native standard mix 1 ng/L prepared in iso-
octane and 100 L nBFRs native standard mix 2 ng/L prepared in toluene) and the validity 
of the spiking was confirmed analytically for both the SRM 2585 and the dust. After spiking, 
samples were shaken for 2h on an orbital shaker and allowed to stand inside a fumehood for 
6h before the gastro-intestinal extraction for the solvent to evaporate, thus facilitating 




3.2.2 Dialysis membrane  
Approximately 16 cm of standard grade, flexible and transparent regenerated cellulose (RC) 
dialysis membrane with 3.5 kDa MWCO and 18 mm flat width (1.1mL/cm) (Spectra/Por™ 3, 
SpectrumLabs Inc., USA) was used to encapsulate the Tenax TA® beads. The membrane 
length and flat width were selected for the sample volume to be added in the membrane using 
an online tool provided by SpectrumLabs Inc. 
(http://www.spectrumlabs.com/dialysis/dtCalc.html), allowing for tube sealing with 19mm 
metallic clips. MWCO selection for the RC membrane is primarily governed by the 
molecular weight (MW) of the biological molecules of the GI compartments and the target 
analytes of our study. The MWCO was selected to be over three-fold higher than the highest 
MW of the target analytes (i.e. BDE183 MW: 722 Da). The diffusion of PBDEs across the 
membrane was aided by the addition of 10mL of GIT fluid inside the RC membrane/Tenax 
TA® system.  
3.2.3 Gastro-intestinal Extraction 
The gastro-intestinal extraction test involved three compartments, namely stomach (1h; 
pH=2.5), small intestine (4h; pH=7) and colon (16h; pH=6.5) tested in sequential mode (Fig. 
1). Fed CE-PBET conditions were achieved by the addition of dietary components into 
stomach and colon incubations as described in (Tilston et al., 2011) and all media were 
prepared in deionised H2O (dH2O). All experiments were conducted in triplicate. Gut media 
aliquots (80 mL) were added into clean, amber 100 mL Duran® glass bottles, sealed with 
PTFE-lined screw caps and stored at -20oC prior use if necessary. Tenax TA® beads were 
cleaned prior use to remove fine particles by ultrasonication with 40mL acetone (x2), 40mL 
acetone:hexane 1:1 (x2) and 40mL hexane (x2) for 10 min in each sonication step. Tenax® 
TA was then allowed to air-dry at 105oC overnight and was stored in a hexane-washed, 
Duran® bottle inside a desiccator.  A short video demonstration of the Tenax TA® inclusion 
in the RC dialysis membrane is available online 
https://figshare.com/s/e7312fa7d177b35bc7d0  .Before employment, the RC dialysis 
membrane was soaked in ultra-pure H2O at room temperature for 45 min under continuous 
stirring to remove any preservatives such as glycerine and sodium azide. The RC membrane 
was then thoroughly rinsed with dH2O and one side sealed with a 19mm hexane-washed, 
metallic clip. Using a small glass funnel, Tenax TA® (0.5 g) was added inside the RC 
membrane, followed by 10 mL of stomach medium. The tubing was then sealed using 
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another metallic clip. Then, 0.5 g of indoor dust were added in the remaining 70 mL of 
stomach fluid and the RC membrane/Tenax TA® system was introduced to the bottle (Fig 
1A). A solid-to-liquid (S/L) ratio 1:140 was achieved, thus preventing any bioaccessibility 
underestimation due to poor dissolution (Abdallah et al., 2012; Dean and Ma, 2007). The 
bottles were placed at 45o angle inside a temperature-controlled waterbath at 37 oC and 
rotated at 130 rpm for 1h, mimicking the GIT peristaltic movement. After 1 h, the samples 
were removed from the waterbath and, due to the continuous character of CE-PBET, stomach 
fluid was converted to small intestine media (SI) by addition of bile salts (0.5 g/L) and 
pancreatine (1.78 g/L) with pH adjusted to 7 using saturated NaHCO3. The small intestine 
incubation continued as above for 4h (Fig 1B). The RC membrane/Tenax TA® system was 
then removed from the bottle and was allowed to sediment for 15min. Due to its hydrophobic 
character, unsaturated Tenax TA® floats on top of the small intestine fluid inside the 
membrane (Fig. SI 1). Tenax TA® was trapped on the one side of the membrane, while the 
other side was carefully unsealed. The small intestine fluid inside the membrane was 
carefully collected (≈8 mL), was subsequently combined with the remaining 70 mL from the 
incubation and stored at +4 oC prior to liquid-liquid extraction (LLE).  
The transition between the small intestine and colon compartments was achieved by physical 
transfer: the dust was recovered from the 70 mL of small intestine media by centrifugation 
(3500rpm, 15min), then added to 70 mL of colon medium. Using the same RC membrane and 
Tenax TA® as in the small intestine compartment, approximately 8 mL of pre-warmed colon 
medium were added and sealed with the metallic clips as described for the stomach 
compartment, re-introduced into the bottle where the indoor dust was re-suspended using the 
colon medium and incubated for 16h (Fig 1C). At the end of the colon incubation, the dust 
pellet was recovered by centrifugation as before and stored at -20oC for extraction. Finally, 
Tenax TA® was recovered using clean cotton wool filtration, the colon fluid was passed 
through cotton wool, combined with the remaining 70 mL of colon fluid and stored at +4 oC 
for LLE (Fig 7). The cotton wool pieces from filtration together with the Tenax TA®, the RC 
membrane and the metallic clippers were collected in one bottle for ultra-sonication assisted 
extraction. More details on Tenax TA® filtration and recovery are available at SI. 
3.2.4 Extraction and clean up 
Before extraction, all samples were spiked with 200 ng of internal standard (ISTD) mix (100 
μL of 2 ng/μL) prepared in toluene (PBDEs: BDE77 for BDE28, 47 and 100, BDE128 for 
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BDE153, 154 and 183 quantifications; nBFRs: 13C-EH-TBB-d17, 13C-BTBPE, 13C-BEH-
TEBP-d17 for EH-TBB, BTBPE and BEH-TEBP, respectively) and shaken on an orbital 
shaker for 1h. Gut fluids were subjected to a LLE using 30 mL hexane/ethyl acetate 3:1 v/v 
twice (Fig.8 – step 1). Two mL of acetone were added to enhance separation, when 
necessary. A gel-like emulsion bilayer (mainly lipid and carbohydrates) was developed, 
especially in the colon compartment. Oven-baked Na2SO4 (400 
oC; powder) was added in the 
combined LLE extracts to absorb all remaining water residues and dissolve the gel-like 
emulsion. All samples were then allowed to settle for 1h at room temperature and the extracts 
were collected by centrifugation (3500rpm, 15min). The residual dust and the recovered 
Tenax TA® beads (together with the glass wool and the metallic clips) were subjected to 
ultra-sonication assisted extraction for 15 min using 30mL acetone/hexane 1:3 v/v twice (Fig. 
SI-2 – step 2 & 3). After each step, the extracts were collected by centrifugation (3500 rpm, 
15 min).   
All extracts collected from each step were combined, evaporated to 1mL hexane using 
Syncore ® Analyst evaporator (Buchi, Switzerland) and then loaded onto Florisil® cartridges 
(2g, 6mL), using a slightly modified method published elsewhere (Van den Eede et al., 
2012b) (Fig. SI2 – step 4). Briefly, Florisil® cartridges were pre-cleaned with 10 mL ethyl 
acetate and 6 mL of hexane; our target analytes were eluted using 20 mL hexane. This eluate 
was further concentrated to 1mL (in hexane) and then subjected to SPE clean-up on 5% 
acidified silica (5% AS) (2 g, 6 mL). The 5% AS cartridges were pre-cleaned with 6 mL 
hexane and 3 mL dichloromethane and then all extracts from the Florisil® step were loaded 
onto the SPE silica column. Our target analytes were eluted using 16 mL hexane and 8 mL 
dichloromethane and after collection, all eluates were concentrated near dryness under a 
gentle stream of N2, reconstituted in 100 μL of toluene and then filtered (0.45 μm). Finally, 
the samples were transferred to injection vials, biphenyl (40 ng) was added as an injection 
recovery standard and analysed by GC-EI-MS. Further details about sample preparation and 




Figure 7– Stepwise representation of RC membrane /Tenax TA system after incubation of each CE-
PBET compartments, namely (A) stomach, (B) small intestine and (C) colon. Please note the 
unsaturated Tenax TA floating on top of the water based gut medium (A &B), while the saturated part 




Figure 8 – Schematic representation of CE-PBET gut compartments and parameters (i.e. stomach (1h, pH=2.5), small intestine (SI) (4h, pH=7) and 
colon (16h, pH=6.5)) using 0.5g Tenax TA® added in 16cm of RC dialysis membrane
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3.2.5 Data analysis  
Bioaccessibility can be expressed as a mass (e.g. ng of a contaminant solubilised in the GI 
tract), a concentration (ng/g of a contaminant in dust) or as a fraction expressed in percentage 
(BAF%) (Guney and Zagury, 2016). In our study, bioaccessibility was determined according 
to (García-Alcega et al., 2016) using Eq. 2, where mass FR (SI+colon+Tenax TA®) is set as 
the sum of FR mass (ng) determined in small intestine (SI), colon and Tenax TA® 
compartments of CE-PBET system and mass (dust residual) is the mass (ng) determined in 
the dust residual collected after 16h-incubation of CE-PBET colon compartment which is 
considered as the non-bioaccessible fraction.  
𝐵𝑖𝑜𝑎𝑐𝑐𝑒𝑠𝑠𝑖𝑏𝑖𝑙𝑖𝑡𝑦 % (𝐵𝐴𝐹%)
=
𝑚𝑎𝑠𝑠 𝐹𝑅 (𝑆𝐼 + 𝐶𝑜𝑙𝑜𝑛 + 𝑇𝑒𝑛𝑎𝑥 TA®) 
𝑚𝑎𝑠𝑠 𝐹𝑅 (𝑆𝐼 + 𝐶𝑜𝑙𝑜𝑛 + 𝑇𝑒𝑛𝑎𝑥) + 𝑚𝑎𝑠𝑠 (𝑑𝑢𝑠𝑡 𝑟𝑒𝑠𝑖𝑑𝑢𝑎𝑙)
 𝑥 100 
 (Eq.2)  
GraphPad Prism® version 7.04 for Windows (GraphPad Software, La Jolla CA, USA) was 
used for statistical analysis. Prior to statistical analysis, all BAF% were converted into 
fractions and arc-sine transformed. This mathematical transformation is necessary for 
statistical analysis of results set in percentages in order to equalise variances (R. R. Sokal and 
Rohlf, 1995). Multiple t-tests (unpaired; p<0.05) were performed to assess statistically 
significant differences among the different Tenax TA® amounts added (sections 3.1 and 3.2), 
whereas ordinary two-way ANOVA (Uncorrected Fisher’s test, p<0.05) was performed to 
assess statistical differences for bioaccessibility with and without the addition of Tenax TA® 
in SRM 2585 method validation (section 3.3). 
3.2.6 Quality assurance and quality control 
All samples were analysed in triplicate together with oven-baked, laboratory-grade sand 
(procedural blank) and SRM 2585 (n=3, NIST, USA) was used for method validation and QC 
testing. Concentrations of our target analytes in method blanks were all below method limit 
of detection (mLOD) (0.05 ng/μL). RC membrane and Tenax TA® blanks were extracted for 
FR background contamination prior use and all values were found below mLOD. Extraction 
efficiency (%) was assessed for SI, colon, Tenax TA® and residual dust compartments by 
spiking experiments (see SI Table 2). Briefly, 100 ng of native PBDEs (100 μL of 1 ng/μL) in 
iso-octane and 200 ng of native EHFRs (100 μL of 2 ng/μL) in toluene were spiked to SI and 
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colon media, Tenax TA® (0.5 g) and dust (0.5 g). All samples were shaken on an orbital 
shaker for 1h. Finally, 30 mL of the corresponding extraction medium was added in each 
compartment, following the same sample preparation processes as before. Extraction 
efficiency values for all target analytes were >60% in all CE-PBET compartments, except 
BDE100 efficiency which was 52% and 54% in Tenax TA® and residual dust, respectively. 
Despite the moderately lower extraction efficiency for BDE100 in comparison to the other 
target analytes, the relative standard deviation (RSD%) of the method for BDE100 was 6%. 
Given the low deviation and variability, no correction was performed for BDE100.Glass test 
tubes were cleaned by soaking for at least 12 h in an alkali solution. After washing, the tubes 









Table 15 – Extraction efficiency (%) for small intestine and colon compartment using LLE, Tenax and residual dust with ultrasonication assisted extraction. All 
samples were assessed in triplicates (n=3).  
 Small Intestine (n=3) Colon (n=3) Tenax (n=3) Residual  dust (n=3) 
Target 
analyte 
AVG% STDEV RSD%* AVG% STDEV RSD% AVG% STDEV RSD% AVG% STDEV RSD% 
BDE-28 74.8 6.0 8.0 76.8 9.2 12.0 66.7 0.1 9.0 71.9 6.5 9.0 
BDE-47 87.7 2.9 3.3 82.9 1.9 2.3 77.1 0.1 8.5 68.0 5.7 8.5 
BDE-100 69.2 9.4 13.6 77.7 10.5 13.5 54.2 0.1 6.0 52.0 3.1 6.0 
BDE-153 58.6 0.03 4.4 77.7 0.1 16.6 89.0 0.1 10.0 92.9 6.0 6.5 
BDE-154 96.7 0.0 2.6 79.3 13.2 0.2 103.7 0.1 10.0 86.0 5.8 6.7 
BDE-183 92.2 0.1 13.8 66.2 0.1 17.9 90.3 0.00 0.1 65.5 0.0 0.1 
EH-TBB 113.2 0.1 6.8 85.5 0.01 0.7 103.0 0.2 19.0 103.4 0.2 18.8 
BTBPE 80.4 0.1 13.3 61.9 0.04 6.4 82.2 0.2 14.0 68.1 0.1 13.7 
BEH-
TEBP 




3.3 Results and discussion 
3.3.1 Tenax TA® optimisation 
The addition of Tenax TA® in CE-PBET considerably increased the bioaccessible fraction 
(%BAF) of all target analytes, illustrating the value of Tenax TA® as an adsorbent matrix for 
HOCs. Different masses of Tenax TA® were added to the CE-PBET system to optimise the 
adsorbent sink to ensure exhaustive FR desorption from indoor dust. PBDE-spiked indoor 
dust samples (n=3) were tested under four different conditions; (A) without any Tenax TA® 
addition (control) and with three different amounts of Tenax TA®, namely 0.25 g (B), 0.5 g 
(C) and 0.75 g (D). The same length of RC dialysis membrane (16cm) and mass of dust (0.5 
g) was used in all treatments. Our results show that Tenax TA® enhanced gut bioaccessibility 
for PBDEs by approximately two-fold (Fig. 10) and the bioaccessible fraction was 
significantly different (p<0.001) between the controls (no Tenax) and with Tenax TA® 
addition, for all target analytes (Fig. 2). For example, with no Tenax TA® (control), the 
bioaccessible fraction of the low brominated PBDEs, BDE28 and BDE47, was 37.7% and 
32.8%, respectively, whereas their BAF% increased with 0.25 g Tenax TA® inclusion to 
55.1% and 54.9%, respectively. A trend to decreasing BAF% with increasing degrees of 
bromination for PBDEs can be seen for the control treatments and the different amounts of 
Tenax (Fig 2). Such findings are in agreement with Fang and Stapleton (2014), where a 
negative relationship between gut bioaccessibility and PBDE physicochemical properties 
such as degrees of bromination, MW and log Kow was described (Fang and Stapleton, 2014).  
Few studies describe the influence of Tenax TA® inclusion on gut bioaccessibility of organic 
pollutants from solid matrices such as indoor dust or soil. CE-PBET and Tenax TA® were 
employed to assess FR gut bioaccessibility and for a wide range of low and high MW FRs 
present in indoor dust including BDE47, BDE100 and BDE183; in their experimental design, 
Fang and Stapleton (2014) used 0.5 g of Tenax as an absorptive sink but the effects of 




Figure 10 – CE-PBET bioaccessibility fraction (%BAF) of PBDEs without any Tenax TA® 
addition (control, A) and CE-PBET with Tenax TA® addition in three different amounts; i.e. 
0.25g (B), 0.5g (C) and 0.75g (D). Statistically significant differences shown here (**; 
p<0.01 and ***; p<0.001) were established between the control (A) and all Tenax TA® 
treatments (B, C, D). Bar charts represent average values of triplicates. Error bars represent 
one standard deviation.  
In a study assessing PAHs bioaccessibility in soils from China, 0.25 g of Tenax TA® were 
added into a PBET in vitro system (Li et al., 2015). According to Li et al (2015), this mass 
was five-fold higher than the small intestine organic matter (OC), thus allowing sufficient 
sorption capacity for the PAHs mobilized during their study (Li et al., 2015). Varying the 
content of Tenax TA® (0.25, 0.5 and 0.75 g) in the CE-PBET system studied here, showed 
few statistically significant differences for our analyte recoveries. Here, statistically 
significant differences among the three Tenax TA® amounts tested were found only for 
BDE28 bioaccessibility as an exception; some increase in BDE28 BAF% with Tenax TA® 
content, rising from 55.1% with 0.25 g Tenax TA® to 66.7% with 0.5 g (0.25 g vs 0.5 g; 
p=0.017) and 69.9% with 0.75 g Tenax TA® added (0.25 g vs 0.5 g; p=0.006) was observed. 
These results reflect the physicochemical properties of this FR as a low MW tri-BDE 
congener; Tenax TA® is a hydrophobic sink and the calculated log Kow (EpiWeb) shows that 
BDE28 (log Kow 5.88) is less hydrophobic than BDE47 (log Kow 6.77) and hence greater 
amounts of the adsorbent may be needed to capture all of the released BDE28. For all other 
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analytes, there were no statistically significant differences in BAF% among the varying 
Tenax TA® amounts tested. Given the a) high sorption capacity of Tenax TA®, b) the broad 
range of physical properties (MW, water solubility and log Kow) of our FRs mobilised from 
the ingested matrix and c) the relatively high Tenax TA® mass recovery (Fig 11), 0.5 g of 
Tenax TA® were selected and subsequently used below. Our results show that in order to 
maintain a constant sorptive gradient for the low MW PBDEs, a larger mass of Tenax TA® is 
required, since 0.25 g of Tenax TA® was not enough to sustain an exhaustive in vitro gut 
extraction for all target analytes.  
 
Figure 11 Bar chart presenting Tenax TA mass recovery% in different amounts of Tenax TA tested 
(n=3). Error bars represent one standard deviation 
3.3.2 Tenax TA® sorption capacity to PBDEs and EHFRs 
An assessment of PBDE release via the gut and Tenax TA® sorption capacity with respect to 
the three CE-PBET compartments was conducted per batch, not in sequential mode. Briefly, 
a fresh Tenax TA® sample (0.5 g) was incubated using a new RC dialysis membrane before 
the initiation of each CE-PBET compartment. All Tenax TA® samples were then collected 
and subjected to extraction and clean up, along with the gut fluids and the residual dust as 
previously described. The scope of this assessment was to evaluate Tenax TA® absorption 
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threshold relative to each CE-PBET compartment. Given the destructive character of the CE-
PBET format per batch in section 3.2, Eq. 1 was not suitable for calculating PBDE sorption 
capacity on the different Tenax TA® batches. Hence, a modification of Eq.2 was used and 
PBDE sorption capacity (%) was determined using equation 2 (Eq. 3), where mass FR in 
Tenax TA® is the FR mass (ng) determined in each Tenax TA® sample incubated per batch 
during each CE-PBET compartment and mass FR in gut fluid is FR mass (ng) determined in 
CE-PBET gut fluids separately.  
𝑆𝑜𝑟𝑝𝑡𝑖𝑜𝑛 (%) =
mass FR in Tenax TA® 
𝑚𝑎𝑠𝑠 𝐹𝑅 in Tenax TA® + 𝑚𝑎𝑠𝑠 FR in gut fluid
 𝑥 100 
(Eq. 2) 
Shown in figure 12 and 13 are the results from PBDEs and EHFRs sorption to Tenax TA® in 
the three different CE-PBET compartments with respect to their incubation step. PBDE 
sorption to Tenax TA® results should not be considered as total PBDE bioaccessibility, but as 
the component attributable to Tenax TA® as an absorptive sink. Within the stomach 
compartment, BDE28 and BDE47 presented higher sorption on Tenax TA® (43.7 % and 
25.6%, respectively) compared to PBDEs with higher bromine content such as BDE154 and 
BDE183 where Tenax TA® sorption ranged from 7.0 % to 8.8 %, respectively. Colon 
sorption to Tenax TA® was similar to small intestine for BDE28 (60.0 % and 66.2 %, 
respectively, whereas it was found repeatedly higher than small intestine for all the other 
target analytes (Fig.3) without any considerable differences, except BDE183 sorption on 
Tenax TA® which was nearly two-fold higher in the colon in comparison to small intestine 
(52.6 % and 36.1 %, respectively). Hence, both the “solvent” capacity of the medium and the 
“sink” capacity of the Tenax TA® are required to achieve optimum extraction of FRs from 
dust as a matrix. Besides Tenax TA®, our results further support the idea of dietary 
components addition in CE-PBET acting as additional mechanism liaising FR mobilisation, 
especially in the lipid-rich colon compartment as reported by (Tilston et al., 2011). 
Desorption processes occurring in the GIT are usually dynamic, hence allowing organic 
contaminants mobilisation from the matrix to the gut fluids. As a result, FRs are readily 
absorbed via the gastro-intestinal membrane barrier towards blood and lymph circulation 
(Oomen et al., 2000). Tenax TA® inclusion in CE-PBET utilises the strong sorption 
properties and affinity of Tenax TA® to organic pollutants, mimicking the GIT absorption 
potential in vivo (Cui et al., 2016). Time-dependent kinetics and the duration of CE-PBET 
incubation steps have been established and discussed previously by (Tilston et al., 2011) with 
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respect to the GIT absorption processes in vivo. Therefore, in the present experimental 
design, kinetic tests assessing FR time-dependent release and sorption on Tenax TA were not 
practiced. Our overall goal was to assess FR sorption capacity with respect to the three CE-
PBET compartments given the already established and validated gut absorption time settings. 
Moreover, bioaccessibility is governed by a) the physicochemical properties controlling 
diffusion, sorption and partitioning potential of the organic pollutant, b) the nature of the 
solid matrix where the pollutant sorption occurs (e.g. indoor dust and organic matter) and c) 
the in vitro test configuration and settings affecting a method’s performance, hence pollutant 
bioaccessibility (Collins et al., 2015; Reichenberg and Mayer, 2006).  
 
 Figure 12 – Bar charts presenting selected EHFRs bioaccessibility (BAF%), EHFRs 
sorption on Tenax TA®  and release separately in stomach (1h), small intestine (SI; 4h) and 
colon (16h) compartments. Bar charts represent average BAF% and %sorption values of 




Figure 13 – Bar charts presenting PBDEs bioaccessibility (BAF%), PBDEs sorption on 
Tenax TA®  and release separately in stomach (1h), small intestine (SI; 4h) and colon (16h) 
compartments. Bar charts represent average BAF% and %sorption values of triplicates. Error 
bars represent one standard deviation.
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3.3.3 Method validation using SRM 2585 
The above CE-PBET parameters were validated using SRM 2585 as a well-characterised and 
homogenous dust sample and the results are shown in Fig. 14. Bioaccessibility was studied 
using a) CE-PBET without the adsorption sink, b) CE-PBET with the addition of 0.5 g of 
Tenax TA® and c) FR-spiked SRM 2585 (100 ng) to evaluate greater FR contamination levels 
under environmentally realistic conditions using the same homogenous dust sample. As 
observed for dust samples from houses in Reading, statistically significant differences 
(p=0.03) were found for all target analytes when comparing CE-PBET with and without 
Tenax TA® addition (Fig 4).  Again, BAF% using Tenax TA® rose between approximately 
two fold (BDE153 and BDE183) with greater increases seen for the less hydrophobic FRs 
such as BDE28 and BDE47 (nearly 3-fold bioaccessibility increases, respectively).  No 
statistically significant spiking effect was found between the two SRM 2585 treatments 
(spiked and non-spiked) which both included 0.5 g of Tenax TA® and different FR 
contamination levels did not present any considerably different bioaccessibility values from 
the same dust matrix.  
 
Figure 14 – CE-PBET bioaccessibility fraction (%BAF) using SRM 2585 without Tenax 
TA® inclusion (A), with Tenax TA® inclusion (B) and artificially spiked SRM 2585 and 
Tenax TA® (C). Statistically significant differences shown here (*; p<0.05, **; p<0.01 and 
***; p<0.001) were established between SRM 2585 BAF% values without (A) and with 
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Tenax TA® (B) inclusion. Bar charts represent average values of triplicates. Error bars 
represent one standard deviation.  
3.3.4 Proposing a unified test approach  
This study describes an efficient method to physically separate Tenax TA® as an absorbent 
sink and indoor dust for in vitro bioaccessibility testing, and our model allows assessment of 
FRs (and potentially other HOCs) bioaccessibility from a solid matrix using artificial gastro-
intestinal fluids. Previous methods used a self-designed stainless steel sieve to separate and 
recover Tenax TA® beads (Fang and Stapleton, 2014; ISO, 2015; Li et al., 2015; C. Li et al., 
2016).  Our approach, using RC dialysis tubing provides some important benefits.  Dialysis 
tubing is readily available, reproducible (quality controlled) and can be sourced with a wide 
range of molecular weight cut offs. This allows investigators to select a membrane with a 
MW cut off sufficient to permit free diffusion of the analytes of interest, whilst restricting 
passage of larger macromolecules such as enzymes or proteins that may be added to 
simulated GI fluids. By restricting the passage of these unwanted materials, the sorption 
capacity of the Tenax TA® is predominantly used for the organic pollutants rather than media 
components and clean up and desorption is thus simplified.  The tubing functions effectively 
to physically separate the Tenax TA® from the solid matrix (dust) and has high pH and 
temperature tolerance. Our study also shows the benefits of using an adsorption sink in the 
CE-PBET system. Compared to controls with no Tenax TA®, inclusion of the resin increased 
gut bioaccessibility for PBDEs with diverse physicochemical profiles. For the low 
brominated BDE28, 0.25 g of Tenax TA® were insufficient for exhaustive in vitro gut 
absorption, illustrating that the amount of Tenax TA® added to the modified CE-PBET 
system should be optimized with respect to the physicochemical properties (e.g. LogKow, 
water solubility) of the target analytes tested. Other than BDE28, for the (hydrophobic) FR’s 
studied here, 0.5 g of Tenax TA® was shown to be an appropriate amount to add in order to 
ensure released pollutants were readily adsorbed.   
3.4 Conclusion  
Under the influence of the ISO 16751 method on the environmental availability of non-polar 
compounds being currently approved for registration, we propose a novel test format for 
assessing in vitro bioaccessibility of PBDEs with Tenax TA® addition as an adsorptive sink. 
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Our data also show that the existing default assessment of risk (i.e. all the ingested pollutant 
in a solid matrix being bioavailable) is an overestimate and that the BAF% varies between 
~60% (BDE47) and ~50% (BDE153).  Well designed in vitro bioaccessibility tests thus 
provide a simple approach for initial human risk assessments from ingested solid matrices 









Chemicals and reagents 
Native standard solutions of BDE 28, 47, 77, 100,128, 153, 154, and 183 were purchased from 
Cambridge Isotope laboratories Inc. (UK). Purity of all standards was >98% unless otherwise stated. 
Standard stock solutions were prepared in toluene for all compounds. Sodium sulphate (anhydrous, 
granular/powder, 99% pure), high purity grade Silica gel pore size 60 Å, 70-230 mesh, 63-200 μm 
(product code: #60741, Sigma-Aldrich), Florisil®  100-200 mesh (product code: #10104980, Acros 
Organics), concentrated Sulfuric acid (H2SO4) 96% analytical grade (Fisher Scientific, UK), Tenax® 
TA Porous Polymer Adsorbent, 60-80 mesh (product code: #11982, Sigma-Aldrich), Standard grade 
regenerated cellulose (RC) Spectra/Por™ 3 (18mm flat width, 1.1mL/cm dialysis membrane MWCO 
3.5 kDa) (Spectrum Labs Inc., USA, product code: #11425859; FisherScientific, UK), micro 
centrifuge filters lined with 0.45μm pore size nylon filter 1.5mL volume capacity (product code #516-
0236, VWR) and 19mm Small Silver Binder Clips (product code: #WW-376137, Staples Inc, UK.). 
Analytical grade inorganic salts were provided from Fisher Scientific (Loughborough, UK). All 
biological reagents used for media preparation and organic solvents used for extraction and clean-up 
steps were of HPLC grade and were obtained from Sigma-Aldrich (Gillingham, UK). Empty, pre-
fritted polypropylene filtration tubes (6 mL) for silica SPE and Florisil cartridge preparation (2 g, 6 
mL) were purchased from Sigma-Aldrich (UK). For 5% acidified silica gel preparation, concentrated 
sulphuric acid (H2SO4, >96%) was used and was purchased from Fisher Scientific. Briefly, 1.9 mL of 
pure sulphuric acid was added drop-wise to 50 g of hexane-washed, oven-dried silica gel under 
continuous and vigorous stirring. Glass test tubes were cleaned by soaking for at least 12 h in a 
phosphate-free, alkali solution. After washing, the tubes were rinsed with deionised water, dried at 
100 ºC for at least 12 h and burned at 400°C to remove all traces of organic contamination.
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Target analytes and analytical characteristics 
Table SI 1 – Target analytes and physicochemical properties calculated from EPIWEB. 




















































A Thermo Trace GC Ultra system equipped with a Thermo TG-SQC capillary column (15 m x 
0.25mm x 0.25 μm) coupled to a Thermo ITQ 1100 mass spectrometer in electron ionisation mode 
((EI-MS) was connected through a heated transfer line (300oC). The injection temperature was set at 
92 °C, hold 0.04 min, ramp 700 °C/min to 295 °C and 5μL of cleaned extracts in toluene were 
injected for GC analysis. Injection was performed under a pressure of 0.19 bar until 1.25 min in 
pulsed splitlless mode 50 mL/min after 1.25 min. The GC temperature program was 90 °C, hold 1.50 
min, ramp 10°C/min to 300°C, hold 3 min, ramp 40 °C/min to 310 °C, hold 5 min. Helium was used 





In vitro inhalation bioaccessibility of plasticisers present in indoor 





Katerina Kademoglou a*, Georgios Giovanoulis b,c, Anna Palm-Cousins b, Cynthia de Wit c, 
Line Småstuen Haug d, Adrian C. Williams e, Jörgen Magnér b, Chris D. Collins a* 
a Soil Research Centre, University of Reading, Reading, RG6 6DW, UK 
b IVL Swedish Environmental Research Institute, SE-100 31, Stockholm, Sweden 
c Department of Environmental Science and Analytical Chemistry (ACES), Stockholm 
University, SE-106 91, Stockholm, Sweden 
d Norwegian Institute of Public Health (NIPH), P.O. Box 4404, Nydalen, 0403 Oslo, Norway 





Plasticisers are additives imparting durability, elasticity and flexibility in the manufacture of 
everyday consumer products. The lack of migration stability has resulted into their 
classification as major indoor contaminants. Despite their extensive use, the process of 
assessing human exposure and possible health effects arising from indoor dust contamination 
especially in children only began the past decade with limited results so far. This is the first 
study assessing the in vitro bioaccessibility (i.e. uptake) of traditional phthalate esters 
including dimethyl phthalate (DMP), diethyl phthalate (DEP) and di-(2-ethylhexyl) phthalate 
(DEHP) and alternative plasticisers used as phthalate substitutes in polymer materials such as 
bis(2-ethylhexyl) terephthalate (DEHT) and cyclohexane-1,2-dicarboxylic acid diisononyl 
ester (DINCH) present in indoor dust with respect to inhalation as an alternative route of 
exposure. Serving as surrogates to phthalate pulmonary release after dust inhalation in vivo, 
two separate artificial lung fluids, mimicking two different interstitial conditions were used, 
namely artificial lysosomal fluid (ALF, pH=4.5) representing the fluid that inhaled particles 
would contact after phagocytosis by alveolar and interstitial macrophages within the lung and 
Gamble’s solution (GMB, pH=7.4) as a fluid for deep dust deposition within the interstitial 
fluid of the lung. Low molecular weight (MW) and short-chained phthalates such as DMP 
and DEP were found to be highly bioaccessible (>75%) in both artificial pulmonary media 
tested (i.e. Gamble’s solution and ALF), regardless of the medium’s pH and chemical 
composition, whereas high MW compounds such as DEHP, DINCH and DEHT were <5% 
bioaccessible. Such findings support the hypothesis of hydrophobicity and water solubility 
primarily influencing inhalation bioaccessibility of organic pollutants. Hence, compared to 
Gamble’s solution, ALF as the artificial pulmonary fluid with the highest organic content 









 First study on in vitro inhalation bioaccessibility of organics from house dust 
 Gamble’s solution and artificial lung fluid were used as pulmonary surrogate media 
 Low MW phthalates DMP and DEP were >75% bioaccessible in both lung fluids  
 Alternative plasticisers DINCH and DEHT were <5% bioaccessible  





Oral bioaccessibility (i.e. uptake) of phthalate esters (PEs) has been studied using 
physiologically-based extraction tests (PBET). In two studies using indoor dust from China, 
the short-chain and low MW PEs such as DMP and DEP gave bioaccessibility values 
between 26 and 30%, compared to BBzP and DEHP whose oral bioaccessibilities were close 
to 10% (Kang et al., 2012; Wang et al., 2013). However, (He et al., 2016b) reported DMP 
was 83% bioaccessible through the GIT using indoor dust samples from different 
environments such as offices, hotels and classrooms, whereas DEHP was very poorly 
bioaccessible at around 1.9% from all the different microenvironments studied. Unlike dust 
ingestion and oral bioaccessibility of phthalate esters, limited studies exist on indoor dust 
particle inhalation, dissolution and the potential uptake of organic pollutants using artificial 
pulmonary fluids. Therefore, the need to establish and validate in vitro pulmonary tests is 
essential due to the prevalence of PEs in the indoor environment and their potential adverse 
health effects for humans, and especially children (Bornehag et al., 2004; Guo and Kannan, 
2011; Hauser and Calafat, 2005),(Carlstedt et al., 2013). Elucidating the dissolution and 
absorption potential of plasticisers via the lung will improve our understanding of the 
importance of this alternative exposure route. 
Human exposure to plasticisers in the indoor environment is a growing concern for human 
health with respect to their potential adverse effects on reproduction, endocrine and thyroid 
homeostasis (Hauser and Calafat, 2005) (Matsumoto et al., 2008; Rudel and Perovich, 2009; 
SCHER, 2007) . This is the first study reporting the in vitro uptake of phthalate esters and 
alternative plasticisers present in indoor house dust via two artificial lung fluids, mimicking 
two different interstitial conditions in the lung. Artificial lysosomal fluid (ALF, pH=4.5) 
represents the fluid that inhaled particles would contact after phagocytosis by alveolar and 
interstitial macrophages within the lung. Gamble’s solution (GMB, pH=7.4) is a surrogate 
fluid for deep dust deposition within the interstitial fluid of the lung (Dean et al., 2017; 
Hedberg et al., 2010). Such fluids have been previously used in in vitro inhalation 
bioaccessibility studies to investigate human exposure to water soluble metal particles and 
their fractions including Zn, Ni, Cu and Fe (Boisa et al., 2014; Hedberg et al., 2010; S.-W. Li 
et al., 2016; Wragg and Klinck, 2007).   
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To bridge this knowledge gap, the main objectives of the present study are: 1) to evaluate the 
in vitro pulmonary uptake (i.e. bioaccessibility) of PEs and alternative plasticisers present in 
indoor dust by employing two different artificial pulmonary fluids, i.e. Gamble’s solution and 
artificial lysosomal fluid representing the healthy and inflammatory status of the 
tracheobronchial environment, respectively and 2) to assess the factors influencing inhalation 
bioaccessibility of plasticisers via indoor dust. 
4.2 Material and methods 
4.2.1 Sampling and dust particle properties 
Ten indoor dust samples were collected from pre-existing vacuum cleaner bags (houses) in 
Norway (Oslo) as a part of the A-TEAM cohort sampling during November 2013 – April 
2014 (Papadopoulou et al., 2016) (Table SI-3). All dust samples were passed through a 
methanol-washed sieve (<63 μm) with respect to inhalable and thoracic aerodynamic 
diameter particle cut off as suggested by the International Organization for Standardization 
(ISO) (International Organization for Standardization, 1995). Oven-baked Na2SO4 (granular) 
was sieved as a  field blank, according to (Abdallah and Covaci, 2014). All dust samples 
were kept in hexane-washed amber glass bottles and stored at 4°C until analysis. Specific 
surface area and dust particle size were determined by laser diffraction spectroscopy 
(Mastersizer 3000, Malvern Ltd., UK) and the average of ten dust samples was 235.6 m2/kg 
and 49.2 μm, respectively. Additional particle size properties such as total carbon (TC%) and 
nitrogen (TN%) content were determined (Thermo Flash 2000), while organic matter content 
(OMC%) was assessed by loss-on-ignition (LOI) as described in (Yu et al., 2012). 
























N04 19.525 0.736 0.607 0.078 7.872 0.638 44.0 196.1 
N08 57.832 4.010 3.706 0.119 22.625 0.709 39.8 284.1 
N13 10.236 0.651 0.243 0.006 10.372 0.256 11.8 652.1 
N14 64.288 0.903 5.541 0.256 28.718 1.093 68.3 147.5 
N19 32.404 0.917 1.116 0.061 8.589 0.736 102.0 117.4 
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N20 39.423 0.724 1.554 0.218 20.782 2.137 44.9 186.4 
N29 69.620 0.456 4.028 0.038 32.922 0.344 39.8 202.6 
N30 57.605 2.440 1.340 0.113 22.380 1.055 65.5 132.6 
N31 25.566 0.647 1.276 0.088 16.057 0.569 43.9 194.0 
N40 62.909 0.531 1.854 1.620 19.798 1.779 32.2 243.4 
*All experiments were conducted in triplicate, apart from particle size and specific surface area where 
the results presented here are from one replicate 
4.2.2 Dust extraction and clean-up 
The analytical method used for dust extraction was based on (Giovanoulis et.al, 2017). 
Briefly, 100mg of dust was extracted with 10 mL acetone: n-hexane (1:1 v/v) using 
microwave-assisted extraction which is considered as an effective and high productivity 
extraction technique for solid matrices such as indoor dust (see SI Fig 1). Methanol-washed, 
high quality Teflon vessels were used for the microwave extraction and all dust samples were 
spiked with 400ng internal standard (ISTD) mix prepared in n-hexane (DMP-d4, DnBP-d4 
and DEHP-d4). After the extraction medium addition, all samples were heated to controlled 
temperature with microwave power. When the microwave-assisted extraction cycle was 
completed, physical separation between the indoor dust (matrix) and the organic solvent 
phase was achieved by centrifuging at 1500rpm for 2 min. Then, all supernatants were 
transferred to oven-baked, transparent glass tubes using a disposable Pasteur pipette and the 
resulting extracts were then concentrated to 0.5mL under a gentle nitrogen (N2) stream; the 
N2 stream was passed through a glass Pasteur pipette tip (150mm) containing charcoal in 
order to eliminate any traces of external contamination. Finally, the solvent was exchanged to 
n-hexane (4ml) to avoid possible breakthrough of phthalates on ENVI-Florisil SPE (500 mg/3 
mL) cartridges and then concentrated to 1mL. Prior to solid phase extraction (SPE), all 
ENVI-Florisil cartridges were pre-treated by two washing steps: a) with methyl tert-butyl 
ether (MTBE) (3ml) and b) with n-hexane (6ml). The 1mL extract was loaded onto the 
ENVI-Florisil cartridge and 9mL of n-hexane was added as a cleaning elution step. During 
the second elution, all target analytes were eluted using 9 mL acetone: n-hexane (1:1) and the 
resulting eluate was concentrated to 1ml with a gentle N2 flow at room temperature, using a 
similar filtration technique as described above. Finally, all extracts were transferred to GC 
vials and biphenyl (300ng) was added as an injection recovery standard prior to GC-MS/MS 





Figure 15 – Sample preparation flowchart for indoor dust extraction of all target analytes 
according to (Giovanoulis et.al., 2017) 
4.2.3 Artificial lung fluid extraction 
The lung fluid extractions involved two different artificial lung fluids, namely Gamble’s 
(GMB) solution and artificial lysosomal fluid (ALF), (Fig. 16). All lung fluid extraction 
experiments were conducted in duplicate. Both media (1L) were prepared in ultra-pure H2O 
118 
 
(18.2 Ω) as described in (Hedberg et al., 2010) (SI table 4) and pH adjustment was achieved 
using either 1M HCl or 1M NaOH.All media were freshly prepared 24h before the initiation 
of each test, were checked for background phthalate contamination and stored in oven-baked 
Duran® glass bottles at 4°C. According to Boisa et al (2014), the experimental volume for 
simulated lung fluid extraction tests should be 20mL, given the pulmonary fluid volume 
capacity of healthy non-smoking adults (0.3 mL/kg; 70kg body mass) (Boisa et al., 2014). In 
order to maintain a 1:100 solid-to-liquid (S/L) ratio between the incubated matrix and the 
lung fluid, 0.2 g of indoor dust (SI Table 3) were combined with 20 mL of each artificial lung 
fluid separately, as suggested by (Schaider et al., 2007) (Fig SI 2). Prior to securely capping 
them, the samples (including procedural blanks) were covered with oven-baked aluminium 
foil to avoid background phthalate contamination and were then continuously incubated for 
96h to mimic human alveolar clearance capacity (Lindström et al., 2006; Wragg and Klinck, 
2007), under continuous shaking (60rpm) at 37°C inside a thermostatic chamber. After 96h, 
the lung solutions and the incubated dust were collected by physical separation; the samples 
were centrifuged at 1500 rpm for 3 min. Using disposable glass Pasteur pipettes, the 
supernatants (lung fluid) were transferred into clean glass vials, while the residual dusts were 
stored at 4ᴼC. Prior to extraction, all samples were spiked with 400ng internal standard 
(ISTD) mix prepared in n-hexane (DMP-d4, DnBP-d4 and DEHP-d4). All the supernatants 
were subjected to liquid-liquid extraction (LLE) using 7mL Hexane: MTBE 3:1, twice. To 
avoid any water residue and remove any gel-like emulsion formulated during LLE, sufficient 
amount of oven-baked Na2SO4 (powder) was added to all the extracts, followed by 1 min 
vortexing and organic phase collection after centrifugation (1500rpm for 2min). Solvent 
exchange to n-hexane followed and the samples were concentrated to 1ml under a gentle N2 
stream at room temperature as described above.  
Ultrasonication-assisted extraction was employed for the residual dusts for 10min using 7mL 
of Acetone: Hexane 1:1, twice. All the extracts were collected by centrifugation at 1500 rpm 
for 3 min, combined, concentrated to 1ml under a gentle N2 stream before clean-up through 
ENVI-Florisil SPE (500 mg/3 mL) cartridges, similarly to the dust extraction procedure 
described above. Briefly, all the Florisil® columns were pre-cleaned with MTBE and 
conditioned with n-hexane. The residual dust extracts in n-hexane were loaded onto the 
Florisil® columns, the first hexane eluate was discarded, while the second eluate was 
collected using 9 mL of MTBE. The resulting eluate was concentrated to 1ml under a gentle 
N2 flow at room temperature, with a similar filtration technique as described above. Finally, 
all extracts (in 1mL) were transferred to oven-baked GC vials and biphenyl (300ng) was 
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added as an injection recovery standard prior to GC-MS/MS analysis. Further details of 
sample preparation and instrumental analysis are available in SI.  
Table 17 - Chemical composition (g/L) of artificial lung fluid (ALF; pH=4.5) and Gamble’s 
solution (GMB; pH=7.4) as suggested by (Hedberg et al., 2010) 
Chemical ingredients 




MgCl2 0.050 0.096 
NaCl 3.21 6.02 
KCl - 0.298 
Na2HPO4 0.071 0.126 
Na2SO4 0.039 0.063 








NaOH 6.00 - 
Citric acid 20.80 - 




C3H5NaO3 (NaLactate) 0.085 - 
C3H5O3Na (NaPyruvate) 0.086 - 





Figure 16 - Schematic representation of inhalation bioaccessibility test using two separate artificial lung fluids, namely a) Gamble’s solution 
(pH=7.4) and b) artificial lysosomal fluid (pH=4.5). Shown in the graph are the different steps of the experimental procedure; lung fluid incubation 
for 96h at 37oC (step 1), sample collection using centrifugation for 3 min at 1500rpm (step 2), sample preparation and clean-up (step 3) and GC-
EI MS/MS instrumental analysis (step 4). 
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4.2.4 Data analysis  
Bioaccessibility can be expressed as a mass (e.g. ng of a contaminant solubilised in the 
respiratory tract), a concentration (ng/g of a contaminant in dust) or as a fraction  - expressed 
as a percentage (BAF%) (Guney and Zagury, 2016). In our study, inhalation bioaccessibility 
(IBAF) was determined using Eq. 4, where mass phthalate ester (lung) is set as the organic 
compound mass (ng) determined in the lung supernatant of the in vitro pulmonary system and 
mass (dust residual) is the mass (ng) determined in the dust residual collected after the 96h-







𝑚𝑎𝑠𝑠 𝑃𝐸 (lung supernatant) + 𝑚𝑎𝑠𝑠 (𝑑𝑢𝑠𝑡 𝑟𝑒𝑠𝑖𝑑𝑢𝑎𝑙)
 𝑥 100     (Eq. 4)  
 
GraphPad Prism® version 7.00 for Windows, (GraphPad Software, La Jolla CA, USA) was 
used for statistical analysis. Prior to statistical analysis, all data were checked for normality 
using the Shapiro–Wilk test and not all data passed the normality test. All data were arc-sine 
transformed, as this mathematical transformation is necessary for statistical analysis of results 
set in percentages in order to equalise variances as proposed by (Rr R. Sokal and Rohlf, 
1995) . Ordinary two-way ANOVA (Uncorrected Fisher’s test, p<0.05) was performed to 
assess statistically significant differences of phthalate esters between both artificial lung 
fluids. Spearman’s correlation (p<0.05) was employed to assess statistical dependence and 
correlation between artificial lung fluids and the physicochemical properties of all target 
analytes. Minitab® version 17 for Windows (Minitab Inc., USA) was used for general linear 
model in order to assess the statistical relationship between inhalation bioaccessibility 
(IBAF%), plasticisers dust concentration, logKow, organic matter content (OMC%) and dust 
particle size.  
4.2.5 Quality assurance and quality control  
All samples were analysed together with SRM 2585 (NIST, USA), used for method 
validation and QC testing during lung fluid testing (n=4) and dust extractions (n=5), 
respectively. Oven-baked, uncontaminated sand was used as a procedural blank during dust 
extractions and the results were blank-corrected for all target analytes by subtraction of the 
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mean blank values from the raw concentration values (expressed in ng/g) according to 
(Abdallah and Covaci, 2014). Four blank lung fluid samples (two from each lung fluid) with 
no added matrix were sequentially incubated and analysed as procedural blanks and all 
IBAF% results were blank corrected for all target analytes. Extraction efficiency for all target 
analytes ranged from 70 – 120% for both lung fluids, apart from BzBP which was equal to 
268% and 242% for Gamble’s and ALF, respectively (Table SI 6). Method limits of detection 
(mLOD) were calculated as three times the standard deviation of the lung fluid blanks (SI 
Table 7). Glass test tubes were cleaned by soaking for at least 12 h in an alkali solution. After 
washing, the tubes were rinsed with water and dried at 100 ºC for at least 12 h and burned at 
400°C to remove all traces of contamination. 





STDEV * RSD% 
Matrix blank 
(ng/g)† 
DMP 2596 243.2 9.4 4.7 
DEP 7848 733.0 9.3 41.5 
DiBP 5438 429.4 7.9 58.7 
DnBP 32069 2589.2 8.1 78.2 
BzBP 85456 5040.0 5.9 5.9 
DEHP 575020 26960.3 4.7 297.3 
DEHT 25101 8521.1 33.9 209.9 
DiNP 199333 15279.1 7.7 127.7 
*DINCH and DPHP not detected in SRM 2585; all values (ng/g) were blank-corrected 
*RSD% =STDEV/AVG*100; † Uncontaminated sand was used as a matrix blank for dust 
extractions 
 
Table 19 – Extraction efficiency for all target analytes for Gamble’s solution (GMB) (n=2) and 
artificial lysosomal fluid (ALF) (n=2) 
 GMB Recovery% ALF Recovery% 
 R1 R2 AVG STDEV R1 R2 AVG STDEV 
DMP 86.7 90.1 88.4 2.4 84.0 90.8 87.4 4.8 
DEP 109.3 114.7 112.0 3.8 106.7 108.4 107.5 1.2 
DiBP 81.2 81.5 81.3 0.2 78.5 82.5 80.5 2.9 
DnBP 79.5 81.2 80.4 1.2 71.2 77.7 74.5 4.6 
BzBP 268.8 267.3 268.1 1.0 264.8 262.1 263.5 1.9 
DEHP 118.5 135.6 127.0 12.1 93.0 102.0 97.5 6.3 
DINCH 105.9 116.9 111.4 7.8 108.9 110.5 109.7 1.2 
DEHT 101.6 107.1 104.4 3.9 94.8 95.7 95.2 0.7 
DPHP 121.1 133.9 127.5 9.0 115.1 119.6 117.3 3.2 
DiNP 116.0 112.9 114.4 2.2 111.3 107.2 109.2 2.9 
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4.2.6 Instrumental analysis 
Analyses used a GC/MS-MS system with electron impact ionization mode (EI). The 
chromatographic separation of plasticizers was obtained on a cross-linked 5% - phenyl/95% - 
dimethylpolysiloxane capillary column 30 m × 0.25 mm (i.d.) × 0.25m film thickness using a 
gradient temperature; Agilent Technologies. The GC column oven temperature programme 
was: 45ᴼC for 1min followed by ramps of 15ᴼC/min to 300ᴼC, which was maintained for 
6min. Ion source temperature was 250ᴼC and the split-splitless injection volume was 1µl in 
Multiple reaction monitoring (MRM) with two ion transitions (quantification and 
qualification) per selected analyte being used; compounds were quantified by calibration with 
the use of a deuterated internal standards. The data were analysed using MassHunter software 
version B.04.00 for quantitative analysis (Agilent Technologies, Inc. 2008). 
4.3 Results and discussion 
4.3.1 Concentration of plasticisers in indoor dust 
All ten plasticisers examined in our study were detected in all the Norwegian dust samples 
(Fig.1; Table SI 5). DEHP was the most abundant phthalate ester in the samples, showing the 
highest median concentration of all the target analytes (225 μg/g), which is comparable to 
house dust concentrations reported from the US (Guo and Kannan, 2011; Rudel et al., 2003), 
Kuwait (Albar et al., 2017) and Denmark (Langer et al., 2010), but is three and four-fold 
lower than house dust concentrations reported from Germany (Abb et al., 2009; Fromme et 
al., 2004) and Bulgaria (Kolarik et al., 2008), respectively and nearly two-fold higher than 
another study from USA (California) (Dodson et al., 2015). Our results confirm the ongoing 
use of DEHP in consumer products in the house environment, despite bilateral legislative 
measures taken from the EU under the REACH regulation framework (European 
Commission, 2015) and the US EPA action plan under the Toxic Substances Control Act 




Figure 17 - Boxplots of indoor dust concentrations for phthalate esters and alternative plasticisers 
from Norwegian houses (N=10). Shown in the whiskers are 25th and 75th percentiles, median (central 
line), mean (+ symbol) and outlier (● symbol) values. All data shown are log transformed. Please note 
the linear scale for concertation (ng g-1) on y axis. 
the continued use of phthalates in consumer products such a children’s toys (Ionas et al., 
2014). DiNP which has been used as a DEHP-alternative since the early 2000s (Bui et al., 
2016), was the second most prevalent phthalate ester with a median concentration of 120 
μg/g, in agreement with levels from German (Abb et al., 2009) and Canadian houses 
(Kubwabo et al., 2013) and gave the highest maximum concentration among all target 
analytes (2,500 μg/g), nearly two-fold higher than the greatest DEHP level found in an 
individual dust sample (1,500 μg/g). Possibly due to the increasing demand for alternative 
plasticizers as a result of legislative restrictions on DEHP in consumer products (e.g. toys), 
alternative plasticisers including DEHT and DINCH were found in considerable and 
comparable levels (DEHT median: 20 μg/g and DINCH median: 17 μg/g, respectively), albeit 
both were an order of magnitude lower than DEHP and DiNP.  
Other traditional phthalate esters such as BzBP, DnBP and DiBP were at three to five-fold 
lower concentrations than DEHT and DINCH in our Norwegian house dust samples. Our 
results reflect the Nordic indoor environment where hard-surfaced wooden flooring is 
prevalent (Roos and Hugosson, 2008), leading to potentially higher use of DEHP alternatives 
in order to meet the ongoing demands of the flooring industry. Compared with levels 
previously reported, BzBP, DnBP and DiBP median concentrations (10.6 μg/g, 10.3 μg/g and 
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6.4 μg/g, respectively) were comparable with a recent study from USA (Dodson et al., 2015), 
though the median concentration of BzBP was three and four-fold lower than house dust 
levels reported from Germany (Fromme et al., 2004) and Canada (Kubwabo et al., 2013) 
respectively. Such results may be attributed to the limited use of BzBP (used as a PVC 
plasticiser) and DnBP (used as plasticiser in cellulose plastics and latex adhesives) (Bornehag 
et al., 2005), and the growing worldwide trend on the use of non-phthalate alternatives (Bui et 
al., 2016). In our study, DEP and DMP presented the lowest median concentrations from all 
target analytes with DEP median concentration (1.8 μg/g) nine-fold higher than DMP (0.2 
ug/g). DEP median concentration in our Norwegian indoor dust samples was in agreement 
with studies from the USA and China (Dodson et al., 2015; Guo and Kannan, 2011), Canada 
(Kubwabo et al., 2013), Denmark (Langer et al., 2010) and Saudi Arabia (Albar et al., 2017), 
while DMP levels were in agreement with data from Sweden (Bergh et al., 2011), but 
considerably lower than reported from the USA (Guo and Kannan, 2011). This may be 
related to the primary usage of DEP and DMP in personal care products, as well as due to 
their short-chain character, low MW and high vapour pressures favouring their partitioning 
primarily to the gas phase rather than on coarse dust particles (Weschler et al., 2008).  
Phthalate ester concentrations have recently been reported in floor and surface dust, sampled 
with dust collection filters, from the same Norwegian population group (n=61) (Xu et al., 
2016). The range of phthalate esters and alternative plasticisers levels in vacuum cleaner 
bags, floor and surface dust (collected from the living room) from Giovanoulis et al (2017) is 
of the same order as the vacuum cleaner dust in the present study (n=10, Norwegian house 
dust).  
4.3.2 Inhalation bioaccessibility  
This is the first study reporting in vitro pulmonary uptake of phthalate esters and alternative 
plasticisers from indoor dust, using two artificial pulmonary fluids, namely Gamble’s 
solution and artificial lysosomal fluid (ALF) to evaluate phthalate bioaccessibility via 
inhalation; Gamble’s solution is representative of the interstitial fluid of the deep lung and 
ALF is representative of the more acidic environment following phagocytosis by alveolar and 
interstitial macrophages within the lung (Boisa et al., 2014; Hedberg et al., 2010). Inhalation 
bioaccessibility values for the low MW phthalates DMP and DEP reached 80% in both 
pulmonary media (Fig. 2). Such findings support the hypothesis that inhalation is an 
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important alternative route of exposure for low MW and short-chained phthalate esters (Bui 
et al., 2017). Across all the target analytes, there were no statistically significant differences  
 
Figure 18 – In vitro inhalation bioaccessibility (IBAF%) of phthalate esters and alternative plasticisers 
present in indoor dust samples (N=10), using two different simulated lung fluids, namely Gamble’s 
solution (GMB) and artificial lysosomal fluid (ALF). Statistically significant differences shown here 
(*; p<0.05). Bar charts represent average values in duplicates. Error bars represent 1STDEV. 
for the uptake of plasticisers between the two media despite their differing pH’s (Gamble’s 
pH = 7.4; ALF pH = 4.5), apart for DMP where a statistically significant difference was 
found (p=0.017) with IBAF% of 71.3% and 82.1% for Gamble’s solution and ALF, 
respectively. Our findings show that the phthalate esters are liberated from the inhaled dust 
particles into “normal” lung fluids (Gamble’s solution) from where they can be absorbed and 
that the dust particles themselves need not undergo phagocytosis before the plasticisers are 
released from the dust matrix; the majority of DMP was also released into the deep lung fluid 
though greater amounts were liberated into the lysosomal media. Similar to gastro-intestinal 
bioaccessibility of organic pollutants which is partly governed by the pollutant’s physico-
chemical properties such as MW and log Kow (Collins et al., 2015), bioaccessibility of 
inhaled phthalates tended to decrease with increasing MW and log Kow (>4), ranging from 
15% to 10% for DiBP, DiNP and BzBP in Gamble’s solution and ALF, respectively (Fig 18 
& 19). Less than 5% bioaccessibility was found for high MW phthalate esters such as DEHP 
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and its alternatives plasticisers DEHT (an isomeric alternative of DEHP) and DINCH, 
supporting research showing that dust ingestion and dermal uptake are the dominant exposure 
routes for very hydrophobic phthalate esters (Bui et al., 2016; Kang et al., 2012; Wormuth et 
al., 2006). Given the novelty of our study, there are no previous reports on the in vitro 
pulmonary uptake of plasticisers. In a study assessing human exposure to phthalates from 
indoor dust in China, Kang et al (2012) reported oral bioaccessibility of DMP and DEP via 
dust ingestion was 32% and 25%, respectively, whereas dermal absorption of DEP and DnBP 
directly from air has been also proposed by (Weschler et al., 2015). Importantly, our findings 
demonstrate that inhalation is a neglected additional and considerable route of exposure for 
low MW and short-chained phthalate esters.  
Table 19 Blank values calculated in mass (ng) and method limits of detection (mLOD) for 
Gamble’s and artificial lysosomal fluid (ALF) 
Mass 
(ng) 
Gamble’s solution Artificial lysosomal fluid (ALF) 
R1 R2 AVG STDEV 
mLOD* 
(ng) 
R1 R2 AVG STDEV 
mLOD 
(ng) 
DMP 0.36 0.35 0.35 0.01 0.03 0.23 0.44 0.33 0.14 0.43 
DEP 16.77 13.83 15.30 2.08 6.24 9.47 22.90 16.19 9.49 28.48 
DiBP 2.42 1.47 1.95 0.67 2.01 1.22 2.26 1.74 0.74 2.21 
DnBP 9.08 4.28 6.68 3.40 10.19 4.03 5.83 4.93 1.27 3.81 
BzBP 1.60 0.46 1.03 0.81 2.43 0.05 0.90 0.47 0.60 1.80 
DEHP 5.85 5.13 5.49 0.51 1.52 8.26 12.22 10.24 2.80 8.40 
DINCH 1.20 3.85 2.53 1.87 5.62 0.21 0.06 0.14 0.11 0.33 
DEHT 0.57 0.77 0.67 0.14 0.43 0.58 0.47 0.53 0.08 0.23 
DPHP 1.65 0.23 0.94 1.00 3.00 0.16 0.17 0.17 0.01 0.03 
DiNP 3.51 1.75 2.63 1.24 3.73 3.15 3.95 3.55 0.56 1.69 
*method limit of detection (mLOD) = 3 x STDEV of blank 
4.3.3 Method validation using SRM 2585  
As we propose a novel method to assess bioaccessibility of inhaled matrices and considering 
that the pulmonary media were designed for nanoparticles and trace elements in vitro 
bioaccessibility studies (Hedberg et al., 2010; Klara Midander, 2010; Wragg and Klinck, 
2007), we performed detailed method validation. Standard reference material SRM 2585 for 
organic contaminants in house dust (NIST, USA) was used for the validation and duplicate 
samples were sequentially incubated alongside the Norwegian house dust samples, following 
the same experimental and analytical conditions. The results of the SRM 2585 method 
validation step (Table 18) confirmed our  findings with IBAF>75% for low MW phthalates, 
while DEHP and DiNP were the least bioaccessible compounds (IBAF% <5%) as the most 
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hydrophobic of our target analytes, following a comparable pattern with our Norwegian 
house dust bioaccessibility results. The SRM 2585 batch that was purchased in our study was 
prepared using a pool of dust samples collected during mid to late 1990s. Therefore, DINCH 
and DPHP were not detected, since their use in consumer products as traditional phthalate 
alternatives peaked after 2010 (Bui et al., 2016).  
Table 20 - Lung fluid method validation using SRM 2585 (n=4) 
Target 
analytes† 






DMP 89.9 1.8 89.5 0.3 
DEP 80.7 1.2 73.7 1.0 
DiBP 17.6 2.7 8.0 0.6 
DnBP 9.8 1.3 6.2 0.5 
BzBP 18.5 3.6 13.2 0.6 
DEHP 3.1 1.6 2.0 0.2 
DEHT 4.9 1.6 4.6 0.6 
DiNP 3.9 1.0 3.5 0.3 
     †DINCH and DPHP not present in SRM 2585 
4.3.4 Factors affecting inhalation bioaccessibility  
Further analysis of the bioaccessibility results for each individual Norwegian house dust 
sample (Fig.3) illustrates an apparent discrepancy with the dust collected for house 3 (H3) 
and the subsequent bioaccessibilities for DMP, BzBP, DnBP and DiBP in both Gamble’s 
solution and ALF (20%<IBAF%<45%). This sample had little DMP (0.02 μg/g) and BzBP 
(0.22 μg/g), while concentrations for DiBP (3.4 μg/g) and DiBP (10.6 μg/g) were below the 
25% percentile. The resulting differences in bioaccessibility suggest that a contaminant’s 
concentration in the studied matrix (e.g. dust) may influence the in vitro release into media; 
such phenomena should be further explored but there may be a fraction of the phthalate esters 
that bind strongly to the dust matrix and which is thus less easily released during the 
incubation.   
Table 21 –Spearman’s correlation between inhalation bioaccessibility in two different 
artificial lung fluids and the physicochemical properties of plasticisers studied here 
 GMB IBAF% ALF IBAF% 
Physico-chemical 
properties† 
Spearman's ρ p value Spearman's ρ p value 
MW -0.561 0.096 -0.561 0.096 
Log Kow -0.705 0.027* -0.705 0.027* 
Log Koa -0.588 0.081 -0.624 0.060 
Vapour pressure -0.535 0.115 -0.559 0.098 
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LogP -0.818 0.006** -0.782 0.011* 
Water solubility 0.661 0.044* 0.636 0.054 
Polarizability -0.535 0.115 -0.559 0.098 
*levels of statistical significance was set p<0.05  
† Physicochemical properties of plasticisers studied here can be found at Table SI 2 
Analysis of variance by general linear models (GLM) among factors which could potentially 
influence bioaccessibility - including phthalate dust concentration, log kow, organic matter 
content (OMC) and particle size - revealed a statistically significant interaction (p<0.05) only 
for log Kow (Fig. 19), explaining 70.6% and 69.5% of variance for Gamble’s solution and 
ALF, respectively. Considering the diverse chemical composition and pH of the two artificial 
pulmonary media studied here and to further elucidate possible physico-chemical properties 
governing inhalation bioaccessibility, Spearman’s correlation was performed between 
bioaccessibility and various physico-chemical properties of our target analytes, including 
molecular weight (MW), water solubility and log Kow. Water solubility and IBAF% were 
moderately correlated (ρ<0.65) with a statistically significant correlation established only for 




Figure 19 - Heat map presenting inhalation bioaccessibility for each separate Norwegian house dust sample (N=10) in two different simulated 
lung fluids, namely Gamble’s solution (GMB) and artificial lysosomal fluid (ALF). Colour gradient represents average values in duplicates.  
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lung. Hydrophobicity and lipophilicity (represented by log Kow and log P, respectively) 
presented strong and statistically significant negative correlations (ρ> -0.7; p<0.05) with 
IBAF for both artificial pulmonary media.  For other properties such as MW and vapour 
pressure, a statistically significant correlation was not achieved (Table 2). However, 
compared to log Kow, higher statistically significant correlations were found between 
inhalation bioaccessibility and logP in both pulmonary media (Table 2). According to 
(Rutkowska et al., 2013), lipophilicity is a physicochemical property which encodes two 
major structural contributions, namely a bulk term reflecting hydrophobic and dispersive 
forces (i.e. hydrophobicity) and a polar term reflecting more directional electrostatic 
interactions and hydrogen bonds (i.e. polarity). Therefore, lipophilicity should be considered 
as the driving force behind inhalation uptake of phthalates during the design and data 
interpretation of dissolution studies employing artificial biological fluids (Marques et al., 
2011). 
4.4 Conclusion 
This is the first study exploring the in vitro inhalation bioaccessibility for a wide range of 
traditional phthalate esters and their alternative plasticisers present in indoor dust from 
Norwegian houses. Low MW and short-chained phthalates such as DMP and DEP were 
found to be highly bioaccessible (>75%) in both artificial pulmonary media tested (i.e. 
Gamble’s solution and ALF), regardless of the medium’s pH and chemical composition. 
Therefore, inhalation can be potentially considered as a considerable route of exposure for 
such compounds, including compounds with comparable physico-chemical properties, e.g. 
chlorinated organophosphates (PFRs) (Schreder et al., 2016). A statistically significant 
relationship between Gamble’s solution and ALF was found only for the bioaccessibility of 
DMP, whereas the inhalation bioaccessibility of heavier (in terms of MW) and more 
hydrophobic plasticisers did not exceed 5%. Also, dust particle properties such as organic 
matter content and particle size did not present any statistically significant interaction with 
the in vitro pulmonary uptake of plasticisers. Our results suggest that 1) inhalation 
bioaccessibility of organic pollutants is primarily governed from pollutant hydrophobicity 
and water solubility and 2) the artificial pulmonary fluid formulation of ALF, due to its 
higher organic content is more representative for inhalation studies of organics may play a 
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pivotal role in surrogate studies regarding in vivo lung tissue function and inflammation 
triggered by phthalate ester exposure. Finally, the unexplored experimental approach and 
employment of surrogate biological fluids (e.g. gastric, sweat etc.) should be explored, 
aiming towards a conservative, yet realistic risk assessment of plasticisers.  
 
Figure 20 – Matrix plots showing the interactions between the bioaccessibility of the two artificial 
pulmonary fluids, namely artificial lysosomal fluid (ALF) (A) and Gamble’s solution (GMB) (B) and 
independent variables including analyte concentration in the dust (Conc), log Kow, organic matter 
content (OMC) and particle size. The parallel lines show no statistically significant interaction 







   Materials and methods  
Chemicals and reagents  
Dimethyl phthalate (99 + %), diethyl phthalate (99%), diisobutyl phthalate (99%), di-n-butyl 
phthalate (99%), benzyl butyl phthalate (98%), bis(2-ethylhexyl) phthalate (99.5%), 
diisononyl phthalate (ester content ≥99 %, mixture of C9 isomers), bis(2-ethylhexyl) 
terephthalate (≥96%) were purchased from Sigma Aldrich (Schenelldorf, Germany). 
Cyclohexane-1,2-dicarboxylic acid diisononyl ester (99%) were supplied from Wuhan 
Yitongtai Science and Technology Co., Ltd (China) and bis(2-propylheptyl) phthalate from 
Toronto Research Chemicals (TRC, Canada). The quantification internal standards (IS), 
dimethyl phthalate-3,4,5,6-d4 (98 atom % D), dibutyl phthalate-3,4,5,6-d4 (98 atom % D) 
and bis(2-ethylhexyl)phthalate-3,4,5,6-d4 (98 atom % D), and the pre-injection recovery IS, 
biphenyl (99.5%) were also purchased from Sigma Aldrich (Schenelldorf, Germany). Methyl 
tert-butyl ether (MTBE), acetone, n-hexane and water were GC chromatographic grade 
bought from Merck. Standard Reference Material (SRM) 2585 - Organic Contaminants in 




Target analytes and analytical characteristics 
Table SI-1. Retention time during chromatographic separation, names, abbreviations, CAS numbers and chemical structures of selected analytes used in 
Multiple Reaction Monitoring (quantifier - qualifier ion transitions & collision energies). 


















131-11-3 Target 11.7 162.9→77.1 40 162.9→92 40 
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93951-89-4 ISTD 11.7 
166.9→137.
1 

















































DMP Phthalate C10 H10 O4 194.184 1.66 6.694 2014 3.08E-03 19.7 1.64 
DEP Phthalate C12 H14 O4 222.237 2.65 7.023 287.2 2.10E-03 23.4 2.7 
DiBP Phthalate C16 H22 O4 278.344 4.46 8.412 5.061 0.00241 30.7 4.46 
DnBP Phthalate C16 H22 O4 278.344 4.61 8.631 2.351 2.01E-05 30.8 4.82 
BzBP Phthalate C19 H20 O4 458.589 8.86 15.099 3.56E-05 1.10E-08 53.8 8.5 
DEHP Phthalate C24 H38 O4 390.556 8.39 12.557 0.001132 1.42E-07 45.4 8.71 
DINCH Alternative C26 H48 O4 424.657 9.82 12.36 8.83E-06 1.77E-06 49.0 9.69 
DEHT Alternative C24 H38 O4 390.556 8.39 11.707 0.0002387 2.14E-05 45.4 9.55 
DPHP Phthalate C28 H46 O4 446.662 10.36 13.184 2.24E-06 2.29E-07 52.8 10.83 
DiNP Phthalate C26 H42 O4 418.609 9.15 12.22 3.59E-05 3.21E-06 49.1 9.04 




Table SI-3 – Sample codes, country of origin, source, collection year and dust mass used per sample (g) for indoor dust extraction and artificial 






Mass used (g) for 
dust extraction 
Mass (g) used for artificial lung fluid incubations 
     ALF - R1 ALF - R2 GMB R1 GMB R2 
H1 Norway House 2013 0.100 0.202 0.203 0.201 0.201 
H2 Norway House 2013 0.101 0.203 0.201 0.201 0.202 
H3 Norway House 2013 0.099 0.201 0.201 0.201 0.201 
H4 Norway House 2013 0.100 0.201 0.202 0.203 0.202 
H5 Norway House 2013 0.101 0.201 0.202 0.202 0.203 
H6 Norway House 2013 0.101 0.201 0.201 0.202 0.202 
H7 Norway House 2013 0.100 0.201 0.202 0.202 0.201 
H8 Norway House 2013 0.101 0.203 0.202 0.203 0.201 
H9 Norway House 2013 0.100 0.202 0.202 0.203 0.201 




Table SI-4 – Descriptive statistics for all target analytes present in indoor dust samples from Norwegian houses (N=10). Concentrations in μg/g.   













DMP 0.022 0.103 0.202 0.632 1.441 0.221 0.411 0.489 100 
DEP 0.522 0.535 1.817 4.723 54.215 2.007 7.557 16.639 100 
DiBP 2.585 3.279 6.366 19.243 106.045 8.871 19.349 31.905 100 
DnBP 6.487 8.968 10.305 23.619 26.727 12.277 13.88 7.634 100 
BzBP 0.217 2.033 10.618 53.379 96.565 9.345 27.23 33.325 100 
DEHP 34.207 82.135 224.976 441.794 1463.954 210.403 360.981 431.19 100 
DINCH 0.676 14.752 17.064 65.214 229.461 21.849 48.37 67.842 100 
DEHT 1.767 10.748 20.052 32.879 38.707 15.841 20.755 12.429 100 
DPHP 1.015 2.098 4.685 5.823 22.098 4.058 5.923 6.341 90 












The aim of this thesis was to explore the human exposure and uptake (i.e. bioaccessibility) of 
legacy and emerging flame retardants via indoor dust using artificial human body fluids. The 
two main research pillars of this PhD thesis were: a) developing and establishing a unified 
approach with the inclusion of an absorptive sink for the assessment of oral bioaccessibility 
via dust ingestion as a predominant route of exposure, whilst b) inhalation was explored with 
respect to human exposure and in vitro uptake of phthalate esters and alternative plasticisers, 
especially the short-chain ones with low MW. EU regulation for the registration, evaluation, 
authorisation and restriction of chemicals (REACH) requires in vitro alternatives which can 
help reduce the amount of animal testing required. Hence, the research methods and the 
accompanying results discussed in chapters 2, 3 and 4 are meant to liaise collectively with 
formerly established testing strategies towards constructive enforcement of in vitro 
bioaccessibility methods and more effective implementation of the “precautionary principle” 
framework by orchestrating and adopting more efficient in vitro alternatives for chemical 
testing.  
In chapter 1, the conceptual difference between bioavailability and bioaccessibility is 
introduced, followed by a meticulous review of existing literature regarding human exposure 
and risk assessment to FRs, PEs and alternative plasticisers. Orchestrated under the 
precautionary principle for organic pollutant assessment and in an attempt to efficiently 
combine the BARGE criteria for in vitro bioaccessibility testing with the ISO 1675 method 
(ISO, 2015), our systematic review puts forward the necessity for the development of a high-
throughput, robust and unified in vitro method for oral bioaccessibility testing of organic 
pollutants. The inclusion of colon microbiota serving as a biologically active “sink” has been 
previously proposed by (Van de Wiele et al., 2005), studying the estrogenic potency of soil-
bound PAHs to humans. Our comprehensive literature regarding “infinite sink” materials and 
bioaccessibility testing, screened among fundamentally diverse materials as candidates 
including Tenax TA®, silicone rods and cyclodextrins. Given its large surface area and high 
sorption capacity for HOCs, Tenax TA® was proposed as the most suitable resin to serve as a 
non-biological absorption sink and was employed in a novel bioaccessibility method 
described in chapter 3. Employing a biologically active (i.e. colon microbiota) and Tenax 
TA® as an absorption sink collectively are not recommended, since each one of them serves a 
profoundly different objective; microbiota inclusion is an ideal solution for the assessment of 
microbial transformation mechanisms and the underlying effects of organic compounds and 
their metabolites to the colon environment. However, the inclusion of Tenax TA® as a non-
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biologically active absorption sink in the CE-PBET configuration is perceived as an 
exhaustive method can potentially improve in vitro bioaccessibility estimates, while it better 
mimics the sorption/desorption processes in the human GIT in vivo. 
In chapter 2, we reported levels of legacy and alternative FRs in house dust samples from 
Norway and the UK, as well as from British stores and offices. Our findings reveal the 
predominant character of PFRs in the indoor (house and office) environment with 
considerable concentrations of monomeric PFRs in indoor dust collected from two 
geographically diverse areas, Norway and the UK. These findings are mainly governed by the 
growing use of PFRs in the global market as PBDEs substitutes (van der Veen and de Boer, 
2012b). Our dust sample collection was conducted during summer 2013 – spring 2014, which 
can be considered as a transition period for the flame retardant industry between the banning 
and phase-out of PBDEs from North America and Europe in 2012 (Dodson et al., 2012; 
Newton et al., 2015), followed by the emerging prevalence of alternative FRs, including 
monomeric and oligomeric PFRs (Tao et al., 2016; Xu et al., 2016). Indoor dust is a suitable 
and well-established matrix not only for monitoring concertation trends and long-term human 
exposure to PBDEs (Allen et al., 2008), as well as for the identification of newer alternative 
FRs such as halogen-free oligomeric PFRs including iDPP, EHDPHP and TXP (monomeric 
PFR), liaised by the support of recent advances in analytical and instrumentational methods 
(Covaci et al., 2011). In our study, monomeric PFRs were found to be considerably higher in 
all samples compared to EHFRs, PBDEs and oligomeric PFRs, while the estimated human 
intakes for FRs for British toddlers were found to be higher than toddlers in Norway and 
below the suggested RfD values. This is the first study reporting human exposure via dust 
ingestion for most oligomeric PFRs, including EHDPH, iDPP and TXP; the work presented 
in chapter 2 acts an open reminder to the environmental and toxicological communities 
worldwide on the need for advanced and state-of-the-art analytical and instrumental methods 
as well as the importance of continuous FR screening via indoor dust as a long-established 
repository sink for organic compounds in the indoor environment.  
In chapter 3, we presented a method development of the CE-PBET model with the inclusion 
of Tenax TA® as an “infinite” sink to the test configuration. With the Tenax TA® inclusion 
we succeed in 2- and 3-fold increase in FR absorption for the high and low brominated 
PBDEs, respectively compared to CE-PBET with no Tenax TA® present. While previously 
published gut bioaccessibility methods involved a self-designed stainless steel sieve for the 
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separation and the recovery of Tenax TA® beads (Fang and Stapleton, 2014; Li et al., 2015), 
in our experimental configuration the RC dialysis tubing provides successful physical 
separation of the Tenax TA® from the solid matrix (dust), has high pH and temperature 
tolerance and the selected 3.5 kDa MWCO of the RC membrane permits successful sorption 
on the Tenax TA® even of highly brominated PBDEs such as BDE 154 and BDE183, thus 
increasing their overall gut bioaccessibility by two-fold via passive diffusion in all CE-PBET 
compartments. Concerning the Tenax TA® mass loading, our results show that 0.25g were 
not enough to sustain an exhaustive gut extraction for the low brominated and more water 
soluble compounds such as BDE28. Hence, 0.5g of Tenax TA® were used in our method 
settings. Our study proposes that Tenax TA® mass loading should be thus optimised with 
respect to the physicochemical properties of the analytes of interest.  
However, the case of selected EHFRs including EH-TBB, BTBPE and BEH-TEBP should be 
considered carefully and the available data cannot be fully interpreted as with the PBDEs. 
This is mostly attributed to instrumental limitations, rather than inefficiencies and 
inappropriateness of the study design. Two coeluting compounds were noted during GC-
EI/MS analysis and their chromatographic separation was unattainable; a) EH-TBB co-elutes 
with BDE99, thus the latter analyte was excluded from the target compound list (Stapleton et 
al., 2008) and b) the 13C-labelled standard of BTBPE co-elutes with the native compound, 
making peak confirmation and peak integration rather challenging especially in full scan 
mode (NCI and SIM mode were not available in the GC-MS instrument configuration used 
during these analyses). Finally, even though a moderate gas flow (1.0 mL/min) and a GC 
column with high temperature tolerance and low-bleed were used during instrumental 
analysis, BEH-TEBP analytical performance did not meet the expected results presenting low 
reproducibility. Hence, the reader is advised to consider all the aforementioned limitations 
when assessing the presented data for the selected EHFRs in chapter 3.   
In an attempt to explore alternative routes of exposure, we presented in chapter 4 the first in 
vitro study assessing the inhalation bioaccessibility for established phthalate esters and 
alternative plasticisers from in indoor dust from Norwegian houses. Low MW and short-
chained phthalates such as DMP and DEP were found to be highly bioaccessible (>75%) in 
both artificial pulmonary media tested (i.e. Gamble’s solution and ALF), regardless of the 
medium’s pH and chemical composition. Among the studied physicochemical properties, 
only hydrophobicity was found to significantly influence the in vitro pulmonary uptake 
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(p<0.05), setting LogKow as the main driving force governing inhalation bioaccessility of 
organic pollutants. Dust particles properties such as dust particle size and OMC failed to 
present any statistically significant relationship with inhalation bioaccessibility. Our results 
reveal that pulmonary uptake may contribute substantially to human exposure for semi-
volatile organic compounds with low MW, hydrophobicity and water solubility. The 










To our knowledge, no biomonitoring studies exist where in vitro bioaccessibility testing and 
different exposure routes (e.g. ingestion, inhalation) are collectively combined. Such study 
design tactics can provide a holistic approach to scientists regarding a more conservative 
human risk assessment of organics. Prior to embarking into any future biomonitoring studies 
proper quantification of exposure should be ensured, while development and validation of 
new analytical methods and commercially available reference standards for emerging 
compounds are essential. The work presented in this PhD thesis identified the weaknesses 
and limitations of previously established in vitro bioaccessibility tests for organic pollutants; 
our effort was towards establishing and validating novel bioaccessibility methods. Our main 
goal was to provide well-designed and state-of-the-art experimental settings with a leap 
towards an integrated and more comprehensive approach not only used by the scientific niche 
of environmental scientists, but to deliver in vitro methods directly applicable for regulators 
and policy decision makers to enforce and implement. Finally, the above listed points in 
addition to a) dust ingestion as a substantial route of exposure for FRs together with b) the 
requirement of Tenax TA® inclusion as an absorptive sink maintaining a desorption gradient 
similar to the in vivo GIT situation are the two central take-home messages supported by our 
results.  
In vitro cell culture-based models of human adenocarcinoma monolayers such as HT-29 and 
Caco-2 have been employed in the past in absorption and bioavailability studies, mimicking 
the permeability potential of the human intestinal barrier (Cavret and Feidt, 2005; Dean and 
Ma, 2007; Tirelli et al., 2007). Such in vitro models combined with ex vivo and in silico 
approaches can be beneficial in understanding and elucidating the permeability potential of 
the intestinal barrier, by predicting GIT absorption, bioavailability and potential metabolism 
of organic pollutants (Pelkonen et al., 2001). However, such epithelium cell lines, given their 
current in vitro permeability configuration settings, present a finicky character during cell 
culture and maintenance with debatable viability success (Le Ferrec et al., 2001). Therefore, 
more effort and research should be encouraged in the future towards refining, re-designing 
and validating such approaches collectively against in vivo bioavailability studies. 
One should bear in mind that the pulmonary media used in this study were initially designed 
for uptake studies of nanoparticles and elements present in soil. Such inorganic compounds 
tend to be more water soluble, thus their bioaccessibility patterns tend to differ compared 
those of organic pollutants; when designing this study, we were fully aware of the pulmonary 
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fluid formulations. Considering the novel character of in vitro pulmonary uptake studies for 
organic pollutants, there is a lot of room for further development towards a more 
representative and physiologically-relevant to the situation in vivo of a) the pulmonary fluid 
formulation with potential addition of biologically relevant surfactants such as 
dipalmitoylphosphatidylcholine (DPCC) (Boisa et al., 2014) and mucin type V (Adler et al., 
2013; Heo et al., 2009), increasing thus the in vitro absorption capacity for less hydrophobic 
compounds and b) the in vitro test settings such as lung volume capacity, dust loading, 
incubation time etc.. Given all the above, future inhalation bioaccessibility studies should be 
primarily focused on in vivo validation younger children (<6 years old) who are the most 
vulnerable age group regarding exposure to phthalate esters through inhalation, rather than  
adults, whose phthalate exposure is primarily governed by dust ingestion and dietary intake 
(Giovanoulis, 2017).  
Formerly unexplored routes of exposure such as inhalation were also investigated as part of a 
holistic future perspective for the testing of uptake of chemicals of emerging concern such as 
phthalate esters and alternative plasticisers. Hence, coming back to the main aims of the 
present PhD thesis and the necessity of in vitro bioaccessibility tests for fine tuning risk 
assessments discussed in chapter 1, we conclude that robust, high-throughput and rigorous in 
vitro uptake assays mimicking the human processes in vivo are essential. Further 
development and validation in vivo should be encouraged, testing for a broad and physico-
chemically diverse range of established and emerging organic compounds. Overall, the 
aforementioned in vitro tests presented in this thesis will form the foundation upon which an 
integrated and robust testing strategy for chemicals of emerging concern can be built, whilst 
other contaminated matrices other than indoor dust such as soil may be tested in the future.  
Future research on suitable in vitro bioaccessibility tests for the screening of pollutants of 
emerging concern, as well as the development and validation of in vitro tests addressing 
alternative routes of exposure such as inhalation and dermal uptake, may lead to a 
comprehensive testing strategy within a realistic and conservative risk assessment 
framework, in conjunction high-throughput analyses such as non-targeted screening, 





Abb, M., Heinrich, T., Sorkau, E., Lorenz, W., 2009. Phthalates in house dust. Environ. Int. 
35, 965–970. doi:10.1016/j.envint.2009.04.007 
Abb M., J.V. Breuer, C. Zeitz & W. Lorenz. 2010. Analysis of pesticides and PCBs in waste 
wood and house dust. Chemosphere, 81, 488-493. 
Abdallah M.A.E., E. Tilston, S. Harrad & C. Collins. 2012. In vitro assessment of the 
bioaccessibility of brominated flame retardants in indoor dust using a colon extended 
model of the human gastrointestinal tract. Journal of Environmental Monitoring, 14, 
3276-3283. 
Abdallah, M.A.-E., Covaci, A., 2014. Organophosphate Flame Retardants in Indoor Dust 
from Egypt: Implications for Human Exposure. Environ. Sci. Technol. 48, 4782–
4789. doi:10.1021/es501078s 
Adler, K.B., Tuvim, M.J., Dickey, B.F., 2013. Regulated Mucin Secretion from Airway 
Epithelial Cells. Front. Endocrinol. 4. doi:10.3389/fendo.2013.00129 
Alaee, M., Arias, P., Sjödin, A., Bergman, Å., 2003. An overview of commercially used 
brominated flame retardants, their applications, their use patterns in different 
countries/regions and possible modes of release. Environ. Int. 29, 683–689. 
doi:10.1016/S0160-4120(03)00121-1 
Albar, H.M.S.A., Ali, N., Shahzad, K., Ismail, I.M.I., Rashid, M.I., Wang, W., Ali, L.N., 
Eqani, S.A.M.A.S., 2017. Phthalate esters in settled dust of different indoor 
microenvironments; source of non-dietary human exposure. Microchem. J. 132, 227–
232. doi:10.1016/j.microc.2017.02.008 
Ali, N., Ali, L., Mehdi, T., Dirtu, A.C., Al-Shammari, F., Neels, H., Covaci, A., 2013. Levels 
and profiles of organochlorines and flame retardants in car and house dust from 
Kuwait and Pakistan: Implication for human exposure via dust ingestion. Environ. Int. 
55, 62–70. doi:10.1016/j.envint.2013.02.001 
Ali, N., Harrad, S., Muenhor, D., Neels, H., Covaci, A., 2011. Analytical characteristics and 
determination of major novel brominated flame retardants (NBFRs) in indoor dust. 
Anal. Bioanal. Chem. 400, 3073–3083. doi:10.1007/s00216-011-4966-7 
Ali, N., Van den Eede, N., Dirtu, A.C., Neels, H., Covaci, A., 2012. Assessment of human 




Allen, J.G., McClean, M.D., Stapleton, H.M., Webster, T.F., 2008. Critical factors in 
assessing exposure to PBDEs via house dust. Environ. Int. 34, 1085–1091. 
doi:10.1016/j.envint.2008.03.006 
Allen-King, R.M., Groenevelt, H., Mackay, D.M., 1995. Analytical Method for the Sorption 
of Hydrophobic Organic Pollutants in Clay-Rich Materials. Environ. Sci. Technol. 29, 
148–153. doi:10.1021/es00001a019 
Alves, A., Kucharska, A., Erratico, C., Xu, F., Hond, E.D., Koppen, G., Vanermen, G., 
Covaci, A., Voorspoels, S., 2014. Human biomonitoring of emerging pollutants 
through non-invasive matrices: state of the art and future potential. Anal. Bioanal. 
Chem. 406, 4063–4088. doi:10.1007/s00216-014-7748-1 
Anh, H.Q., Nam, V.D., Tri, T.M., Ha, N.M., Ngoc, N.T., Mai, P.T.N., Anh, D.H., Minh, 
N.H., Tuan, N.A., Minh, T.B., 2016. Polybrominated diphenyl ethers in plastic 
products, indoor dust, sediment and fish from informal e-waste recycling sites in 
Vietnam: a comprehensive assessment of contamination, accumulation pattern, 
emissions, and human exposure. Environ. Geochem. Health 1–20. 
doi:10.1007/s10653-016-9865-6 
Bakker M.I., R. de Winter-Sorkina, A. de Mul, P.E. Boon, G. van Donkersgoed, J.D. van 
Klaveren, B.A. Baumann, W.C. Hijman, S.P.J. van Leeuwen, J. de Boer & M.J. 
Zeilmaker. 2008. Dietary intake and risk evaluation of polybrominated diphenyl ethers 
in The Netherlands. Molecular Nutrition & Food Research, 52, 204-216. 
Ballesteros-Gómez, A., Aragón, Á., Van den Eede, N., de Boer, J., Covaci, A., 2016. 
Impurities of Resorcinol Bis(diphenyl phosphate) in Plastics and Dust Collected on 
Electric/Electronic Material. Environ. Sci. Technol. doi:10.1021/acs.est.5b05351 
Ballesteros-Gómez, A., Brandsma, S.H., de Boer, J., Leonards, P.E.G., 2014. Analysis of two 
alternative organophosphorus flame retardants in electronic and plastic consumer 
products: Resorcinol bis-(diphenylphosphate) (PBDPP) and bisphenol A bis 
(diphenylphosphate) (BPA-BDPP). Chemosphere, Flame Retardants in the 
Environment - Papers presented at 6th International Symposium on Flame Retardants 
(BFR2013), San Francisco from April 7-10 116, 10–14. 
doi:10.1016/j.chemosphere.2013.12.099 
Batterman, S., Godwin, C., Chernyak, S., Jia, C., Charles, S., 2010. Brominated flame 
retardants in offices in Michigan, U.S.A. Environ. Int. 36, 548–556. 
doi:10.1016/j.envint.2010.04.008 
Bearr, J.S., Mitchelmore, C.L., Roberts, S.C., Stapleton, H.M., 2012. Species specific 
differences in the in vitro metabolism of the flame retardant mixture, Firemaster® 
BZ-54. Aquat. Toxicol. 124–125, 41–47. doi:10.1016/j.aquatox.2012.06.006 
150 
 
Bekö, G., Weschler, C.J., Langer, S., Callesen, M., Toftum, J., Clausen, G., 2013. Children’s 
Phthalate Intakes and Resultant Cumulative Exposures Estimated from Urine 
Compared with Estimates from Dust Ingestion, Inhalation and Dermal Absorption in 
Their Homes and Daycare Centers. PLoS ONE 8, e62442. 
doi:10.1371/journal.pone.0062442 
Bellinger, D.C., 2013. Prenatal Exposures to Environmental Chemicals and Children’s 
Neurodevelopment: An Update. Saf. Health Work 4, 1–11. 
doi:10.5491/SHAW.2013.4.1.1 
Ben, Y.-J., Li, X.-H., Yang, Y.-L., Li, L., Di, J.-P., Wang, W.-Y., Zhou, R.-F., Xiao, K., 
Zheng, M.-Y., Tian, Y., Xu, X.-B., 2013. Dechlorane Plus and its dechlorinated 
analogs from an e-waste recycling center in maternal serum and breast milk of women 
in Wenling, China. Environ. Pollut. 173, 176–181. doi:10.1016/j.envpol.2012.09.028 
Bergh C., R. Torgrip, G. Emenius & C. Östman. 2011. Organophosphate and phthalate esters 
in air and settled dust – a multi-location indoor study. Indoor Air, 21, 67-76. 
Bergh, C., Torgrip, R., Emenius, G., Östman, C., 2011. Organophosphate and phthalate esters 
in air and settled dust – a multi-location indoor study. Indoor Air 21, 67–76. 
doi:10.1111/j.1600-0668.2010.00684.x 
Berntssen M.H.G., P.A. Olsvik, B.E. Torstensen, K. Julshamn, T. Midtun, A. Goksoyr, J. 
Johansen, T. Sigholt, N. Joerum, J.V. Jakobsen, A.K. Lundebye & E.J. Lock. 2010. 
Reducing persistent organic pollutants while maintaining long chain omega-3 fatty acid 
in farmed Atlantic salmon using decontaminated fish oils for an entire production cycle. 
Chemosphere, 81, 242-252. 
Betts, K.S., 2013. Exposure to TDCPP Appears Widespread. Environ. Health Perspect. 121, 
a150. doi:10.1289/ehp.121-a150 
Boisa, N., Elom, N., Dean, J.R., Deary, M.E., Bird, G., Entwistle, J.A., 2014. Development 
and application of an inhalation bioaccessibility method (IBM) for lead in the PM10 
size fraction of soil. Environ. Int. 70, 132–142. doi:10.1016/j.envint.2014.05.021 
Bornehag, C.-G., Lundgren, B., Weschler, C.J., Sigsgaard, T., Hagerhed-Engman, L., 
Sundell, J., 2005. Phthalates in Indoor Dust and Their Association with Building 
Characteristics. Environ. Health Perspect. 113, 1399–1404. doi:10.1289/ehp.7809 
Bornehag, C.G., Nanberg, E., 2010. Phthalate exposure and asthma in children. Int. J. Androl. 
33, 333–345. doi:10.1111/j.1365-2605.2009.01023.x 
Bornehag, C.-G., Sundell, J., Weschler, C.J., Sigsgaard, T., Lundgren, B., Hasselgren, M., 
Hägerhed-Engman, L., 2004. The Association between Asthma and Allergic 
Symptoms in Children and Phthalates in House Dust: A Nested Case-Control Study. 
Environ. Health Perspect. 112, 1393–1397. 
151 
 
Brandon, E.F.A., Oomen, A.G., Rompelberg, C.J.M., Versantvoort, C.H.M., van Engelen, 
J.G.M., Sips, A.J.A.M., 2006. Consumer product in vitro digestion model: 
Bioaccessibility of contaminants and its application in risk assessment. Regul. 
Toxicol. Pharmacol. 44, 161–171. doi:10.1016/j.yrtph.2005.10.002 
Brandsma, S.H., Sellström, U., de Wit, C.A., de Boer, J., Leonards, P.E.G., 2013. Dust 
Measurement of Two Organophosphorus Flame Retardants, Resorcinol 
Bis(diphenylphosphate) (RBDPP) and Bisphenol A Bis(diphenylphosphate) (BPA-
BDPP), Used as Alternatives for BDE-209. Environ. Sci. Technol. 47, 14434–14441. 
doi:10.1021/es404123q 
Brasche S. & W. Bischof. 2005. Daily time spent indoors in German homes--baseline data for 
the assessment of indoor exposure of German occupants. International journal of hygiene 
and environmental health, 208, 247-253. 
Brommer S., S. Harrad, N.V.d. Eede & A. Covaci. 2012. Concentrations of organophosphate 
esters and brominated flame retardants in German indoor dust samples. Journal of 
Environmental Monitoring, 14, 2482-2487. 
Brommer, S., Harrad, S., 2015. Sources and human exposure implications of concentrations 
of organophosphate flame retardants in dust from UK cars, classrooms, living rooms, 
and offices. Environ. Int. 83, 202–207. doi:10.1016/j.envint.2015.07.002 
Brommer, S., Harrad, S., Eede, N.V. den, Covaci, A., 2012. Concentrations of 
organophosphate esters and brominated flame retardants in German indoor dust 
samples. J. Environ. Monit. 14, 2482–2487. doi:10.1039/C2EM30303E 
Bruce S., B. Noller, V. Matanitobua & J. Ng. 2007. In vitro physiologically based extraction 
test (PBET) and bioaccessibility of arsenic and lead from various mine waste materials. 
Journal of Toxicology and Environmental Health-Part a-Current Issues, 70, 1700-1711. 
Bui, T.T., Alves, A., Palm-Cousins, A., Voorspoels, S., Covaci, A., Cousins, I.T., 2017. 
Estimating uptake of phthalate ester metabolites into the human nail plate using 
pharmacokinetic modelling. Environ. Int. 100, 148–155. 
doi:10.1016/j.envint.2017.01.007 
Bui, T.T., Giovanoulis, G., Cousins, A.P., Magnér, J., Cousins, I.T., de Wit, C.A., 2016. 
Human exposure, hazard and risk of alternative plasticizers to phthalate esters. Sci. 
Total Environ. 541, 451–467. doi:10.1016/j.scitotenv.2015.09.036 
Butte W. & B. Heinzow. 2002. Pollutants in house dust as indicators of indoor 
contamination. Rev Environ Contam Toxicol, 175, 1-46. 
Calabrese E.J., E.J. Stanek, R. Barnes, D.E. Burmaster, B.G. Callahan, J.S. Heath, D. 
Paustenbach, J. Abraham & L.A. Gephart. 1996. Methodology to estimate the amount 
152 
 
and particle size of soil ingested by children: implications for exposure assessment at 
waste sites. Regulatory toxicology and pharmacology : RTP, 24, 264-268. 
Cao, Z., Xu, F., Covaci, A., Wu, M., Wang, H., Yu, G., Wang, B., Deng, S., Huang, J., 
Wang, X., 2014a. Distribution Patterns of Brominated, Chlorinated, and Phosphorus 
Flame Retardants with Particle Size in Indoor and Outdoor Dust and Implications for 
Human Exposure. Environ. Sci. Technol. doi:10.1021/es501224b 
Cao, Z., Xu, F., Covaci, A., Wu, M., Yu, G., Wang, B., Deng, S., Huang, J., 2014b. 
Differences in the seasonal variation of brominated and phosphorus flame retardants 
in office dust. Environ. Int. 65, 100–106. doi:10.1016/j.envint.2013.12.011 
Carlstedt, F., Jönsson, B. a. G., Bornehag, C.-G., 2013. PVC flooring is related to human 
uptake of phthalates in infants. Indoor Air 23, 32–39. doi:10.1111/j.1600-
0668.2012.00788.x 
Cave M.R., J. Wragg, I. Harrison, C.H. Vane, E. De Groeve, T. Van De Wiele, C.P. 
Nathanail, M. Ashmore, R. Thomas, J. Robinson & P. Daly. 2010a. Comparison of 
Batch Mode and Dynamic Physiologically Based Bioaccessibility Tests for PAHs in Soil 
Samples. 44, 2654-2660. 
Cave, M.R., Wragg, J., Harrison, I., Vane, C.H., Wiele, T.V. de, Groeve, E.D., Nathanail, 
C.P., Ashmore, M., Thomas, R., Robinson, J., Daly, P., 2010. Comparison of Batch 
Mode and Dynamic Physiologically Based Bioaccessibility Tests for PAHs in Soil 
Samples. Environ. Sci. Technol. 44, 2654–2660. doi:10.1021/es903258v 
Cavret, S., Feidt, C., 2005. Intestinal metabolism of PAH: in vitro demonstration and study of 
its impact on PAH transfer through the intestinal epithelium. Environ. Res. 98, 22–32. 
doi:10.1016/j.envres.2004.10.010 
Cequier, E., Ionas, A.C., Covaci, A., Marcé, R.M., Becher, G., Thomsen, C., 2014. 
Occurrence of a Broad Range of Legacy and Emerging Flame Retardants in Indoor 
Environments in Norway. Environ. Sci. Technol. 48, 6827–6835. 
doi:10.1021/es500516u 
Cequier, E., Sakhi, A.K., Marcé, R.M., Becher, G., Thomsen, C., 2015. Human exposure 
pathways to organophosphate triesters — A biomonitoring study of mother–child 
pairs. Environ. Int. 75, 159–165. doi:10.1016/j.envint.2014.11.009 
Chemtura Corp, 2013. Great Lakes solutions Flame Retardants Product Guide. 
Cheng Z., X.-P. Nie, H.-S. Wang & M.-H. Wong. 2013. Risk assessments of human exposure 
to bioaccessible phthalate esters through market fish consumption. Environment 
International, 57-58, 75-80. 
153 
 
Collins C.D., M. Mosquera-Vazquez, J.L. Gomez-Eyles, P. Mayer, V. Gouliarmou & E. 
Blum. 2013. Is there sufficient 'sink' in current bioaccessibility determinations of organic 
pollutants in soils? Environmental Pollution, 181, 128-132. 
Collins, C.D., Craggs, M., Garcia-Alcega, S., Kademoglou, K., Lowe, S., 2015. ‘Towards a 
unified approach for the determination of the bioaccessibility of organic pollutants.’ 
Environ. Int. 78, 24–31. doi:10.1016/j.envint.2015.02.005 
Collins, C.D., Mosquera-Vazquez, M., Gomez-Eyles, J.L., Mayer, P., Gouliarmou, V., Blum, 
F., 2013. Is there sufficient ‘sink’ in current bioaccessibility determinations of organic 
pollutants in soils? Environ. Pollut. 181, 128–132. doi:10.1016/j.envpol.2013.05.053 
Cornelissen, G., van Noort, P.C.M., Govers, H.A.J., 1997. Desorption kinetics of 
chlorobenzenes, polycyclic aromatic hydrocarbons, and polychlorinated biphenyls: 
Sediment extraction with Tenax® and effects of contact time and solute 
hydrophobicity. Environ. Toxicol. Chem. 16, 1351–1357. 
doi:10.1002/etc.5620160703 
Correia-Sá, L., Schütze, A., Norberto, S., Calhau, C., Domingues, V.F., Koch, H.M., 2017. 
Exposure of Portuguese children to the novel non-phthalate plasticizer di-(iso-nonyl)-
cyclohexane-1,2-dicarboxylate (DINCH). Environ. Int. 
doi:10.1016/j.envint.2017.02.001 
Costa, L.G., Giordano, G., 2007. Developmental neurotoxicity of polybrominated diphenyl 
ether (PBDE) flame retardants. NeuroToxicology 28, 1047–1067. 
doi:10.1016/j.neuro.2007.08.007 
Covaci, A., Harrad, S., Abdallah, M.A.-E., Ali, N., Law, R.J., Herzke, D., de Wit, C.A., 2011. 
Novel brominated flame retardants: A review of their analysis, environmental fate and 
behaviour. Environ. Int. 37, 532–556. doi:10.1016/j.envint.2010.11.007 
Cui, X.-Y., Xiang, P., He, R.-W., Juhasz, A., Ma, L.Q., 2016. Advances in in vitro methods 
to evaluate oral bioaccessibility of PAHs and PBDEs in environmental matrices. 
Chemosphere 150, 378–389. doi:10.1016/j.chemosphere.2016.02.041 
Cunha S.C., K. Kalachova, J. Pulkrabova, J.O. Fernandes, M.B.P.P. Oliveira, A. Alves & J. 
Hajslova. 2010. Polybrominated diphenyl ethers (PBDEs) contents in house and car dust 
of Portugal by pressurized liquid extraction (PLE) and gas chromatography–mass 
spectrometry (GC–MS). Chemosphere, 78, 1263-1271. 
Darnerud P.O. 2003. Toxic effects of brominated flame retardants in man and in wildlife. 
Environment International, 29, 841-853. 
de Wit, C.A., Herzke, D., Vorkamp, K., 2010. Brominated flame retardants in the Arctic 




Dean, J.R., Elom, N.I., Entwistle, J.A., 2017. Use of simulated epithelial lung fluid in 
assessing the human health risk of Pb in urban street dust. Sci. Total Environ. 579, 
387–395. doi:10.1016/j.scitotenv.2016.11.085 
Dean, J.R., Ma, R., 2007. Approaches to assess the oral bioaccessibility of persistent organic 
pollutants: A critical review. Chemosphere 68, 1399–1407. 
doi:10.1016/j.chemosphere.2007.03.054 
Derouet, D., Morvan, F., Brosse, J.C., 1996. Chemical modification of epoxy resins by 
dialkyl(or aryl) phosphates: Evaluation of fire behavior and thermal stability. J. Appl. 
Polym. Sci. 62, 1855–1868. doi:10.1002/(SICI)1097-
4628(19961212)62:11<1855::AID-APP10>3.0.CO;2-Y 
Deutschle, T., Reiter, R., Butte, W., Heinzow, B., Keck, T., Riechelmann, H., 2008. A 
Controlled Challenge Study on Di(2-ethylhexyl) Phthalate (DEHP) in House Dust and 
the Immune Response in Human Nasal Mucosa of Allergic Subjects. Environ. Health 
Perspect. 116, 1487–93. 
Dodson, R.E., Camann, D.E., Morello-Frosch, R., Brody, J.G., Rudel, R.A., 2015. 
Semivolatile Organic Compounds in Homes: Strategies for Efficient and Systematic 
Exposure Measurement Based on Empirical and Theoretical Factors. Environ. Sci. 
Technol. 49, 113–122. doi:10.1021/es502988r 
Dodson, R.E., Perovich, L.J., Covaci, A., Van den Eede, N., Ionas, A.C., Dirtu, A.C., Brody, 
J.G., Rudel, R.A., 2012. After the PBDE phase-out: a broad suite of flame retardants in 
repeat house dust samples from California. Environ. Sci. Technol. 46, 13056–13066. 
doi:10.1021/es303879n 
Doelman, C.J., Borm, P.J., Bast, A., 1990. Plasticisers and bronchial hyperreactivity. Lancet 
Lond. Engl. 335, 725. 
de Wit C.A. 2002. An overview of brominated flame retardants in the environment. 
Chemosphere, 46, 583-624. 
Dean J.R. & R.L. Ma. 2007. Approaches to assess the oral bioaccessibility of persistent 
organic pollutants: A critical review. Chemosphere, 68, 1399-1407. 
Denys S., J. Caboche, K. Tack, G. Rychen, J. Wragg, M. Cave, C. Jondreville & C. Feidt. 
2012. In Vivo Validation of the Unified BARGE Method to Assess the Bioaccessibility 
of Arsenic, Antimony, Cadmium, and Lead in Soils. Environmental Science & 
Technology, 46, 6252-6260. 
Domingo J.L., A. Bocio, G. Falcó & J.M. Llobet. 2007. Benefits and risks of fish 
consumption: Part I. A quantitative analysis of the intake of omega-3 fatty acids and 
chemical contaminants. Toxicology, 230, 219-226. 
155 
 
Duan L., T. Palanisami, Y. Liu, Z. Dong, M. Mallavarapu, T. Kuchel, K.T. Semple & R. 
Naidu. 2014. Effects of ageing and soil properties on the oral bioavailability of benzo a 
pyrene using a swine model. Environment International, 70, 192-202. 
EBFRIP, 2008. European Brominated Flame Retardant Industry Panel (EBFRIP) - 
Legislation on BFRs in Norway [WWW Document]. URL http://www.ebfrip.org/main-
nav/european-regulatory-centre/national-regulations/norway (accessed 7.12.16). 
ECB. 2002. European Chemicals Bureau - European Union Risk Assessment Report: bis 
(pentabromophenyl) ether. Office for Official Publications of the European 
Communities, Luxembourg. 
ECHA, 2008a. EU RISK ASSESSMENT – tris(1,3-dichloro-2-propyl)phosphate TCPP CAS 
13674-84-5 [WWW Document]. URL 
https://echa.europa.eu/documents/10162/13630/trd_rar_ireland_tccp_en.pdf (accessed 
9.12.16). 
ECHA, 2008b. EU RISK ASSESSMENT – tris(2-chloro-1-(chloromethyl)ethyl) phosphate 
TDCP CAS 13674-87-8 [WWW Document]. URL 
https://echa.europa.eu/documents/10162/13630/trd_rar_ireland_tccp_en.pdf (accessed 
9.12.16). 
ECHA, 2008c. EU RISK ASSESSMENT – tetraekis(2-chlorethyl)-
dichloroisopentyldiphosphate (V6) CAS 38051-10-4 [WWW Document]. URL 
https://echa.europa.eu/documents/10162/c38476f5-ebfc-43b2-8800-83f04e623c74 
(accessed 9.12.16). 
ECHA, 2012. Bis(pentabromophenyl) ether (decabromodiphenyl... - Candidate List of 
substances of very high concern for Authorisation - ECHA [WWW Document]. URL 
https://echa.europa.eu/candidate-list-table/-/dislist/details/0b0236e1807dd2e6 (accessed 
9.7.16). 
ECHA, 2013. ANNEX XV – IDENTIFICATION OF TRIXYLYLPHOSPHATE (TXP) CAS 
25155-23-1 AS SVHC [WWW Document]. URL 
https://echa.europa.eu/documents/10162/953524f2-7965-430c-be61-0bb02f08f83c 
(accessed 9.12.16). 
ECHA, 2015. Trixylyl phosphate CAS 25155-23-1 Draft background document for trixylyl 
phosphate in the context of ECHA’s seventh recommendation for  the inclusion of 





Ertl H. & W. Butte. 2012. Bioaccessibility of pesticides and polychlorinated biphenyls from 
house dust: in-vitro methods and human exposure assessment. Journal of exposure 
science & environmental epidemiology, 22, 574-583. 
Ertl, H., Butte, W., 2012. Bioaccessibility of pesticides and polychlorinated biphenyls from 
house dust: in-vitro methods and human exposure assessment. J. Expo. Sci. Environ. 
Epidemiol. 22, 574–583. doi:10.1038/jes.2012.50 
European Commission, 2015. EC amendment Annex II to Directive 2011/65/EU of the 
European Parliament and of the  Council as regards the list of restricted substances 
[WWW Document]. URL http://ec.europa.eu/transparency/regdoc/rep/3/2015/EN/3-
2015-2067-EN-F1-1.PDF (accessed 2.21.17). 
European Commission, 2016. Regulation amending Annex XVII to Regulation (EC) No 
1907/2006 of the European Parliament and of the Council concerning the Registration, 
Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards 




Fang, M., Stapleton, H.M., 2014. Evaluating the Bioaccessibility of Flame Retardants in 
House Dust Using an In Vitro Tenax Bead-Assisted Sorptive Physiologically Based 
Method. Environ. Sci. Technol. doi:10.1021/es503918m 
Fang, M., Webster, T.F., Gooden, D., Cooper, E.M., McClean, M.D., Carignan, C., Makey, 
C., Stapleton, H.M., 2013. Investigating a Novel Flame Retardant Known as V6: 
Measurements in Baby Products, House Dust, and Car Dust. Environ. Sci. Technol. 47, 
4449–4454. doi:10.1021/es400032v 
Franken, C., Lambrechts, N., Govarts, E., Koppen, G., Den Hond, E., Ooms, D., Voorspoels, 
S., Bruckers, L., Loots, I., Nelen, V., Sioen, I., Nawrot, T.S., Baeyens, W., Van 
Larebeke, N., Schoeters, G., 2017. Phthalate-induced oxidative stress and association 
with asthma-related airway inflammation in adolescents. Int. J. Hyg. Environ. Health. 
doi:10.1016/j.ijheh.2017.01.006 
Fromme, H., Lahrz, T., Kraft, M., Fembacher, L., Dietrich, S., Sievering, S., Burghardt, R., 
Schuster, R., Bolte, G., Völkel, W., 2013. Phthalates in German daycare centers: 
Occurrence in air and dust and the excretion of their metabolites by children (LUPE 3). 
Environ. Int. 61, 64–72. doi:10.1016/j.envint.2013.09.006 
Fromme, H., Lahrz, T., Piloty, M., Gebhart, H., Oddoy, A., Rüden, H., 2004. Occurrence of 
phthalates and musk fragrances in indoor air and dust from apartments and 




García-Alcega, S., Rauert, C., Harrad, S., Collins, C.D., 2016. Does the source migration 
pathway of HBCDs to household dust influence their bio-accessibility? Sci. Total 
Environ. 569–570, 244–251. doi:10.1016/j.scitotenv.2016.04.178 
Gerberding J. 2004. Toxicological Profile for Polybrominated Biphenyls and Polybrominated 
Diphenyl Ethers (PBBs and PBDEs). U.S. Department of Health and Human Services, 
Public Health Service Agency for Toxic Substances and Disease Registry (ATSDR), 
Atlanta, Georgia. 
Gevao, B., Al-Ghadban, A.N., Bahloul, M., Uddin, S., Zafar, J., 2013. Phthalates in indoor 
dust in Kuwait: implications for non-dietary human exposure. Indoor Air 23, 126–
133. doi:10.1111/ina.12001 
Giovanoulis, G., 2017. What contributes to human body burdens of phthalate esters? : An 
experimental approach. 
Gouliarmou V., C.D. Collins, E. Christiansen & P. Mayer. 2013. Sorptive Physiologically 
Based Extraction of Contaminated Solid Matrices: Incorporating Silicone Rod As 
Absorption Sink for Hydrophobic Organic Contaminants. Environmental Science & 
Technology, 47, 941-948. 
Gouliarmou, V., Collins, C.D., Christiansen, E., Mayer, P., 2013. Sorptive Physiologically 
Based Extraction of Contaminated Solid Matrices: Incorporating Silicone Rod As 
Absorption Sink for Hydrophobic Organic Contaminants. Environ. Sci. Technol. 47, 
941–948. doi:10.1021/es303165u 
Gouliarmou, V., Mayer, P., 2012. Sorptive Bioaccessibility Extraction (SBE) of Soils: 
Combining a Mobilization Medium with an Absorption Sink. Environ. Sci. Technol. 
46, 10682–10689. doi:10.1021/es301515s 
Gron C., A. Oomen, E. Weyand & J. Wittsiepe. 2007. Bioaccessibility of PAH from Danish 
soils. Journal of Environmental Science and Health Part a-Toxic/Hazardous 
Substances & Environmental Engineering, 42, 1233-1239. 
Guney, M., Zagury, G.J., 2016. Bioaccessibility and other key parameters in assessing oral 
exposure to PAH-contaminated soils and dust: A critical review. Hum. Ecol. Risk 
Assess. Int. J. 22, 1396–1417. doi:10.1080/10807039.2016.1185691 
Guo L., Y. Qiu, G. Zhang, G.J. Zheng, P.K.S. Lam & X. Li. 2008. Levels and 
bioaccumulation of organochlorine pesticides (OCPs) and polybrominated diphenyl 
ethers (PBDEs) in fishes from the Pearl River estuary and Daya Bay, South China. 
Environmental Pollution, 152, 604-611. 
Guo, Y., Kannan, K., 2011. Comparative Assessment of Human Exposure to Phthalate Esters 




Hack A. & F. Selenka. 1996. Mobilization of PAH and PCB from contaminated soil using a 
digestive tract model. Toxicology Letters, 88, 199-210. 
Harper, C., 2003. Handbook of Building Materials for Fire Protection. McGraw Hill 
Professional. 
Harrad S., C. Ibarra, M.A.-E. Abdallah, R. Boon, H. Neels & A. Covaci. 2008. 
Concentrations of brominated flame retardants in dust from United Kingdom cars, 
homes, and offices: Causes of variability and implications for human exposure. 
Environment International, 34, 1170-1175. 
Hauser, R., Calafat, A.M., 2005. Phthalates and Human Health. Occup. Environ. Med. 62, 
806–818. doi:10.1136/oem.2004.017590 
Hauser, R., Duty, S., Godfrey-Bailey, L., Calafat, A.M., 2004. Medications as a source of 
human exposure to phthalates. Environ. Health Perspect. 112, 751–753. 
Hazrati S. & S. Harrad. 2006. Causes of Variability in Concentrations of Polychlorinated 
Biphenyls and Polybrominated Diphenyl Ethers in Indoor air. Environmental Science 
& Technology, 40, 7584-7589. 
He, R., Li, Y., Xiang, P., Li, C., Zhou, C., Zhang, S., Cui, X., Ma, L.Q., 2016a. 
Organophosphorus flame retardants and phthalate esters in indoor dust from different 
microenvironments: Bioaccessibility and risk assessment. Chemosphere 150, 528–
535. doi:10.1016/j.chemosphere.2015.10.087 
Hedberg, Y., Gustafsson, J., Karlsson, H.L., Möller, L., Wallinder, I.O., 2010. 
Bioaccessibility, bioavailability and toxicity of commercially relevant iron- and 
chromium-based particles: in vitro studies with an inhalation perspective. Part. Fibre 
Toxicol. 7, 23. doi:10.1186/1743-8977-7-23 
Henry T.R. & M.J. DeVito. 2003. NON-DIOXIN-LIKE PCBs: EFFECTS AND 
CONSIDERATION IN ECOLOGICAL RISK ASSESSMENT. pp. 49-49. 
Heo, H.J., Lee, S.Y., Lee, M.N., Lee, H.J., Seok, J.H., Lee, C.J., 2009. Genistein and 
curcumin suppress epidermal growth factor-induced MUC5AC mucin production and 
gene expression from human airway epithelial cells. Phytother. Res. 23, 1458–1461. 
doi:10.1002/ptr.2801 
Heudorf, U., Mersch-Sundermann, V., Angerer, J., 2007. Phthalates: Toxicology and 
exposure. Int. J. Hyg. Environ. Health, Children’s Environment in Central Europe - 
Threats and ChancesResults of an International Workshop held on November 21-24, 
2006 in Osnabrück 210, 623–634. doi:10.1016/j.ijheh.2007.07.011 
Hsu, N.-Y., Lee, C.-C., Wang, J.-Y., Li, Y.-C., Chang, H.-W., Chen, C.-Y., Bornehag, C.-G., 
Wu, P.-C., Sundell, J., Su, H.-J., 2012. Predicted risk of childhood allergy, asthma, 
159 
 
and reported symptoms using measured phthalate exposure in dust and urine. Indoor 
Air 22, 186–199. doi:10.1111/j.1600-0668.2011.00753.x 
Hu X., Y. Zhang, Z. Ding, T. Wang, H. Lian, Y. Sun & J. Wu. 2012. Bioaccessibility and 
health risk of arsenic and heavy metals (Cd, Co, Cr, Cu, Ni, Pb, Zn and Mn) in TSP 
and PM2.5 in Nanjing, China. Atmospheric Environment, 57, 146-152. 
Jaakkola, J.J., Oie, L., Nafstad, P., Botten, G., Samuelsen, S.O., Magnus, P., 1999. Interior 
surface materials in the home and the development of bronchial obstruction in young 
children in Oslo, Norway. Am. J. Public Health 89, 188–192. 
doi:10.2105/AJPH.89.2.188 
Jaakkola, J.J.K., Knight, T.L., 2008. The Role of Exposure to Phthalates from Polyvinyl 
Chloride Products in the Development of Asthma and Allergies: A Systematic 
Review and Meta-analysis. Environ. Health Perspect. 116, 845–53. 
James K., R.E. Peters, B.D. Laird, W.K. Ma, M. Wickstrom, G.L. Stephenson & S.D. 
Siciliano. 2011. Human Exposure Assessment: A Case Study of 8 PAH Contaminated 
Soils Using in Vitro Digestors and the Juvenile Swine Model. Environmental Science 
& Technology, 45, 4586-4593. 
James, K., Peters, R.E., Laird, B.D., Ma, W.K., Wickstrom, M., Stephenson, G.L., Siciliano, 
S.D., 2011. Human Exposure Assessment: A Case Study of 8 PAH Contaminated 
Soils Using in Vitro Digestors and the Juvenile Swine Model. Environ. Sci. Technol. 
45, 4586–4593. doi:10.1021/es1039979 
Jones-Otazo, H.A., Clarke, J.P., Diamond, M.L., Archbold, J.A., Ferguson, G., Harner, T., 
Richardson, G.M., Ryan, J.J., Wilford, B., 2005. Is House Dust the Missing 
Exposure Pathway for PBDEs? An Analysis of the Urban Fate and Human Exposure 
to PBDEs. Environ. Sci. Technol. 39, 5121–5130. doi:10.1021/es048267b 
Jonsson, R., 2005. The end consumer’s choice of floorcovering in the Netherlands and the 
United Kingdom: a comparative pilot study of substitute competition. J. Wood Sci. 
51, 154–160. doi:10.1007/s10086-004-0632-4 
Juhasz A.L., E. Smith, J. Weber, M. Rees, A. Rofe, T. Kuchel, L. Sansom & R. Naidu. 2007. 
Comparison of in vivo and in vitro methodologies for the assessment of arsenic 
bioavailability in contaminated soils. Chemosphere, 69, 961-966. 
Juhasz A.L., J. Weber, G. Stevenson, D. Slee, D. Gancarz, A. Rofe & E. Smith. 2014. In vivo 
measurement, in vitro estimation and fugacity prediction of PAH bioavailability in 




ICL IP Inc., 2008. Syn-O-Ad® 8475 MSDS ICL-Industrial Products [WWW Document]. 
URL http://icl-ip.com/wp-content/uploads/2012/03/7071SA_enSYN-O-AD.pdf 
(accessed 9.12.16). 
Ionas, A.C., Dirtu, A.C., Anthonissen, T., Neels, H., Covaci, A., 2014. Downsides of the 
recycling process: Harmful organic chemicals in children’s toys. Environ. Int. 65, 54–
62. doi:10.1016/j.envint.2013.12.019 
ISO, 2015. ISO/DIS 16751 - Soil quality -- Environmental availability of non-polar organic 
compounds -- Determination of the potential bioavailable fraction and the non-
bioavailable fraction using a strong adsorbent or complexing agent [WWW 
Document]. URL https://www.iso.org/standard/64272.html (accessed 7.21.17). 
Kademoglou, K., Xu, F., Padilla-Sanchez, J.A., Haug, L.S., Covaci, A., Collins, C.D., 2017. 
Legacy and alternative flame retardants in Norwegian and UK indoor environment: 
Implications of human exposure via dust ingestion. Environ. Int. 102, 48–56. 
doi:10.1016/j.envint.2016.12.012 
Kalantzi, O.I., Martin, F.L., Thomas, G.O., Alcock, R.E., Tang, H.R., Drury, S.C., 
Carmichael, P.L., Nicholson, J.K., Jones, K.C., 2004. Different Levels of 
Polybrominated Diphenyl Ethers (PBDEs) and Chlorinated Compounds in Breast 
Milk from Two U.K. Regions. Environ. Health Perspect. 112, 1085–1091. 
doi:10.1289/ehp.6991 
Kanazawa, A., Saito, I., Araki, A., Takeda, M., Ma, M., Saijo, Y., Kishi, R., 2010. 
Association between indoor exposure to semi-volatile organic compounds and 
building-related symptoms among the occupants of residential dwellings. Indoor Air 
20, 72–84. doi:10.1111/j.1600-0668.2009.00629.x 
Kang Y., Y. Yin, Y. Man, L. Li, Q. Zhang, L. Zeng, J. Luo & M.H. Wong. 2013. 
Bioaccessibility of polychlorinated biphenyls in workplace dust and its implication for 
risk assessment. Chemosphere, 93, 924-930. 
Kang Y., Y.B. Man, K.C. Cheung & M.H. Wong. 2012. Risk Assessment of Human 
Exposure to Bioaccessible Phthalate Esters via Indoor Dust around the Pearl River 
Delta. Environmental Science & Technology, 46, 8422-8430. 
Kang, Y., Man, Y.B., Cheung, K.C., Wong, M.H., 2012. Risk Assessment of Human 
Exposure to Bioaccessible Phthalate Esters via Indoor Dust around the Pearl River 
Delta. Environ. Sci. Technol. 46, 8422–8430. doi:10.1021/es300379v 
Kim, J.-W., Isobe, T., Muto, M., Tue, N.M., Katsura, K., Malarvannan, G., Sudaryanto, A., 
Chang, K.-H., Prudente, M., Viet, P.H., Takahashi, S., Tanabe, S., 2014. 
Organophosphorus flame retardants (PFRs) in human breast milk from several Asian 
countries. Chemosphere, Flame Retardants in the Environment - Papers presented at 
161 
 
6th International Symposium on Flame Retardants (BFR2013), San Francisco from 
April 7-10 116, 91–97. doi:10.1016/j.chemosphere.2014.02.033 
Klara Midander, A. de F., 2010. Bioaccessibility studies of ferro-chromium alloy particles for 
a simulated inhalation scenario: a comparative study with the pure metals and 
stainless steel. Integr. Environ. Assess. Manag. 6, 441–55. doi:10.1002/ieam.32 
Kocbach Bølling, A., Holme, J.A., Bornehag, C.G., Nygaard, U.C., Bertelsen, R.J., Nånberg, 
E., Bodin, J., Sakhi, A.K., Thomsen, C., Becher, R., 2013. Pulmonary phthalate 
exposure and asthma - is PPAR a plausible mechanistic link? EXCLI J. 12, 733–759. 
Koch I., K.J. Reimer, M.I. Bakker, N.T. Basta, M.R. Cave, S. Denys, M. Dodd, B.A. Hale, R. 
Irwin, Y.W. Lowney, M.M. Moore, V. Paquin, P.E. Rasmussen, T. Repaso-Subang, 
G.L. Stephenson, S.D. Siciliano, J. Wragg & G.J. Zagury. 2013. Variability of 
bioaccessibility results using seventeen different methods on a standard reference 
material, NIST 2710. Journal of Environmental Science and Health Part a-
Toxic/Hazardous Substances & Environmental Engineering, 48, 641-655. 
Kolarik, B., Naydenov, K., Larsson, M., Bornehag, C.-G., Sundell, J., 2008. The Association 
between Phthalates in Dust and Allergic Diseases among Bulgarian Children. Environ. 
Health Perspect. 116, 98–103. 
Kriebel, D., Tickner, J., Epstein, P., Lemons, J., Levins, R., Loechler, E.L., Quinn, M., Rudel, 
R., Schettler, T., Stoto, M., 2001. The precautionary principle in environmental 
science. Environ. Health Perspect. 109, 871–876. 
Kubwabo, C., Rasmussen, P.E., Fan, X., Kosarac, I., Wu, F., Zidek, A., Kuchta, S.L., 2013. 
Analysis of selected phthalates in Canadian indoor dust collected using household 
vacuum and standardized sampling techniques. Indoor Air 23, 506–514. 
doi:10.1111/ina.12048 
Laird, B.D., Van de Wiele, T.R., Corriveau, M.C., Jamieson, H.E., Parsons, M.B., Verstraete, 
W., Siciliano, S.D., 2007. Gastrointestinal Microbes Increase Arsenic Bioaccessibility 
of Ingested Mine Tailings Using the Simulator of the Human Intestinal Microbial 
Ecosystem. Environ. Sci. Technol. 41, 5542–5547. doi:10.1021/es062410e 
Lamoureux G.L. & D.G. Rusness. 1986. Xenobiotic Conjugation in Higher Plants. In: 
Xenobiotic Conjugation Chemistry, pp. 62-105. American Chemical Society. 
Langer, S., Weschler, C.J., Fischer, A., Bekö, G., Toftum, J., Clausen, G., 2010. Phthalate 
and PAH concentrations in dust collected from Danish homes and daycare centers. 
Atmos. Environ. 44, 2294–2301. doi:10.1016/j.atmosenv.2010.04.001 
Latendresse, J.R., Brooks, C.L., Capen, C.C., 1994. Pathologic Effects of Butylated 
Triphenyl Phosphate-Based Hydraulic Fluid and Tricresyl Phosphate on the Adrenal 
162 
 
Gland, Ovary, and Testis in the Fischer-344 Rat. Toxicol. Pathol. 22, 341–352. 
doi:10.1177/019262339402200401 
Le Ferrec, E., Chesne, C., Artusson, P., Brayden, D., Fabre, G., Gires, P., Guillou, F., 
Rousset, M., Rubas, W., Scarino, M.L., 2001. In vitro models of the intestinal barrier. 
The report and recommendations of ECVAM Workshop 46. European Centre for the 
Validation of Alternative methods. Altern. Lab. Anim. ATLA 29, 649–668. 
Lee L.K. & J. He. 2010. Reductive debromination of polybrominated diphenyl ethers by 
anaerobic bacteria from soils and sediments. Applied and environmental microbiology, 
76, 794-802. 
Legler, J., Brouwer, A., 2003. Are brominated flame retardants endocrine disruptors? 
Environ. Int. 29, 879–885. doi:10.1016/S0160-4120(03)00104-1 
Lepom P., M. Berndt, A. Duffek & E. Warmbrunn-Suckrow. 2010. Oral Bioaccessibility of 
PBDEs in Dust Using an In Vitro Gastrointestinal Model. In: Brominated Flame 
Retardants 2010. 
Leufroy A., L. Noel, D. Beauchemin & T. Guerin. 2012. Use of a continuous leaching 
method to assess the oral bioaccessibility of trace elements in seafood. Food 
Chemistry, 135, 623-633. 
Li, C., Cui, X., Fan, Y., Teng, Y., Nan, Z., Ma, L.Q., 2015. Tenax as sorption sink for in vitro 
bioaccessibility measurement of polycyclic aromatic hydrocarbons in soils. Environ. 
Pollut. 196, 47–52. doi:10.1016/j.envpol.2014.09.016 
Li, C., Sun, H., Juhasz, A.L., Cui, X., Ma, L.Q., 2016. Predicting the Relative Bioavailability 
of DDT and Its Metabolites in Historically Contaminated Soils Using a Tenax-
Improved Physiologically Based Extraction Test (TI-PBET). Environ. Sci. Technol. 
50, 1118–1125. doi:10.1021/acs.est.5b03891 
Li, S.-W., Li, H.-B., Luo, J., Li, H.-M., Qian, X., Liu, M.-M., Bi, J., Cui, X.-Y., Ma, L.Q., 
2016. Influence of pollution control on lead inhalation bioaccessibility in PM2.5: A 
case study of 2014 Youth Olympic Games in Nanjing. Environ. Int. 94, 69–75. 
doi:10.1016/j.envint.2016.05.010 
Lindström, M., Falk, R., Hjelte, L., Philipson, K., Svartengren, M., 2006. Long-term 
clearance from small airways in subjects with ciliary dysfunction. Respir. Res. 7, 79. 
doi:10.1186/1465-9921-7-79 
Liu, L.-Y., He, K., Hites, R.A., Salamova, A., 2016. Hair and Nails as Noninvasive 
Biomarkers of Human Exposure to Brominated and Organophosphate Flame 
Retardants. Environ. Sci. Technol. 50, 3065–3073. doi:10.1021/acs.est.5b05073 
163 
 
Ljung K., O. Selinus, E. Otabbong & M. Berglund. 2006. Metal and arsenic distribution in 
soil particle sizes relevant to soil ingestion by children. Applied Geochemistry, 21, 
1613-1624. 
Lopez, P., Brandsma, S.A., Leonards, P.E.G., de Boer, J., 2011. Optimization and 
development of analytical methods for the determination of new brominated flame 
retardants and polybrominated diphenyl ethers in sediments and suspended particulate 
matter. Anal. Bioanal. Chem. 400, 871–883. doi:10.1007/s00216-011-4807-8 
Luongo, G., Östman, C., 2016. Organophosphate and phthalate esters in settled dust from 
apartment buildings in Stockholm. Indoor Air 26, 414–425. doi:10.1111/ina.12217 
Marklund, A., Andersson, B., Haglund, P., 2003. Screening of organophosphorus compounds 
and their distribution in various indoor environments. Chemosphere 53, 1137–1146. 
doi:10.1016/S0045-6535(03)00666-0 
Marques, M.R., Loebenberg, R., Almukainzi, M., 2011. Simulated biological fluids with 
possible application in dissolution testing. Dissolution Technol 18, 15–28. 
doi:dx.doi.org/10.14227/DT180311P15 
Matsukami, H., Suzuki, G., Takigami, H., 2015. Compositional Analysis of Commercial 
Oligomeric Organophosphorus Flame Retardants Used as Alternatives for PBDEs: 
Concentrations and Potential Environmental Emissions of Oligomers and Impurities. 
Environ. Sci. Technol. 49, 12913–12921. doi:10.1021/acs.est.5b03447 
Matsumoto, M., Hirata-Koizumi, M., Ema, M., 2008. Potential adverse effects of phthalic 
acid esters on human health: A review of recent studies on reproduction. Regul. 
Toxicol. Pharmacol. 50, 37–49. doi:10.1016/j.yrtph.2007.09.004 
Mayer, P., Hilber, I., Gouliarmou, V., Hale, S.E., Cornelissen, G., Bucheli, T.D., 2016. How 
to Determine the Environmental Exposure of PAHs Originating from Biochar. 
Environ. Sci. Technol. doi:10.1021/acs.est.5b05603 
Meeker, J.D., Stapleton, H.M., 2010. House Dust Concentrations of Organophosphate Flame 
Retardants in Relation to Hormone Levels and Semen Quality Parameters. Environ. 
Health Perspect. 118, 318–323. doi:10.1289/ehp.0901332 
Mendell, M.J., 2007. Indoor residential chemical emissions as risk factors for respiratory and 
allergic effects in children: a review. Indoor Air 17, 259–277. doi:10.1111/j.1600-
0668.2007.00478.x 
Mihajlović, I., 2015. Recent Development of Phosphorus Flame Retardants in Thermoplastic 
Blends and Nanocomposites, in: Visakh, P.M., Arao, Y. (Eds.), Flame Retardants, 
Engineering Materials. Springer International Publishing, pp. 79–114. 
164 
 
Moya, J., Bearer, C.F., Etzel, R.A., 2004. Children’s Behavior and Physiology and How It 
Affects Exposure to Environmental Contaminants. Pediatrics 113, 996–1006. 
Newton, S., Sellström, U., de Wit, C.A., 2015. Emerging Flame Retardants, PBDEs, and 
HBCDDs in indoor and outdoor media in Stockholm, Sweden. Environ. Sci. Technol. 
doi:10.1021/es505946e 
Nerc & Dtz. 2009. Bioaccessibility Testing of Contaminated Land for Threats to Human 
Health Background to Bioaccessibility. pp. 1-11. 
Oberdorster, G., 1995. Lung Particle Overload: Implications for Occupational Exposures to 
Particles. Regul. Toxicol. Pharmacol. 21, 123–135. doi:10.1006/rtph.1995.1017 
OECD. 2013. OECD Guidelines for the Testing of Chemicals - Section 5 - Other Test 





Oie, L., Hersoug, L.G., Madsen, J.O., 1997. Residential exposure to plasticizers and its 
possible role in the pathogenesis of asthma. Environ. Health Perspect. 105, 972–978. 
Oomen A.G., A. Hack, M. Minekus, E. Zeijdner, C. Cornelis, G. Schoeters, W. Verstraete, T. 
Van de Wiele, J. Wragg, C.J.M. Rompelberg, A. Sips & J.H. Van Wijnen. 2002. 
Comparison of five in vitro digestion models to study the bioaccessibility of soil 
contaminants. Environmental Science & Technology, 36, 3326-3334. 
Oomen A.G., A.J.A.M. Sips, J.P. Groten, D.T.H.M. Sijm & J. Tolls. 2000. Mobilization of 
PCBs and Lindane from Soil during in Vitro Digestion and Their Distribution among 
Bile Salt Micelles and Proteins of Human Digestive Fluid and the Soil. Environmental 
Science & Technology, 34, 297-303. 
Oomen, A.G., Rompelberg, C.J.M., Bruil, M.A., Dobbe, C.J.G., Pereboom, D.P.K.H., Sips, 
A.J. a. M., 2003. Development of an In Vitro Digestion Model for Estimating the 
Bioaccessibility of Soil Contaminants. Arch. Environ. Contam. Toxicol. 44, 0281–
0287. doi:10.1007/s00244-002-1278-0 
Oomen, A.G., Sips, A.J.A.M., Groten, J.P., Sijm, D.T.H.M., Tolls, J., 2000. Mobilization of 
PCBs and Lindane from Soil during in Vitro Digestion and Their Distribution among 
Bile Salt Micelles and Proteins of Human Digestive Fluid and the Soil. Environ. Sci. 
Technol. 34, 297–303. doi:10.1021/es990446j 
Ortega-Calvo, J.-J., Harmsen, J., Parsons, J.R., Semple, K.T., Aitken, M.D., Ajao, C., 
Eadsforth, C., Galay-Burgos, M., Naidu, R., Oliver, R., Peijnenburg, W.J.G.M., 
Römbke, J., Streck, G., Versonnen, B., 2015. From Bioavailability Science to 
165 
 
Regulation of Organic Chemicals. Environ. Sci. Technol. 49, 10255–10264. 
doi:10.1021/acs.est.5b02412 
Papadopoulou, E., Padilla-Sanchez, J.A., Collins, C.D., Cousins, I.T., Covaci, A., de Wit, 
C.A., Leonards, P.E.G., Voorspoels, S., Thomsen, C., Harrad, S., Haug, L.S., 2016. 
Sampling strategy for estimating human exposure pathways to consumer chemicals. 
Emerg. Contam. doi:10.1016/j.emcon.2015.12.002 
Patisaul, H.B., Roberts, S.C., Mabrey, N., McCaffrey, K.A., Gear, R.B., Braun, J., Belcher, 
S.M., Stapleton, H.M., 2013. Accumulation and Endocrine Disrupting Effects of the 
Flame Retardant Mixture Firemaster® 550 in Rats: An Exploratory Assessment. J. 
Biochem. Mol. Toxicol. 27, 124–136. doi:10.1002/jbt.21439 
Pelkonen, O., Boobis, A.R., Gundert-Remy, U., 2001. In vitro prediction of gastrointestinal 
absorption and bioavailability: an experts’ meeting report. Eur. J. Clin. Pharmacol. 57, 
621–629. doi:10.1007/s002280100369 
Pillai, H.K., Fang, M., Beglov, D., Kozakov, D., Vajda, S., Stapleton, H.M., Webster, T.F., 
Schlezinger, J.J., 2014. Ligand binding and activation of PPARγ by Firemaster® 550: 
effects on adipogenesis and osteogenesis in vitro. Environ. Health Perspect. 122, 
1225–1232. doi:10.1289/ehp.1408111 
Pollard, P.C., 1987. Dialysis: a simple method of separating labelled bacterial DNA and 
tritiated thymidine from aquatic sediments. J. Microbiol. Methods 7, 91–101. 
doi:10.1016/0167-7012(87)90029-7 
Quintana, J.B., Rosende, M., Montes, R., Rodríguez-Álvarez, T., Rodil, R., Cela, R., Miró, 
M., 2017. In-vitro estimation of bioaccessibility of chlorinated organophosphate 
flame retardants in indoor dust by fasting and fed physiologically relevant extraction 
tests. Sci. Total Environ. 580, 540–549. doi:10.1016/j.scitotenv.2016.11.210 
Quiros-Alcala L., A. Bradman, K. Smith, G. Weerasekera, M. Odetokun, D.B. Barr, M. 
Nishioka, R. Castorina, A.E. Hubbard, M. Nicas, S.K. Hammond, T.E. McKone & B. 
Eskenazi. 2012. Organophosphorous pesticide breakdown products in house dust and 
children's urine. J Expos Sci Environ Epidemiol, 22, 559-568. 
Raffensperger, C., Tickner, J., 1999. Protecting Public Health and the Environment; 
Implementing The Precautionary Principle. 
Reichenberg, F., Mayer, P., 2006. Two complementary sides of bioavailability: Accessibility 
and chemical activity of organic contaminants in sediments and soils. Environ. 
Toxicol. Chem. 25, 1239–1245. doi:10.1897/05-458R.1 
Robinson, E.C., Hammond, B.G., Johannsen, F.R., Levinskas, G.J., Rodwell, D.E., 1986. 
Teratogenicity studies of alkylaryl phosphate ester plasticizers in rats. Fundam. Appl. 
Toxicol. Off. J. Soc. Toxicol. 7, 138–143. 
166 
 
Rodríguez-Navas, C., Rosende, M., Miró, M., 2017. In-vitro physiologically based extraction 
of solid materials: Do we have reliable analytical methods for bioaccessibility studies 
of emerging organic contaminants? TrAC Trends Anal. Chem. 91, 42–52. 
doi:10.1016/j.trac.2017.03.005 
Roos, A., Hugosson, M., 2008. Consumer preferences for wooden and laminate flooring. 
Wood Mater. Sci. Eng. 3, 29–37. doi:10.1080/17480270802573586 
Roosens L., M.A.-E. Abdallah, S. Harrad, H. Neels & A. Covaci. 2009. Exposure to 
Hexabromocyclododecanes (HBCDs) via Dust Ingestion, but Not Diet, Correlates with 
Concentrations in Human Serum: Preliminary Results. Environmental Health 
Perspectives, 117, 1707-1712. 
Rosner, D., Markowitz, G., 2002. Industry challenges to the principle of prevention in public 
health: the precautionary principle in historical perspective. Public Health Rep. 117, 
501–512. 
Rostami I. & A.L. Juhasz. 2011. Assessment of Persistent Organic Pollutant (POP) 
Bioavailability and Bioaccessibility for Human Health Exposure Assessment: A Critical 
Review. Critical Reviews in Environmental Science and Technology, 41, 623-656. 
Ruby M.V. & Y.W. Lowney. 2012. Selective Soil Particle Adherence to Hands: Implications 
for Understanding Oral Exposure to Soil Contaminants. Environmental Science & 
Technology, 46, 12759-12771. 
Ruby M.V., A. Davis, R. Schoof, S. Eberle & C.M. Sellstone. 1996. Estimation of lead and 
arsenic bioavailability using a physiologically based extraction test. Environmental 
Science & Technology, 30, 422-430. 
Ruby, M.V., Davis, A., Schoof, R., Eberle, S., Sellstone, C.M., 1996. Estimation of Lead and 
Arsenic Bioavailability Using a Physiologically Based Extraction Test. Environ. Sci. 
Technol. 30, 422–430. doi:10.1021/es950057z 
Ruby, M.V., Fehling, K.A., Paustenbach, D.J., Landenberger, B.D., Holsapple, M.P., 2002. 
Oral Bioaccessibility of Dioxins/Furans at Low Concentrations (50−350 ppt Toxicity 
Equivalent) in Soil. Environ. Sci. Technol. 36, 4905–4911. doi:10.1021/es020636l 
Rudel R.A., D.E. Camann, J.D. Spengler, L.R. Korn & J.G. Brody. 2003. Phthalates, 
Alkylphenols, Pesticides, Polybrominated Diphenyl Ethers, and Other Endocrine-
Disrupting Compounds in Indoor Air and Dust. Environmental Science & Technology, 
37, 4543-4553. 
Rudel, R.A., Camann, D.E., Spengler, J.D., Korn, L.R., Brody, J.G., 2003. Phthalates, 
Alkylphenols, Pesticides, Polybrominated Diphenyl Ethers, and Other Endocrine-




Rudel, R.A., Perovich, L.J., 2009. Endocrine disrupting chemicals in indoor and outdoor air. 
Atmospheric Environ. Oxf. Engl. 1994 43, 170–181. 
doi:10.1016/j.atmosenv.2008.09.025 
Rutkowska, E., Pajak, K., Jóźwiak, K., 2013. Lipophilicity--methods of determination and its 
role in medicinal chemistry. Acta Pol. Pharm. 70, 3–18. 
Schaider, L.A., Senn, D.B., Brabander, D.J., McCarthy, K.D., Shine, J.P., 2007. 
Characterization of Zinc, Lead, and Cadmium in Mine Waste:  Implications for 
Transport, Exposure, and Bioavailability. Environ. Sci. Technol. 41, 4164–4171. 
doi:10.1021/es0626943 
SCHER, 2007. European Comission. Scientific Committee on Health and Environmental 
Risks Opinion on risk assessment on indoor air quality [WWW Document]. URL 
http://ec.europa.eu/health/ph_risk/committees/04_scher/docs/scher_o_055.pdf 
(accessed 9.14.16). 
Schreder, E.D., Uding, N., La Guardia, M.J., 2016. Inhalation a significant exposure route for 
chlorinated organophosphate flame retardants. Chemosphere 150, 499–504. 
doi:10.1016/j.chemosphere.2015.11.084 
Scott W.C. & J.R. Dean. 2005. An assessment of the bioavailability of persistent organic 
pollutants from contaminated soil. Journal of Environmental Monitoring, 7, 710-715. 
Semple, K.T., Doick, K.J., Jones, K.C., Burauel, P., Craven, A., Harms, H., 2004. Defining 
Bioavailability and Bioaccessibility of Contaminated Soil and Sediment is 
Complicated. Environ. Sci. Technol. 38, 228A–231A. doi:10.1021/es040548w 
Shalat S.L., K.C. Donnelly, N.C.G. Freeman, J.A. Calvin, S. Ramesh, M. Jimenez, K. Black, 
C. Coutinho, L.L. Needham, D.B. Barr & J. Ramirez. 2003. Nondietary ingestion of 
pesticides by children in an agricultural community on the US/Mexico border: 
Preliminary results. Journal of Exposure Science and Environmental Epidemiology, 
13, 42-50. 
Siciliano S.D., B.D. Laird & C.L. Lemieux. 2010. Polycyclic aromatic hydrocarbons are 
enriched but bioaccessibility reduced in brownfield soils adhered to human hands. 
Chemosphere, 80, 1101-1108. 
Sjodin A, O. Papke, E. McGahee, J.F. Focant, R.S. Jones, T. Pless-Mulloli, L.M. Toms, T. 
Herrmann, J. Muller, L.L. Needham & D.G. Patterson, Jr. 2008. Concentration of 
polybrominated diphenyl ethers (PBDEs) in household dust from various countries. 
Chemosphere, 73, S131-136. 
Sjödin, A., Hagmar, L., Klasson-Wehler, E., Kronholm-Diab, K., Jakobsson, E., Bergman, 
A., 1999. Flame retardant exposure: polybrominated diphenyl ethers in blood from 
Swedish workers. Environ. Health Perspect. 107, 643–648. 
168 
 
Smith E., J. Weber, A. Rofe, D. Gancarz, R. Naidu & A.L. Juhasz. 2012. Assessment of DDT 
Relative Bioavailability and Bioaccessibility in Historically Contaminated Soils Using 
an in Vivo Mouse Model and Fed and Unfed Batch in Vitro Assays. Environmental 
Science & Technology, 46, 2928-2934. 
Sokal, R.R., Rohlf, F.J., 1995. Analysis of frequencies. Biometry Princ. Pract. Stat. Biol. Res. 
685–793. 
Sokal, R.R., Rohlf, F.J., 1995. Biometry: the principles and practices of statistics in biological 
research, 3rd edn.,(WH Freeman: New York). 
Stanek E.J.C.E.J.. 2000. Daily Soil Ingestion Estimates for Children at a Superfund Site. Risk 
Analysis: An International Journal., 20. 
Stapleton H.M., S. Eagle, A. Sjödin & T.F. Webster. 2012. Serum PBDEs in a North 
Carolina Toddler Cohort: Associations with Handwipes, House Dust, and 
Socioeconomic Variables. Environmental Health Perspectives, 120, 1049-1054. 
Stapleton, H.M., Allen, J.G., Kelly, S.M., Konstantinov, A., Klosterhaus, S., Watkins, D., 
McClean, M.D., Webster, T.F., 2008. Alternate and New Brominated Flame 
Retardants Detected in U.S. House Dust. Environ. Sci. Technol. 42, 6910–6916. 
doi:10.1021/es801070p 
Stapleton, H.M., Eagle, S., Sjödin, A., Webster, T.F., 2012. Serum PBDEs in a North 
Carolina Toddler Cohort: Associations with Handwipes, House Dust, and 
Socioeconomic Variables. Environ. Health Perspect. 120, 1049–1054. 
doi:10.1289/ehp.1104802 
Stapleton, H.M., Klosterhaus, S., Eagle, S., Fuh, J., Meeker, J.D., Blum, A., Webster, T.F., 
2009. Detection of Organophosphate Flame Retardants in Furniture Foam and U.S. 
House Dust. Environ. Sci. Technol. 43, 7490–7495. doi:10.1021/es9014019 
Stapleton, H.M., Klosterhaus, S., Keller, A., Ferguson, P.L., van Bergen, S., Cooper, E., 
Webster, T.F., Blum, A., 2011. Identification of Flame Retardants in Polyurethane 
Foam Collected from Baby Products. Environ. Sci. Technol. 45, 5323–5331. 
doi:10.1021/es2007462 
State of Washington, 2016. House Bill 2545 [WWW Document]. Wash. State Legis. URL 
http://app.leg.wa.gov/billinfo/summary.aspx?year=2015&bill=2545 (accessed 7.7.16). 
Stockholm Convention, 2009a. UNEP/POPS/POPRC.4/14 Listing of hexabromodiphenyl 
ether and heptabromodiphenyl ether. 
Stockholm Convention, 2009b. UNEP/POPS/POPRC.4/18 Listing of tetrabromodiphenyl 
ether and pentabromodiphenyl ether. 
169 
 
Suzuki, G., Tue, N.M., Malarvannan, G., Sudaryanto, A., Takahashi, S., Tanabe, S., Sakai, 
S., Brouwer, A., Uramaru, N., Kitamura, S., Takigami, H., 2013. Similarities in the 
Endocrine-Disrupting Potencies of Indoor Dust and Flame Retardants by Using 
Human Osteosarcoma (U2OS) Cell-Based Reporter Gene Assays. Environ. Sci. 
Technol. 47, 2898–2908. doi:10.1021/es304691a 
Tajima, S., Araki, A., Kawai, T., Tsuboi, T., Ait Bamai, Y., Yoshioka, E., Kanazawa, A., 
Cong, S., Kishi, R., 2014. Detection and intake assessment of organophosphate flame 
retardants in house dust in Japanese dwellings. Sci. Total Environ. 478, 190–199. 
doi:10.1016/j.scitotenv.2013.12.121 
Tao S., Y. Lu, D.Y. Zhang, Y.F. Yang, Y. Yang, X.X. Lu & D.J. Sai. 2009. Assessment of 
Oral Bioaccessibility of Organochlorine Pesticides in Soil Using an In Vitro 
Gastrointestinal Model. Environmental Science & Technology, 43, 4524-4529. 
Tao, F., Abdallah, M.A.-E., Harrad, S., 2016. Emerging and Legacy Flame Retardants in UK 
Indoor Air and Dust: Evidence for Replacement of PBDEs by Emerging Flame 
Retardants? Environ. Sci. Technol. doi:10.1021/acs.est.6b02816 
Tilston, E.L., Gibson, G.R., Collins, C.D., 2011. Colon Extended Physiologically Based 
Extraction Test (CE-PBET) Increases Bioaccessibility of Soil-Bound PAH. Environ. 
Sci. Technol. 45, 5301–5308. doi:10.1021/es2004705 
Tirelli, V., Catone, T., Turco, L., Di Consiglio, E., Testai, E., De Angelis, I., 2007. Effects of 
the pesticide clorpyrifos on an in vitro model of intestinal barrier. Toxicol. In Vitro, In 
Vitro Cytotoxicity Mechanisms. Proceedings of the 46th ETCS International Meeting 
and the 3rd International Joint Meeting of AICC and CELLTOX 21, 308–313. 
doi:10.1016/j.tiv.2006.08.015 
Uemura H., K. Arisawa, M. Hiyoshi, S. Dakeshita, A. Kitayama, H. Takami, F. Sawachika, 
M. Yamaguchi & S. Sasai. 2010. Congener-specific body burden levels and possible 
determinants of polybrominated diphenyl ethers in the general Japanese population. 
Chemosphere, 79, 706-712. 
UK Department for Business, Energy & Industrial Strategy, 2016. Consultations on furniture 
and furnishings fire safety regulations: proposed changes [WWW Document]. URL 
https://www.gov.uk/government/consultations/furniture-and-furnishing-fire-safety-
regulations-proposed-changes-2016 (accessed 9.14.16). 
UK Environment Agency, 2009a. An overview of the environmental risk evaluation reports 
for aryl phosphate esters [WWW Document]. URL 
https://www.gov.uk/government/publications/an-overview-of-the-environmental-risk-
evaluation-reports-for-aryl-phosphate-esters (accessed 7.10.16). 
170 
 
UK Environment Agency, 2009b. Environmental risk evaluation report: Isodecyl diphenyl 
phosphate (iDPP) CAS no. 29761-21-5 [WWW Document]. URL 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/290853
/scho0809bquf-e-e.pdf 
UK Environment Agency, 2009c. Environmental risk evaluation report: 2-Ethylhexyl 
diphenyl phosphate (EHDPHP) (CAS no. 1241-94-7) [WWW Document]. URL 
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/290842
/scho0809bqty-e-e.pdf 
UK Environmental Agency. 2005. International workshop on the potential use of 
bioaccessibility testing in risk assessment of land contamination. In: Science Report 
SC040054, Environment Agency, Rio House, Waterside Drive, Aztec West, 
Almondsbury, Bristol, BS32 4UD. 
US EPA, 2010. An Exposure Assessment of Polybrominated Diphenyl Ethers (PBDE) (Final) 
(Reports & Assessments No. EPA/600/R-08/086F). 
US EPA, 2012. US EPA Phthalates Action Plan under Toxic Substances Control Act [WWW 
Document]. URL https://www.epa.gov/sites/production/files/2015-
09/documents/phthalates_actionplan_revised_2012-03-14.pdf (accessed 2.21.17). 
USDA. 2012. United States Departent of Agriculture National Agricultural Library - Nutrient 
Data Laboratory. http://ndb.nal.usda.gov/ndb/foods/list [Accessed 01/05/2012]. 




31 (accessed 4.1.15). 
USEPA. 2008. Standard Operating Procedure for an In Vitro Bioaccessibility Assay for Lead 
in Soil. EPA 9200.1-86. 
Van de Wiele, T., Vanhaecke, L., Boeckaert, C., Peru, K., Headley, J., Verstraete, W., 
Siciliano, S., 2005. Human Colon Microbiota Transform Polycyclic Aromatic 
Hydrocarbons to Estrogenic Metabolites. Environ. Health Perspect. 113, 6–10. 
doi:10.1289/ehp.7259 
Van de Wiele, T.R., Verstraete, W., Siciliano, S.D., 2004. Polycyclic aromatic hydrocarbon 
release from a soil matrix in the in vitro gastrointestinal tract. J. Environ. Qual. 33, 
1343–1353. 
Van den Eede, N., Dirtu, A.C., Ali, N., Neels, H., Covaci, A., 2012a. Multi-residue method 
for the determination of brominated and organophosphate flame retardants in indoor 
dust. Talanta 89, 292–300. doi:10.1016/j.talanta.2011.12.031 
171 
 
Van den Eede, N., Dirtu, A.C., Neels, H., Covaci, A., 2011. Analytical developments and 
preliminary assessment of human exposure to organophosphate flame retardants from 
indoor dust. Environ. Int. 37, 454–461. doi:10.1016/j.envint.2010.11.010 
van der Veen, I., de Boer, J., 2012a. Phosphorus flame retardants: Properties, production, 
environmental occurrence, toxicity and analysis. Chemosphere 88, 1119–1153. 
doi:10.1016/j.chemosphere.2012.03.067 
Venier, M., Audy, O., Vojta, Š., Bečanová, J., Romanak, K., Melymuk, L., Krátká, M., 
Kukučka, P., Okeme, J., Saini, A., Diamond, M.L., Klánová, J., 2016. Brominated 
flame retardants in the indoor environment — Comparative study of indoor 
contamination from three countries. Environ. Int. 94, 150–160. 
doi:10.1016/j.envint.2016.04.029 
Wang H.-S, Y.-G. Zhao, Y.-B. Man, C.K.C. Wong & M.-H. Wong. 2011a. Oral 
bioaccessibility and human risk assessment of organochlorine pesticides (OCPs) via 
fish consumption, using an in vitro gastrointestinal model. Food Chemistry, 127, 
1673-1679. 
Wang H.-S., Y.-B. Man, F.-Y. Wu, Y.-G. Zhao, C.K.C. Wong & M.-H. Wong. 2010. Oral 
Bioaccessibility of Polycyclic Aromatic Hydrocarbons (PAHs) through Fish 
Consumption, Based on an in Vitro Digestion Model. Journal of Agricultural and 
Food Chemistry, 58, 11517-11524. 
Wang H.-S., Z.-J. Chen, W. Wei, Y.-B. Man, J.P. Giesy, J. Du, G. Zhang, C.K.-C. Wong & 
M.-H. Wong. 2013a. Concentrations of organochlorine pesticides (OCPs) in human 
blood plasma from Hong Kong: Markers of exposure and sources from fish. 
Environment International, 54, 18-25. 
Wang P. & A.A. Keller. 2008. Particle-Size Dependent Sorption and Desorption of Pesticides 
within a Water−Soil−Nonionic Surfactant System. Environmental Science & 
Technology, 42, 3381-3387. 
Wang W., F.-Y. Wu, M.-J. Huang, Y. Kang, K.C. Cheung & M.H. Wong. 2013d. Size 
fraction effect on phthalate esters accumulation, bioaccessibility and in vitro 
cytotoxicity of indoor/outdoor dust, and risk assessment of human exposure. Journal 
of Hazardous Materials, 261, 753-762. 
Wang W., M.-J. Huang, F.-Y. Wu, Y. Kang, H.-S. Wang, K.C. Cheung & M.H. Wong. 
2013b. Risk assessment of bioaccessible organochlorine pesticides exposure via 
indoor and outdoor dust. Atmospheric Environment, 77, 525-533. 
Wang W., M.-J. Huang, J.-S. Zheng, K.C. Cheung & M.H. Wong. 2013c. Exposure 
assessment and distribution of polychlorinated biphenyls (PCBs) contained in indoor 
172 
 
and outdoor dusts and the impacts of particle size and bioaccessibility. Science of the 
Total Environment, 463–464, 1201-1209. 
Wang Z., J. Zhao, L. Song, H. Mashayekhi, B. Chefetz & B. Xing. 2011b. Adsorption and 
Desorption of Phenanthrene on Carbon Nanotubes in Simulated Gastrointestinal 
Fluids. Environmental Science & Technology, 45, 6018-6024. 
Wang, J., Tian, M., Chen, S.-J., Zheng, J., Luo, X.-J., An, T.-C., Mai, B.-X., 2011. 
Dechlorane Plus in house dust from E-waste recycling and urban areas in South 
China: Sources, degradation, and human exposure. Environ. Toxicol. Chem. 30, 
1965–1972. doi:10.1002/etc.587 
Wang, W., Wu, F.-Y., Huang, M.-J., Kang, Y., Cheung, K.C., Wong, M.H., 2013. Size 
fraction effect on phthalate esters accumulation, bioaccessibility and in vitro 
cytotoxicity of indoor/outdoor dust, and risk assessment of human exposure. J. 
Hazard. Mater. 261, 753–762. doi:10.1016/j.jhazmat.2013.04.039 
Watanabe I. & S. Sakai. 2003. Environmental release and behavior of brominated flame 
retardants. Environ Int, 29, 665 - 682. 
Webster L., M. Russell, P. Walsham, L.A. Phillips, I. Hussy, G. Packer, E.J. Dalgarno & C.F. 
Moffat. 2011. An assessment of persistent organic pollutants in Scottish coastal and 
offshore marine environments. Journal of Environmental Monitoring, 13, 1288-1307. 
Weschler, C.J., Bekö, G., Koch, H.M., Salthammer, T., Schripp, T., Toftum, J., Clausen, G., 
2015. Transdermal Uptake of Diethyl Phthalate and Di(n-butyl) Phthalate Directly 
from Air: Experimental Verification. Environ. Health Perspect. 123. 
doi:10.1289/ehp.1409151 
Weschler, C.J., Salthammer, T., Fromme, H., 2008. Partitioning of phthalates among the gas 
phase, airborne particles and settled dust in indoor environments. Atmos. Environ. 42, 
1449–1460. doi:10.1016/j.atmosenv.2007.11.014 
Whitehead T.P., F.R. Brown, C. Metayer, J.-S. Park, M. Does, M.X. Petreas, P.A. Buffler & 
S.M. Rappaport. 2013. Polybrominated diphenyl ethers in residential dust: Sources of 
variability. Environment International, 57–58, 11-24. 
Wilkes, C.E., Summers, J.W., Daniels, C.A., Berard, Mark, T., 2005. PVC Handbook. Hanser 
Gardner Pubns. 
Wong M.H., A.O. Leung, J.K. Chan & M.P. Choi. 2005. A review on the usage of POP 
pesticides in China, with emphasis on DDT loadings in human milk. Chemosphere, 
60, 740-752. 
Wong, L.I.L., Reers, A.R., Currier, H.A., Williams, T.D., Cox, M.E., Elliott, J.E., Beischlag, 
T.V., 2015. The Effects of the Organic Flame-Retardant 1,2-Dibromo-4-(1,2-
173 
 
dibromoethyl) Cyclohexane (TBECH) on Androgen Signaling in Human Prostate 
Cancer Cell Lines. J. Biochem. Mol. Toxicol. n/a-n/a. doi:10.1002/jbt.21784 
Woolgar, P.J., Jones, K.C., 1999. Studies on the Dissolution of Polycyclic Aromatic 
Hydrocarbons from Contaminated Materials Using a Novel Dialysis Tubing 
Experimental Method. Environ. Sci. Technol. 33, 2118–2126. doi:10.1021/es980638z 
Wormuth, M., Scheringer, M., Vollenweider, M., Hungerbühler, K., 2006. What Are the 
Sources of Exposure to Eight Frequently Used Phthalic Acid Esters in Europeans? 
Risk Anal. 26, 803–824. doi:10.1111/j.1539-6924.2006.00770.x 
Wragg, J., Klinck, B., 2007. The bioaccessibility of lead from Welsh mine waste using a 
respiratory uptake test. J. Environ. Sci. Health Part A 42, 1223–1231. 
doi:10.1080/10934520701436054 
Xing G.H., Y. Yang, J.K.Y. Chan, S. Tao & M.H. Wong. 2008. Bioaccessibility of 
polychlorinated biphenyls in different foods using an in vitro digestion method. 
Environmental Pollution, 156, 1218-1226. 
Xu, F., Giovanoulis, G., Van Waes, S., Padilla Sanchez, J.A., Papadopoulou, E., Magnér, J., 
Haug, L.S., Neels, H., Covaci, A., 2016. A Comprehensive Study of Human External 
Exposure to Organophosphate Flame Retardants via Air, Dust and Hand wipes: the 
Importance of Sampling and Assessment Strategy. Environ. Sci. Technol. 
doi:10.1021/acs.est.6b00246 
Yu Y., D. Yang, X. Wang, N. Huang, X. Zhang, D. Zhang & J. Fu. 2013. Factors influencing 
on the bioaccessibility of polybrominated diphenyl ethers in size-specific dust from 
air conditioner filters. Chemosphere. 
Yu Y., S. Han, D. Zhang, T. Van de Wiele, M. Lu, D. Wang, Z. Yu, M. Wu, G. Sheng & J. 
Fu. 2009. Factors Affecting the Bioaccessibility of Polybrominated Diphenylethers in 
an in Vitro Digestion Model. Journal of Agricultural and Food Chemistry, 57, 133-
139. 
Yu, Y.-X., Pang, Y.-P., Li, C., Li, J.-L., Zhang, X.-Y., Yu, Z.-Q., Feng, J.-L., Wu, M.-H., 
Sheng, G.-Y., Fu, J.-M., 2012. Concentrations and seasonal variations of 
polybrominated diphenyl ethers (PBDEs) in in- and out-house dust and human daily 
intake via dust ingestion corrected with bioaccessibility of PBDEs. Environ. Int. 42, 
124–131. doi:10.1016/j.envint.2011.05.012 
Zander, J., 2010. The Application of the Precautionary Principle in Practice: Comparative 
Dimensions. Cambridge University Press. 
Zhang, J. (Jim), Smith, K.R., 2003. Indoor air pollution: a global health concern. Br. Med. 
Bull. 68, 209–225. doi:10.1093/bmb/ldg029 
174 
 
Zhang, Y., Pignatello, J.J., Tao, S., 2016. Bioaccessibility of nitro- and oxy-PAHs in fuel soot 
assessed by an in vitro digestive model with absorptive sink. Environ. Pollut. 218, 
901–908. doi:10.1016/j.envpol.2016.08.021 
Zhang, Y., Pignatello, J.J., Tao, S., Xing, B., 2015. Bioacessibility of PAHs in Fuel Soot 
Assessed by an in Vitro Digestive Model: Effect of Including an Absorptive Sink. 
Environ. Sci. Technol. 49, 3905–3912. doi:10.1021/es505898v 
Zheng, J., Luo, X.-J., Yuan, J.-G., Wang, J., Wang, Y.-T., Chen, S.-J., Mai, B.-X., Yang, Z.-
Y., 2011. Levels and sources of brominated flame retardants in human hair from 
urban, e-waste, and rural areas in South China. Environ. Pollut. 159, 3706–3713. 
doi:10.1016/j.envpol.2011.07.009 
Zheng, X., Xu, F., Chen, K., Zeng, Y., Luo, X., Chen, S., Mai, B., Covaci, A., 2015. Flame 
retardants and organochlorines in indoor dust from several e-waste recycling sites in 
South China: Composition variations and implications for human exposure. Environ. 
Int. 78, 1–7. doi:10.1016/j.envint.2015.02.006 
Zhu, J., Feng, Y.-L., Shoeib, M., 2007. Detection of dechlorane plus in residential indoor dust 











My PhD research is a part of an EU-funded Marie Curie 
Innovative Training Network (ITN) called “Advanced 
Tools For Exposure Assessment and Biomonitoring” 
(http://www.ateam-research.com/). Our main objectives 
are to develop analytical methods and human 
biomonitoring methods for assessing human exposure to 
emerging organic compounds such as halogenated flame 
retardants and phthalate esters present in everyday consumer products. 
Short Biography: 
Katerina Kademoglou was born in Serres, Greece on March 12, 1986. In 2009, she received a 
five-year Bachelor of Science degree in Biological Applications and Technology from the 
University of Ioannina in Greece. During that time, she conducted her BSc thesis on the 
feeding habits of Atherina boyeri in the lagoons of Nestos River in NE Greece under the 
guidance of prof. Ioannis Leonardos from the University of Ioannina and Dr. Manos 
Koutrakis, senior researcher at the National Fisheries Institute at Nea Peramos (Kavala) in 
Greece. In 2010, Katerina enrolled at Wageningen University in the Netherlands, following a 
two-year Master of Science degree in Environmental Sciences with specialisation in 
Environmental Toxicology. She conducted her Master Thesis on the “Effects of xenobiotics 
on Thyroid-stimulating hormone (TSH) synthesis and activity” at the department of 
Toxicology of Wageningen University under the leadership of Prof Ivonne Rietjens and the 
supervision of PhD candidate Barae Jomaa. In 2012, Katerina completed her MSc curriculum 
with an internship at the National Water Research Institute at Monza (Italy), performing algal 
toxicity tests assessing the trophic status of Lake Occhito (Italy) according to OECD and 
USEPA standard procedures. In 2013, she was awarded a Marie-Curie doctoral research 
fellowship within the EU-funded Innovative Training Network (ITN) named “Advanced 
Tools for Exposure Assessment and Biomonitoring” and was enrolled as a PhD student at the 
University of Reading in the UK, conducting her PhD research on the “In vitro 
bioaccessibility of emerging flame retardants (FRs) via air, dust and diet” under the guidance 
of Prof Chris D. Collins and Prof Adrian C. Williams. From 2013 until the completion of her 
177 
 
PhD thesis, Katerina has attended several national and international conferences presenting 
her PhD research.  
EDUCATION  
May 2013 – March 2017  PhD in Environmental Science 
Marie Curie Action - Innovative Training Network (ITN) “A-TEAM” 
Department of Geography and Environmental Sciences, University of Reading (UoR), 
Reading - UK 
PhD thesis: In vitro bioaccessibility of flame retardants (FRs) via air, dust and diet  
Human exposure assessment and uptake (i.e. bioaccessibility) of emerging flame retardants 
(FRs) via indoor dust using in vitro simulated human gut and lung fluids techniques    
PhD thesis Supervisor: Prof. Chris Collins (UoR) 
2010 – 2012:     MSc Environmental Sciences – Environmental 
toxicology  
Wageningen University and Research Centre (WUR), Wageningen - The Netherlands 
MSc thesis: Effects of xenobiotics on Thyroid-stimulating hormone (TSH) synthesis and 
activity 
Method development and validation of in vitro bioassays towards an in vitro screening 
strategy of potential thyroid-disrupting chemicals on established mammalian cell lines, MSc 
Thesis Grade: 7.5/10 
MSc thesis Supervisor: Prof. dr. ir. I.M.C.M. Rietjens (WUR) 
2003 - 2009:     5-year BSc degree in Biology (Grade: 6.68/10, Very 
Good) 
Department of Biological Applications and Technologies, University of Ioannina (UoI), 
Ioannina – Greece 
178 
 
BSc thesis title:  Feeding behaviour and intraspecific competition of Atherina boyeri (Risso, 
1810) in the Lagoons of Nestos River (Greece), BSc Thesis Grade: 9.5/10 
BSc thesis Supervisor: Prof. Ioannis Leonardos (UoI) 
HONOURS AND AWARDS 
February 2017   2016 Best Postgraduate Research Output 
Award for best PhD student publication in 2016 within the School of Archaeology, 
Geography and Environmental Science at the University of Reading for the paper “Legacy 
and alternative flame retardants in Norwegian and UK indoor environment: Implications of 
human exposure via dust ingestion”, (2016), Environment International, doi: 
10.1016/j.envint.2016.12.012 
April 2016    “Athena Swan Network” Silver Award  
Athena SWAN Charter is a scheme to recognise and share good practice on gender equality 
in science, technology, engineering, mathematics and medicine (STEMM) in UK higher 
education employment. During the preparation phase of Athena SWAN application, I was a 
postgraduate representative of the department of Geography and Environmental Science at 
the University of Reading to the departmental committee. I had a leading role in assessing 
and reporting qualitative and quantitative data on gender equality and well-being of PhD 
students at departmental level. 
September 2013  Dr. Emmanuel Lahaniatis fellowship for young scientists  
The 5,000 euro scholarship was awarded for young researcher scientific excellence by the 
scientific organising committee of the 17th International Symposium on Environmental 
Pollution and its Impact on Life in the Mediterranean Region (MESAEP) in Istanbul, Turkey 
May 2013     Marie Curie Doctoral Fellowship   
PhD research within the EU-sponsored (FP7) Marie Curie Innovative Training Network 
“Advanced Tools for Exposure Assessment and Biomonitoring (A-TEAM)” made up of eight 
partners across Europe including the University of Reading.  
179 
 
The aim of the ATEAM project was to assess prospective chemicals for exposure potential in 
humans with respect to biologically-relevant monitoring of external exposure. 
RESEARCH INTERESTS 
- Human exposure to emerging organic pollutants  
- Occurrence, fate and effects of emerging contaminants in the environment  
- Investigation of bioavailability and biological effects of environmental pollutants 
- Endocrine and thyroid disruption in humans and the wildlife 
